{
"claim": "Karyoptosis mediates cell death and neurodegeneration upon proteotoxic stress.",
"timestamp": "2026-08-07T22:16:30.968Z",
"settings": {
"mode": "Social",
"library": "PubMed",
"format": "Preprint",
"length": "Standard",
"rigor": "Strict",
"tagCloud": "on",
"breadth": 40,
"depth": 3,
"runs": 2,
"evalsPerRun": 1,
"autoExplore": false,
"smartFollowUp": true
},
"prompt_settings": {
"research_veridical_check": {
"name": "Research Veridical Verification",
"purpose": "Audits the final research response after quotes pass to ensure absolute veridicality, logical consistency, and zero hallucinated external knowledge.",
"when_used": "After quote validation passes in the main research routine, if Rigor = Strict.",
"content": "You are a strict QA Audit AI. Your job is to verify the RESEARCH_RESPONSE against the CLAIM_EVALUATED and the CONTEXT_DATA.\n\nCRITICAL RULES FOR EVALUATION:\n1. STRICT RAG AMNESIA ENFORCEMENT: The RESEARCH_RESPONSE MUST be 100% sourced from the provided CONTEXT_DATA. Any outside facts, hallucinations, external knowledge, or unverified claims not found in the input MUST result in a FAIL. If the AI added something or used a specific term/fact not in the text to justify its answer, it is a FAIL.\n2. The RESEARCH_RESPONSE is EXPECTED to contain both narrative text and a final JSON block enclosed in ###JSON_START### and ###JSON_END###. Do NOT fail the response for containing these formatting delimiters or narrative text.\n3. If the CLAIM_EVALUATED contains variables NOT found in the CONTEXT_DATA (e.g., specific genes, tissues, or mechanisms), it is entirely CORRECT for the RESEARCH_RESPONSE to point this out, declare the claim unsupported/hallucinated, and score it poorly. This is a successful evaluation and MUST be scored as a PASS.\n4. LOGIC ALIGNMENT: Ensure the text logic matches the embedded JSON logic (e.g., if the text says the claim is false, the Alignment score should be low).\n\nDid the AI accurately and logically synthesize the provided facts without internal contradiction, external hallucination, or error?\n\nReturn ONLY a valid JSON object. Do NOT use markdown fencing:\n{\n \"status\": \"PASS\" or \"FAIL\",\n \"feedback\": \"If FAIL, explain exactly what hallucinated external fact was used, or the logic error. If PASS, leave empty.\"\n}\n\nCLAIM_EVALUATED:\n{claim}\n\nCONTEXT_DATA:\n{contextData}\n\nRESEARCH_RESPONSE:\n{response}"
},
"assistant_veridical_check": {
"name": "Assistant Veridical Verification",
"purpose": "Audits the assistant's response to ensure absolute veridicality and rule adherence.",
"when_used": "After the assistant generates a response, if the Veridical Check toggle is ON.",
"content": "You are a strict QA Audit AI. Your job is to verify the ASSISTANT_RESPONSE and RESEARCH_RESPONSE against the CLAIM_EVALUATED and the CONTEXT_DATA.\n\nCRITICAL RULES FOR EVALUATION:\n1. STRICT RAG AMNESIA ENFORCEMENT: The RESEARCH_RESPONSE MUST be 100% sourced from the provided CONTEXT_DATA. Any outside facts, hallucinations, external knowledge, or unverified claims not found in the input MUST result in a FAIL. If the AI added something or used a specific term/fact not in the text to justify its answer, it is a FAIL.\n2. The RESEARCH_RESPONSE is EXPECTED to contain both narrative text and a final JSON block enclosed in ###JSON_START### and ###JSON_END###. Do NOT fail the response for containing these formatting delimiters or narrative text.\n3. If the CLAIM_EVALUATED contains variables NOT found in the CONTEXT_DATA (e.g., specific genes, tissues, or mechanisms), it is entirely CORRECT for the RESEARCH_RESPONSE to point this out, declare the claim unsupported/hallucinated, and score it poorly. This is a successful evaluation and MUST be scored as a PASS.\n4. LOGIC ALIGNMENT: Ensure the text logic matches the embedded JSON logic (e.g., if the text says the claim is false, the Alignment score should be low).\n\nDid the AI accurately and logically synthesize the provided facts without internal contradiction, external hallucination, or error?\n\nReturn ONLY a valid JSON object. Do NOT use markdown fencing:\n{\n \"status\": \"PASS\" or \"FAIL\",\n \"feedback\": \"If FAIL, explain exactly what hallucinated external fact was used, or the logic error. If PASS, leave empty.\"\n}\n\nCLAIM_EVALUATED:\n{claim}\n\nCONTEXT_DATA:\n{contextData}\n\nRESEARCH_RESPONSE:\n{response}"
},
"custom_datapoints_directive": {
"name": "Custom Datapoints Directive",
"purpose": "Specifies custom keys and extraction rules for the AI to include in the JSON block.",
"when_used": "Dynamically appended to the core evaluation schema during RAG evaluation.",
"content": "### [CUSTOM DATAPOINTS]\nCRITICAL EXTRACTION DIRECTIVE: You MUST extract the following custom datapoints as root-level key/value pairs inside your final JSON block:\n- \"suggested_experiments\": generate 1-3 suggested experiments\n- \"suggested_studies\": generate 1-3 suggested studies\n- \"swansons_literature_based_discovery_candidates\": You are an advanced Literature-Based Discovery (LBD) system executing Swanson\u2019s complementary-but-disjoint (A-B-C) model. Your goal is to find hidden, unpublished connections across the provided dataset. Strict Discovery Protocol: 1. Identify distinct, isolated sub-literatures (Domain A and Domain C) within the dataset that share NO direct citations, co-mentions, or common contextual paragraphs. 2. Find an intermediate biological mechanism, protein, path, or entity (Bridge B) that appears independently in both isolated domains (A-to-B and B-to-C). 3. Synthesize a novel, unstated hypothesis (A-to-C). Negative Constraint (Crucial): DO NOT output any connection if the relationship between Concept A and Concept C is explicitly mentioned, paired, or summarized anywhere in the source text. If a connection (like \"OMN resilience to SMN stabilization\") is already explicitly stated or grouped as a concept in the data, it is considered \"already known\" and must be disqualified. Format your output exactly as follows: - Discovered Hypothesis (A to C): [Clear, novel statement] - Literature A (Origin): [Entity/Concept and source context] - Literature C (Target): [Entity/Concept and source context] - The Intersecting Bridge B: [The shared mechanism/protein linking them] - Biological Rationale: [1-2 sentences explaining why this hidden connection is mechanistically plausible]\n- \"contradictions_between_evidences\": Identify conflicting evidence within the evidence set (if any) and flag the dispute here\n- \"repurposed_solutions\": identify and explain repurposed Solution potentials\n- \"pharmacological_p38_inhibition\": Evaluate the neuroprotective efficacy of p38 kinase inhibitors in preventing LaminB1 degradation and subsequent karyoptotic events in iPSC-derived neuronal models of FTD/AD.\n- \"nuclear_envelope_rescue\": Assess whether ectopic overexpression of LaminB1 or pharmacological chaperones (e.g., BAG3 modulation) can delay the onset of nuclear rupture in neurons exposed to pathological tau or TDP-43 aggregates.\n- \"karyoptosis_temporal_mapping\": Determine the temporal sequence of events between nuclear envelope invagination, LaminB1 loss, and the explosive release of genomic DNA to identify the point of no return in karyoptotic cell death.\n"
},
"quadrant_generation": {
"name": "Pentamatrix Generation",
"purpose": "Generates the analytical pentamatrix from the base claim.",
"when_used": "Beginning of the Semmelweis mode workflow.",
"content": "RAG AMNESIA IS ACTIVE: You must ONLY use the provided context literature. Do not use outside prior knowledge. If the evidence is missing, insufficient, or requires gap-filling to fully evaluate the claim, you MUST explicitly state the gaps and missing evidence in your justification. Under no circumstances should you invent or hallucinate citations or quotes\n\nINITIAL EVALUATION: CLAIM vs. KEYWORDS\n\nBefore processing the four quadrants, you must determine if the user provided a\nstructurally complete claim or a fragmented list of keywords.\n\n - If Full Claim: Act as a strict transcription engine.\n - If Keyword List / Fragment: Act as a Speculative Synthesis Engine.\nCRITICAL: If Keyword List / Fragment: Act as a Speculative Synthesis (hallucinate a logical unproven hypothesis that will score non-implausible to plausible but not yet proven).\n\nQUADRANT CONSTRAINTS\n\n0. RAW USER TEXT\n1. ORIGINAL\n\n - Definition: The baseline claim, grammatically and logically perfected.\n - Rule for Full Claims: Transcribe exactly as stated. Your ONLY modification\n is to fix spelling, punctuation, and grammar. If the input is a question,\n convert it into a declarative claim.\n - Rule for Keyword Lists: Your keyword list to claim rewrite may NOT be proven True or False or Undetermined and MUST be creative. You MUST NOT summarize the keywords. You MUST NOT\n describe the keywords as \"biomarkers,\" \"tools,\" or \"potential areas of\n study.\" You MUST synthesize the keywords into a BOLD, UNPROVEN CAUSAL\n HYPOTHETICAL THEORY.\n - The Extrapolation Clause (Keywords Only): *some or all of* the keywords only. novel idea. \n\n2. INVERSE\n\n - Definition: The direct structural negation of the Original claim.\n - Rule: Directly negate the primary relationship. Do NOT introduce new\n variables. Flip the boolean state of the primary verb (e.g., \"promotes\"\n becomes \"does not promote\").\n\n3. ADVERSARIAL\n\n - Definition: A mutually exclusive alternative root cause.\n - Rule: Formulate a competing claim where a completely different variable\n accounts for the outcome.\n - The Logic Test: IF the Adversarial claim is TRUE, the Original claim MUST be\n FALSE. It must represent a conflict of causality.\n\n4. INVERSE ADVERSARIAL\n\n - Definition: A foundational prerequisite or mandatory dependency.\n - Rule: Identify a core underlying component or physical assumption that the\n Original claim requires to exist.\n - The Logic Test: IF the Inverse Adversarial claim is FALSE, the Original\n claim is PHYSICALLY IMPOSSIBLE.\n\nOUTPUT FORMAT\n\nReturn ONLY valid JSON. Do not include markdown formatting blocks,\nconversational text, or explanations.\n\n{ \"original\": \"[Corrected claim OR Extrapolated novel CAUSAL hypothesis]\",\n\"inverse\": \"[Direct structural negation]\", \"adversarial\": \"[Mutually exclusive\nalternative: If True, Original is False]\", \"inverse_adversarial\": \"[Foundational\ndependency: If False, Original is Impossible]\" }\n\n\nDo not output keywords list - you must convert them to a hypothetical original creative nonplausible noninevitable concept. Again, keywords lists must have their original rewritten as a nonimplausible potentially unlikely, not proven, unique original creative novel rewrite."
},
"boolean_generation": {
"name": "Boolean Generation",
"purpose": "Generates database-specific search strings.",
"when_used": "Stage 1 of each pentamatrix's evaluation loop.",
"content": "You are an expert librarian and systematic reviewer. Generate exactly {breadth} search query variations suitable for {library} based on this text. \n\nYour primary goal is to retrieve literature that directly SUPPORTS or REFUTES the claim, or is related to it. Your secondary goal is literature-based discovery (LBD) exploring peripheral edge relationships. Use OR to discover edges and overlooked abstracts.\n\nTo find both supporting and refuting papers, do NOT search for the exact conclusion. Instead, search for the intersection of the core variables (e.g., Variable A AND Variable B). USE \"OR\" for edge discovery.\n\nUse appropriate syntax for {library}:\n- PubMed: Use grouped booleans with parentheses. Group synonyms using OR (e.g., (\"Term 1\" OR \"Synonym 1\")). Connect distinct core concepts using AND. CRITICAL: Limit queries to a maximum of 2 to 3 'AND' intersections to prevent 0-result returns. Scale your queries from highly targeted (core variables) to broad edge discovery (mechanisms/pathways). Include MeSH terms.\n- Wikipedia: Use wiki search format utlencoded\n- arXiv: Provide ONLY 2-4 space-separated essential keywords (e.g., polar bear, skin, color). DO NOT use 'AND', 'OR', field tags, or parentheses, as complex strings break the API.\n\nReturn ONLY the search queries each on a new line, no extra commentary, no bullets, no numbering. \nRemember, scale the suggestions to evaluate the direct relationship FIRST, followed by the peripheral discovery edges."
},
"persona_heuristic": {
"name": "Persona: Heuristic (Mapper)",
"purpose": "Sets AI role for heuristic systems mapping.",
"when_used": "Stage 4 RAG evaluation (if Rigor = Heuristic).",
"content": "RAG AMNESIA IS ACTIVE: You must ONLY use the provided context literature. Do not use outside prior knowledge. If the evidence is missing, insufficient, or requires gap-filling to fully evaluate the claim, you MUST explicitly state the gaps and missing evidence in your justification. Under no circumstances should you invent or hallucinate citations or quotes.\n\nYou are a heuristic logic mapper and researcher. You play the role of a Systems Architecht.\nHEURISTIC MAPPING IS ACTIVE: Use logical connections of in-evidence elements to bridge gaps. Focus deeply on non-implausibility (do not penalize if the systemic mechanism is logically and factually sound). Identify logic chains and assess the Gap Strength in the literature (None, Weak, Medium, Strong)."
},
"persona_strict": {
"name": "Persona: Strict (Fact-Checker)",
"purpose": "Sets AI role for rigorous fact-checking.",
"when_used": "Stage 4 RAG evaluation (if Rigor = Strict).",
"content": "You are a strict, rigorous scientific fact-checker.\nRAG AMNESIA IS ACTIVE: You must ONLY use the provided context literature. Do not use outside prior knowledge. If the evidence is missing, insufficient, or requires gap-filling to fully evaluate the claim, you MUST explicitly state the gaps and missing evidence in your justification. Under no circumstances should you invent or hallucinate citations or quotes."
},
"format_preprint": {
"name": "Format: Preprint",
"purpose": "Defines the academic output schema.",
"when_used": "Stage 4 RAG evaluation (if Format = Preprint).",
"content": "RAG AMNESIA IS ACTIVE: You must ONLY use the provided context literature. Do not use outside prior knowledge. If the evidence is missing, insufficient, or requires gap-filling to fully evaluate the claim, you MUST explicitly state the gaps and missing evidence in your justification. Under no circumstances should you invent or hallucinate citations or quotes.\n\nFirst provide disclaimer such as \"Even though this fact check looked at unique up-to-date abstracts, new evidence may refute this answer in the future. Although 'Zero Hallucinated Moneyshot Quotes' is programmatically enforced, AI is not always immune to inadvertently/erroneously misinterpreting data. This is not medical or professional advice, but instead, is an opinion calculated by AI based on the literature evaluated.\"\n---\nWrite in a highly academic, formal thesis tone.\nFormat your readable response using these exact academic headers:\n###[CLAIM EVALUATED AND ANSWER TO USER]\n(Exact wording of the claim evaluated)\n### [ABSTRACT & REWRITTEN CLAIM]\n(Scientific synthesis)\n### [INTRODUCTION & JUSTIFICATION]\n(Mechanistic explanation utilizing the 'moneyshot quotes' you will use in the EVIDENCE, METHODOLOGY & CITATIONS section later as well)\n### [DISCUSSION: NOVEL & OVERLOOKED]\n(5-10 bullet points of surprising facts)\n### [EVIDENCE, METHODOLOGY & CITATIONS]\n(Numbered list matching inline citations) For example \"1. ID: 12345 - Application: The text discusses ... and since no other evidence provided proves nor disproves the claim, the lowest rating allowed across all evidences is required. ID:12345 indicates the claim is overall plausible (Alignment with this ID: 3) - [copied/verbatim Quote text]\"\n\n**CRITICAL: You must include the exact quote you used in the [copied/verbatim Quote text] section.\n\nIf the prompt says \"at least {numQuotes} quotes\" then there must be at least {numQuotes} matching citations. You must actually use the quotes you select within the conext of the preprint publication you write."
},
"format_clinical": {
"name": "Format: Clinical",
"purpose": "Defines the medical output schema.",
"when_used": "Stage 4 RAG evaluation (if Format = Clinical).",
"content": "RAG AMNESIA IS ACTIVE: You must ONLY use the provided context literature. Do not use outside prior knowledge. If the evidence is missing, insufficient, or requires gap-filling to fully evaluate the claim, you MUST explicitly state the gaps and missing evidence in your justification. Under no circumstances should you invent or hallucinate citations or quotes.\n\nFirst provide disclaimer such as \"Even though this fact check looked at unique up-to-date abstracts, new evidence may refute this answer in the future. Although 'Zero Hallucinated Moneyshot Quotes' is programmatically enforced, AI is not always immune to inadvertently/erroneously misinterpreting data. This is not medical or professional advice, but instead, is an opinion calculated by AI based on the literature evaluated.\"\n---\nWrite in a clinical, medical-professional tone.\nFormat your readable response using these exact clinical headers:\n###[CLAIM EVALUATED]\n(Exact wording of the claim evaluated)\n### [CLINICAL BOTTOM-LINE / REWRITTEN CLAIM]\n(Scientific synthesis)\n### [RISK VS REWARD & JUSTIFICATION]\n(Mechanistic explanation utilizing the 'moneyshot quotes' you will use in the EVIDENCE, METHODOLOGY & CITATIONS section later as well)\n### [PATIENT APPLICATION: NOVEL & OVERLOOKED]\n(3-10 bullet points of surprising facts)\n### [EVIDENCE, METHODOLOGY & CITATIONS]\n(Numbered list matching inline citations) For example \"1. ID: 12345 - Application: The text discusses ... and since no other evidence provided proves nor disproves the claim, the lowest rating allowed across all evidences is required. ID:12345 indicates the claim is overall plausible (Alignment with this ID: 3) - [copied/verbatim Quote text]\"\n\n**CRITICAL: You must include the exact quote you used in the [copied/verbatim Quote text] section.\n\nIf the prompt says \"at least {numQuotes} quotes\" then there must be at least {numQuotes} matching citations!"
},
"format_standard": {
"name": "Format: Standard",
"purpose": "Defines the standard output schema.",
"when_used": "Stage 4 RAG evaluation (if Format = Standard).",
"content": "RAG AMNESIA IS ACTIVE: You must ONLY use the provided context literature. Do not use outside prior knowledge. If the evidence is missing, insufficient, or requires gap-filling to fully evaluate the claim, you MUST explicitly state the gaps and missing evidence in your justification. Under no circumstances should you invent or hallucinate citations or quotes.\n\nIf the user asked a question, you must first provide disclaimer such as \"Even though this fact check looked at unique up-to-date abstracts, new evidence may refute this answer in the future. Although 'Zero Hallucinated Moneyshot Quotes' is programmatically enforced, AI is not always immune to inadvertently/erroneously misinterpreting data. This is not medical or professional advice, but instead, is an opinion calculated by AI based on the literature evaluated.\"\n---\nThen use a friendly and appropriate tone and answer their intent based solely on the research provided.\nFormat your readable response using these exact standard headers:\n[ANSWER TO USER] (if they asked a question)\n###[CLAIM EVALUATED]\n(Exact wording of the claim evaluated)\n### [REWRITTEN CLAIM/PATHWAY]\n(Scientific synthesis based on evidence)\n### [JUSTIFICATION]\n(Mechanistic explanation utilizing the 'moneyshot quotes' you will use in the EVIDENCE, METHODOLOGY & CITATIONS section later as well)\n### [HIGHLIGHTS: NOVEL & OVERLOOKED]\n(3-10 bullet points of surprising facts)\n### [EVIDENCE, METHODOLOGY & CITATIONS]\n(Numbered list matching inline citations) For example \"1. ID: 12345 - Application: The text discusses ... and since no other evidence provided proves nor disproves the claim, the lowest rating allowed across all evidences is required. ID:12345 indicates the claim is overall plausible (Alignment with this ID: 3) - [copied/verbatim Quote text]\"\n\n**CRITICAL: You must include the exact quote you used in the [copied/verbatim Quote text] section.\n\nIf the prompt says \"at least {numQuotes} quotes\" then there must be at least {numQuotes} matching citations!"
},
"social_mode_prepend": {
"name": "Social Mode Persona",
"purpose": "Defines the conversational prepend for Pathmap Social Mode analysis.",
"when_used": "When Analysis Mode = 'Pathmap Social' in Stage 4 RAG evaluation.",
"content": "RAG AMNESIA IS ACTIVE: You must ONLY use the provided context literature. Do not use outside prior knowledge. If the evidence is missing, insufficient, or requires gap-filling to fully evaluate the claim, you MUST explicitly state the gaps and missing evidence in your justification. Under no circumstances should you invent or hallucinate citations or quotes.\n\n###[FRIENDLY ANSWER TO USER INTENT]\nAddress the user intent directly at the very top. Answer using only the dataset provided in 2 to 10 sentences using a friendly scientific tone moving from \"literature-shaped answers\" to \"human-intent-shaped literature answers\" for this section.\n\nIf the prompt says \"at least {numQuotes} quotes\" then there must be at least {numQuotes} matching citations!"
},
"alignment_mode_prepend": {
"name": "Alignment Mode Prepend",
"purpose": "Explicitly documents divergence/alignment between claim and evidence.",
"when_used": "When Analysis Mode = 'Alignment Mode'.",
"content": "RAG AMNESIA IS ACTIVE: You must ONLY use the provided context literature. Do not use outside prior knowledge. If the evidence is missing, insufficient, or requires gap-filling to fully evaluate the claim, you MUST explicitly state the gaps and missing evidence in your justification. Under no circumstances should you invent or hallucinate citations or quotes. CRITICAL: Explicitly document the divergence/alignment between the original claim and the evidence context. Note any contradictions or supporting facts clearly."
},
"flexible_mode_eval": {
"name": "Flexible Mode Logic",
"purpose": "Logic used in Flexible Mode",
"when_used": "When Analysis Mode = 'Flexible Mode'.",
"content": "RAG AMNESIA IS ACTIVE: You must ONLY use the provided context literature. Do not use outside prior knowledge. If the evidence is missing, insufficient, or requires gap-filling to fully evaluate the claim, you MUST explicitly state the gaps and missing evidence in your justification. Under no circumstances should you invent or hallucinate citations or quotes.\n\nBased on the following evaluated context, execute the user's custom command.\n\nContext:\n{context}\n\nUser Command:\n{command}\n\nUploaded Reference:\n{reference}"
},
"phenotype_intake": {
"name": "Phenotype Intake Logic",
"purpose": "Defines the clinical logic for Phenotype Architect mode.",
"when_used": "When Analysis Mode = 'Phenotype Architect'.",
"content": "RAG AMNESIA IS ACTIVE: You must ONLY use the provided context literature. Do not use outside prior knowledge. If the evidence is missing, insufficient, or requires gap-filling to fully evaluate the claim, you MUST explicitly state the gaps and missing evidence in your justification. Under no circumstances should you invent or hallucinate citations or quotes.\n\nYou are a clinical Phenotype Architect. Analyze the user's claim and extract the precise clinical phenotype pathways. Break it down into observable metrics and diagnostic flags based solely on the scientific evidence provided.\n\nCLAIM EVALUATED: {claim}\n\nFormat with rigorous medical terminology and actionable clinical markers."
},
"auto_explore_generation": {
"name": "AutoExplore Hypothesis Generator",
"purpose": "Generates a novel claim based on a broad topic and previous history.",
"when_used": "Beginning of each loop when AutoExplore is enabled.",
"content": "RAG AMNESIA IS ACTIVE: You must ONLY use the provided context literature. Do not use outside prior knowledge. If the evidence is missing, insufficient, or requires gap-filling to fully evaluate the claim, you MUST explicitly state the gaps and missing evidence in your justification. Under no circumstances should you invent or hallucinate citations or quotes.\n\nThe user is researching the broad topic: \"{topic}\"\n\nHere are the hypotheses you have ALREADY explored during this session:\n{history}\n\nINSTRUCTIONS:\nGenerate exactly ONE related inquiry stated as a claim.\n- It MUST be formatted as a declarative statement.\n- DO NOT wrap it in quotes.\n- DO NOT include conversational text or explanations.\n- Just return the simple claim."
},
"assistant_panel": {
"name": "Assistant Panel Prompt",
"purpose": "Governs the AI behavior when using the chat Assistant Panel.",
"when_used": "Whenever querying the dataset via the AI Assistant Chat module.",
"content": "You are an expert Data Scientist and Visualization Architect. Answer the user directly and truthfully. Do not introduce yourself.\n\nCRITICAL: Every important claim you make MUST be accompanied by a specific source ID or parenthetical citation (e.g., [ID: 12345]) if it is derived from the context.\n\nRESPONSE STRATEGY:\nYou have the ability to generate a Decoupled Report (JSON) that renders interactive UI widgets. Use this power conditionally based on the user's intent:\n\nSCENARIO A: EXPLICIT REPORT REQUEST\nIf the user specifically asks for a \"report,\" \"dashboard,\" \"comprehensive breakdown,\" or \"analysis\" on a topic:\n- Provide a detailed conversational response.\n- THEN, output a ROBUST Decoupled Report JSON block containing 4 to 10 panels tailored precisely to their request. (Include \"synthesis\" and \"pathmap\" as mandatory selections).\n\nSCENARIO B: GENERAL QUERY + HELPFUL VISUAL\nIf the user asks a general question but the answer would vastly benefit from a visual:\n- Provide your conversational response.\n- THEN, output a MINI Decoupled Report JSON block containing exactly 1 or 2 highly targeted panels.\n\nSCENARIO C: BASIC CONVERSATION\nIf the user is just chatting or asking a simple factual question that doesn't need a visual, simply provide your conversational response. Omit the JSON block entirely.\n\n================================================================\nDECOUPLED REPORT PROTOCOL (JSON)\n================================================================\nDo NOT generate raw HTML, CSS, or JS. Output ONLY valid JSON inside the fencing.\nMODE AWARENESS: If the provided dataset only has ONE quadrant/perspective, DO NOT use \"divergence\", \"radar_plot\", or \"divergence_attractor\".\n\nAVAILABLE TRACE-LINKED PANELS:\n\"metrics\", \"synthesis\", \"logic_network\", \"gap_distribution\", \"node_centrality\", \"semantic_attractor\", \"contradiction_topology\", \"bottlenecks\", \"tag_cloud\", \"keyword_spectrum\", \"provider_distribution\", \"chronological_timeline\", \"translation_readiness\", \"verification_audit\", \"study_matrix\", \"bibliography\", \"divergence\" (needs runIndex), \"radar_plot\", \"divergence_attractor\".\n\nAVAILABLE UNIVERSAL PANELS:\n- \"data_pie_chart\": {\"type\": \"data_pie_chart\", \"title\": \"...\", \"data\": [{\"label\": \"A\", \"value\": 10}]}\n- \"data_bar_chart\": {\"type\": \"data_bar_chart\", \"title\": \"...\", \"xAxisLabel\": \"...\", \"data\": [{\"label\": \"A\", \"value\": 10}]}\n- \"event_timeline\": {\"type\": \"event_timeline\", \"title\": \"...\", \"data\": [{\"date\": \"1990\", \"title\": \"...\", \"desc\": \"...\"}]}\n- \"comparison_matrix\": {\"type\": \"comparison_matrix\", \"title\": \"...\", \"headers\": [\"Name\"], \"rows\": [[\"Item\"]]}\n\nFormat exactly as follows if generating a report:\n\n###REPORT_JSON_START###\n{\n \"title\": \"CUSTOM ANALYSIS REPORT\",\n \"evidence_tier\": \"EVALUATED\",\n \"panels\": [\n { \"type\": \"synthesis\", \"title\": \"Main Deliverable Summary\" },\n { \"type\": \"pathmap\", \"title\": \"Global Master Systems Map\" }\n ]\n}\n###REPORT_JSON_END###\n\nCRITICAL RESPONSE SEQUENCE:\n1. First, provide your conversational response.\n2. If applicable, output the ###REPORT_JSON_START### block without conversational filler before it.\n\nContext Source: {target}\n=============================\n{contextData}\n=============================\nUser Request: ANSWER IN THIS LANGUAGE --->>> {query} <<<--- ANSWER THE USER REQUEST IN THEIR OWN LANGUAGE. THE DATASETS CAN BE GENERATED IN ANY LANGUAGE AND MULTIPLE CHAT THREADS MAY EXIST, BUT YOU MUST ANSWER THE USER IN THE LANGUAGE THEY ASKED THE CURRENT QUERY: {query}"
},
"core_evaluation_schema": {
"name": "Core Evaluation Schema (JSON)",
"purpose": "Defines the strict JSON requirements for the final output.",
"when_used": "Appended to every Stage 4 RAG evaluation.",
"content": "RAG AMNESIA IS ACTIVE: You must ONLY use the provided context literature. Do not use outside prior knowledge. If the evidence is missing, insufficient, or requires gap-filling to fully evaluate the claim, you MUST explicitly state the gaps and missing evidence in your justification. Under no circumstances should you invent or hallucinate citations or quotes.\n\n###critical: WRAP YOUR THOUGHTS WITH ... tags at the very beginning of your response.\n\n=======================================================\nCONTEXT LITERATURE (STATIC CACHE):\nID: 42540688\nTitle: NAT10 inhibition corrects nuclear defects in tau mutant human neurons and extends lifespan in a Drosophila tauopathy model.\nAbstract: Mutations in the gene encoding the microtubule-associated protein tau (MAPT) that are causal for frontotemporal dementia result in nuclear envelope deformation and disrupted nucleocytoplasmic transport when expressed in human neurons. A small-molecule inhibitor of the acetyltransferase NAT10 has been shown to correct similar nuclear membrane defects in Hutchinson-Gilford progeria syndrome, primarily by modulating microtubule dynamics. We report here that NAT10 inhibition and loss of function correct nuclear membrane abnormalities in human MAPT-mutant neurons. Similarly, NAT10 inhibition and haploinsufficiency correct neuronal nuclear shape defects and extend lifespan in vivo in a Drosophila model of tauopathy. NAT10 inhibition changes microtubule dynamics and corrects aberrant nucleocytoplasmic transport, and NAT10 directly interacts with regulators of microtubule dynamics in human MAPT-mutant neurons. We conclude that NAT10 mediates neuronal pathologies in tauopathies and is a potential therapeutic target in these diseases.\n\nID: 42350373\nTitle: Karyoptosis mediates cell death and neurodegeneration upon proteotoxic stress.\nAbstract: Neurodegenerative diseases are frequently associated with proteotoxic stress linked to disease specific proteins. The autophagy-lysosome system provides essential control of proteotoxic stress and its failure can lead to initiation of apoptosis. However, in aging and neurodegenerative diseases apoptosis is insufficient to account for all neuronal death, and several different cell death types have been reported in these contexts. Here we show that karyoptosis, a distinct form of cell death, can be induced by proteotoxic stress and then develops through nuclear degeneration and cellular expulsion of nuclear material. We establish that karyoptosis is regulated by the p38 kinase signalling pathway, which controls stability of the nuclear lamina protein LaminB1 via direct phosphorylation. We demonstrate that karyoptosis affects neurons in models of amyotrophic lateral sclerosis/frontotemporal dementia (ALS/FTD) pathology. Finally, we identify karyoptotic features in post-mortem frontal cortex of FTD and Alzheimer's disease (AD) patients. Together these findings characterise a form of cell death directly linked to proteotoxic stress and nuclear lamina stability that is associated with neurodegeneration.\n\nID: 42140180\nTitle: Metabolic underpinnings of cuproptosis.\nAbstract: Cuproptosis is a recently defined form of regulated cell death (RCD) driven by copper-induced mitochondrial proteotoxic stress. Distinct from other RCD pathways such as apoptosis and ferroptosis, cuproptosis arises when copper binds to lipoylated metabolic enzymes in mitochondria, leading to their aggregation, loss of iron-sulfur cluster proteins, and metabolic collapse. This discovery establishes a mechanistic link between metal homeostasis and mitochondrial metabolism, positioning cuproptosis as a \"cell-sabotage\" pathway in which essential metabolic processes become self-destructive when dysregulated. In this review, we synthesize recent advances in understanding the molecular and metabolic basis of cuproptosis, its intersection with other metabolic cell death pathways such as ferroptosis, and its emerging therapeutic relevance in cancer. We further discuss the potential involvement of cuproptosis-like mechanisms in neurodegenerative disorders and highlight the outstanding questions and translational challenges that will guide future efforts to exploit this unique metabolic vulnerability for disease intervention.\n\nID: 42121950\nTitle: Valosin-Containing Protein Contributes to Plexiform Neurofibroma Formation and Represents a Novel Therapeutic Target.\nAbstract: Neurofibromatosis type 1 (NF1) patients are predisposed to develop plexiform neurofibromas (PNFs). By cross-comparison of RNA sequencing and RUNX1-CHIP sequencing data on mouse PNFs, we found that transcripts encoding the NF1-interacting p97/valosin-containing protein (VCP) gene are overexpressed in PNFs. Co-immunoprecipitation confirmed that VCP bounded to neurofibromin. Western blot and immunostaining confirmed VCP overexpression in both mouse and human PNFs. Treatment of primary mouse PNF Schwann cells with CB-5083, a p97/VCP inhibitor, led to accumulation of poly-ubiquitinated proteins and generation of irresolvable proteotoxic stress. Pharmacological or genetic inhibition of VCP reduced mouse PNF cell-derived sphere number, and genetic inhibition of Vcp in Schwann cell precursors decreased tumor-like lesion numbers in a cell transplantation model. In vivo treatment with CB-5083 in Nf1fl/fl;DhhCre PNF mice significantly inhibited cell proliferation, increased cell apoptosis and reduced PNF volume. The combination with a MEK inhibitor did not increase efficacy compared to the single agent, supporting the hypothesis that VCP functions in parallel to, and may be modulated by, RAS-MAPK signaling under stress or oncogenic conditions. The significant effects of VCP inhibition in this pre-clinical study suggest a potential novel therapy for patients with PNFs.\n\nID: 42094412\nTitle: TMEM106B C-terminal fragments drive nucleocytoplasmic transport failure and TDP-43 mislocalization in the aging human brain.\nAbstract: TMEM106B is a lysosomal membrane protein and major genetic modifier of multiple neurodegenerative diseases, including frontotemporal lobar degeneration, Alzheimer's disease, and amyotrophic lateral sclerosis. Proteolytically generated C-terminal fragments of TMEM106B assemble into amyloid fibrils that accumulate in the brains of individuals with neurodegenerative disease and in cognitively normal aged adults, yet how these fibrils produce neuronal dysfunction has remained unclear. Here, we show that cytosolic and lysosome-directed TMEM106B C-terminal fragments (CTF and gCTF) form detergent-insoluble amyloid aggregates, drive redistribution of endogenous TDP-43 from the nucleus to the cytoplasm, and accelerate neuronal death. Unbiased proximity proteomics identified the inner nuclear membrane LAP1-TorsinA axis as a fragment-specific interactome, and co-immunoprecipitation confirmed a direct physical interaction between gCTF and LAP1 that was not observed with full-length TMEM106B. Fragment expression disrupted Lamin B1 organization, mislocalized the nuclear import machinery KPNB1 and RanGAP1, and impaired importin-dependent nuclear transport in primary cortical neurons. Critically, neurons harboring endogenous TMEM106B fibrillar pathology in aged human frontal cortex exhibited the same phenotypes, namely disrupted Lamin B1 and LAP1 localization and cytoplasmic redistribution of TDP-43, whereas fibril-negative neurons from the same cases and younger control tissue retained intact nuclear envelope organization. These findings define TMEM106B proteinopathy as an upstream driver of nuclear envelope disruption and nucleocytoplasmic transport failure, linking a widespread feature of brain aging to a central mechanism of neurodegeneration.\n\nID: 42017968\nTitle: Tau oligomerization induces nuclear lamina invagination and chromatin remodeling in Alzheimer's disease.\nAbstract: The aggregation of the microtubule-associated protein tau into oligomeric complexes is strongly correlated with the onset and progression of neurodegeneration in Alzheimer's disease (AD). Increasing evidence implicates nuclear membrane disruption in AD and related tauopathies; however, whether this is a cause or consequence of neurodegeneration remains unresolved. Here, we show that nuclear lamina disruption emerges at the early Braak stages, coinciding with the initial formation of pathological tau aggregates in post-mortem AD brain tissue. Using the tauopathy mouse model (P301S PS19), we demonstrate that oligomeric tau (oTau) directly binds to the Lamin B Receptor (LBR), inducing nuclear envelope invaginations as revealed by electron microscopy. These structural alterations are accompanied by chromatin remodeling and gene expression dysregulation. To dissect the underlying mechanism, we employed a light-inducible OptoTau system (4R1N Tau::mCherry::Cry2Olig) in human iPSC-derived neurons, enabling real-time visualization of tau aggregation dynamics. This system revealed selective recruitment of oTau to the nuclear envelope and direct interactions with LBR and Lamin B2, leading to nuclear deformation and activation of the protein translational stress response. Together, these findings identify nuclear membrane disruption as an early and potentially causative event in tau-mediated neurodegeneration, establishing a mechanistic link between tau oligomerization, nuclear stress, and chromatin remodeling. Targeting nuclear destabilization may offer new therapeutic avenues for mitigating AD pathogenesis.\n\nID: 41897286\nTitle: Ferroptosis and Cuproptosis in Cancer and Neurodegeneration: A Comprehensive Review of Modulation by Iron and Copper Chelators and Related Agents.\nAbstract: Dysregulation of iron and copper homeostasis is a pivotal driver of regulated cell death through two distinct yet interconnected modalities: ferroptosis and cuproptosis. This comprehensive review evaluates the therapeutic modulation of these metal-driven pathways within a dual paradigm: their deployment as a cytotoxic weapon in oncology and their inhibition for neuroprotection. We synthesize evidence ranging from small-molecule synergy to advanced nanomedicine, examining how the interplay between iron and copper governs cellular fate in resistant malignancies and neurodegenerative diseases such as Parkinson's disease and Multiple Sclerosis. In oncology, bimetallic nanoplatforms and CRISPR-Cas9 nano-ionophores exploit \"iron addiction\" and metabolic vulnerabilities to induce fatal lipid peroxidation and FDX1-mediated proteotoxic stress, often by circumventing efflux transporters like ATP7A/B. Conversely, neuroprotective strategies focus on site-specific chelation, utilizing brain-penetrant molecules like SK4 (targeting the LAT1 transporter) and radical trapping antioxidants like CuII(atsm). Importantly, we elucidate the \"iron trap\" mechanism, where copper deficiency inactivates multicopper ferroxidases-including ceruloplasmin and hephaestin-thereby triggering iron-dependent ferroptosis. Our analysis reveals a self-amplifying cycle of oxidative damage driven by metal-induced ATP depletion and glutathione exhaustion. By delineating the molecular machinery of iron and copper metabolism, this article provides a roadmap for leveraging regulated cell death to overcome apoptosis resistance in cancer and preserve neural integrity in chronic degeneration.\n\nID: 41550140\nTitle: Oxidative stress-driven transcriptomic remodeling in human astrocytes reveals network signatures associated with neurodegenerative and cardiovascular processes.\nAbstract: Astrocytes are central to brain homeostasis, supporting neuronal metabolism, synaptic activity, and the blood-brain barrier. With aging, these glial cells undergo molecular and functional changes that weaken support functions and promote neuroinflammation, contributing to neurodegeneration. Yet the systems-level mechanisms by which astrocytes respond to aging-related stressors remain poorly defined in human models. Because aging also heightens risk for cardiovascular disease, cognitive impairment, type 2 diabetes, and systemic inflammation, clarifying shared astrocytic pathways is critical for understanding brain-body crosstalk. Using an in vitro human astrocyte model exposed to sublethal oxidative stress (10\u202f\u00b5M H\u2082O\u2082) as a proxy for age-related cellular stress, we profiled transcriptomic changes and identified differentially expressed genes across antioxidant defenses, proteostasis, transcriptional regulation, vesicular trafficking, and inflammatory signaling. We then performed network-prioritization analyses on a curated human protein-protein interactome: one seeded with the astrocyte oxidative stress responsive genes and six with phenotype-associated gene sets (Alzheimer's disease, cardiovascular disease, cognitive impairment, type 2 diabetes, oxidative stress, and inflammation). Intersecting the top 5\u202f% scoring genes from each run yielded a 127-gene core shared across all seven, enriched for proteostasis, DNA repair, mitochondrial regulation, and telomere and nuclear envelope maintenance. Structure-guided analyses highlighted vulnerable interfaces, including lamin A/C-lamin B1, \u03b1-actinin-filamins, 14-3-3 dimers, and aminoacyl-tRNA synthetase assemblies, where pathogenic variants are predicted to destabilize or aberrantly stabilize protein interactions. Structure-based interface predictions also highlight potential interactions between amyloid precursor protein (APP) and valosin-containing protein (VCP), and between p53 and 14-3-3\u03b6, potentially linking proteostasis and stress signaling. Together, these analyses identify a conserved astrocyte-centered network signature that may relate neurodegenerative and cardiovascular processes, and prioritize structurally testable candidates for biomarker and intervention hypothesis testing.\n\nID: 41227326\nTitle: The Dynamics of the ESCRT Machinery in Open Mitosis from Physiology to Pathology.\nAbstract: The Endosomal Sorting Complex Required for Transport (ESCRT) is a highly conserved machinery best known for its role in endosomal trafficking and membrane remodeling. Increasing evidence shows that ESCRT components are also key regulators during open mitosis, where precise membrane dynamics are essential for nuclear envelope reformation and spindle disassembly. In this review, we explore how the ESCRT machinery coordinates mitotic processes under physiological conditions and how their dysregulation contributes to genomic instability, altered cell division, and disease. We highlight recent findings on the spatiotemporal control of ESCRT recruitment at mitotic membranes, the interplay with chromatin and nuclear envelope-associated factors, and the consequences of defective ESCRT function in pathological contexts such as cancer and neurodegeneration. By connecting molecular mechanisms with cellular outcomes, we provide an integrated view of how the ESCRT machinery acts as critical guardian of mitotic fidelity and offer some routes for the identification of potential therapeutic targets in human disease.\n\nID: 41207102\nTitle: Cuproptosis as a regulator in human diseases: From basic mechanisms to clinical relevance.\nAbstract: Cuproptosis is a novel, copper-dependent regulated cell death (RCD) pathway identified in 2022. It is distinct from other forms of cell death, such as ferroptosis, due to its unique mechanism involving mitochondrial copper overload, aggregation of lipoylated TCA-cycle proteins, and subsequent proteotoxic stress. Although secondary reactive oxygen species (ROS) production may occur, cuproptosis is not driven by lipid peroxidation, highlighting its specificity. The significance of cuproptosis extends beyond cancer, notably to neurodegenerative disorders such as Alzheimer's disease (AD), where copper dyshomeostasis exacerbates pathology. In oncology, cuproptosis induction has emerged as a promising therapeutic strategy, with agents including copper ionophores, nanomaterials, and repurposed drugs showing efficacy. This review highlights the molecular uniqueness of cuproptosis, its clinical relevance, and translational challenges in therapeutic applications.\n\nID: 41187062\nTitle: Stra8 links neuronal activity to inhibitory circuit protection in the adult mouse brain.\nAbstract: While neuronal activity is essential for brain function, it also poses threats to neuronal integrity. Here, we show that activity-induced expression of stimulated by retinoic acid gene 8 (Stra8) protects neurons from degeneration. Previously considered germline specific, Stra8 is expressed in the adult mouse brain and is induced by neuronal activity via calcium influx and N-methyl-D-aspartate (NMDA) receptor signaling. Neuron-specific Stra8 knockout mice display hallmark features of neurodegeneration, including DNA damage, impaired proteostasis, inflammation, nuclear envelope erosion, reduced dendritic plasticity, memory deficits, and heightened excitotoxic vulnerability. Electrophysiological studies reveal disrupted inhibitory circuit function. Mechanistically, Stra8 binds regulatory regions of neuromodulator genes and regulates their expression. Notably, Stra8 loss upregulates the expression of Npas4, an immediate-early gene critical for inhibitory circuits, but the aberrant protein is mislocalized to the nuclear periphery. These findings identify Stra8 as an activity-dependent transcriptional regulator that safeguards neuronal structure and function.\n\nID: 41169507\nTitle: Endolysosomal dysfunction impairs proteostasis and induces neurodegeneration in vivo.\nAbstract: Transactive response (TAR) DNA-binding protein 43 (TDP-43) inclusions are a pathological hallmark of the frontotemporal dementia (FTD)-amyotrophic lateral sclerosis (ALS) spectrum. Dysfunction of the endolysosomal system, which plays a crucial role in protein trafficking and maintaining proteostasis, has been implicated in FTD-ALS pathogenesis. While the impact of endolysosomal dysfunction on TDP-43 pathology remains unclear, we demonstrated that disrupting the endolysosomal pathway by expressing the constitutively active endosomal protein, Rab5Q79L, induces TDP-43 aggregation in cultured cells. Here, we generated a mouse model expressing GFP-tagged Rab5Q79L, demonstrating that GFP-Rab5Q79L mice exhibit early motor deficits and endolysosomal dysfunction, including enlarged endosomes, abnormal lysosome morphology, and p62- or ubiquitin-positive inclusions. These mice also developed significant neuronal loss, neuroinflammation, phosphorylated TDP-43 (pTDP-43) inclusions, and nuclear envelope and nuclear pore structural defects reminiscent of FTD-ALS. Accordingly, GFP-Rab5Q79L mice will prove useful in expanding our understanding of endolysosomal dysfunction in proteostasis and pTDP-43 pathology.\n\nID: 40717513\nTitle: Arsenic binds to nuclear transport factors and disrupts nucleocytoplasmic transport.\nAbstract: Human exposure to arsenicals is associated with devastating diseases such as cancer and neurodegeneration. At the same time, arsenic-based drugs are used as therapeutic agents. The ability of arsenic to directly bind to proteins is correlated with its toxic and therapeutic effects, highlighting the importance of elucidating arsenic-protein interactions. In this study, we took a proteomic approach and identified 174 proteins that bind to arsenic in Saccharomyces cerevisiae. Proteins involved in nucleocytoplasmic transport were markedly enriched among the arsenic-binding proteins, and we demonstrate that arsenic binding to nuclear import factors results in their relocation from the nuclear envelope and subsequent aggregation in the cytosol. Similarly, nuclear pore proteins that make up the nuclear pore complex mislocalized and aggregated in arsenic-exposed cells. Consequently, arsenic was shown to inhibit nuclear protein import and export. We propose a model in which arsenic binding to nuclear transport factors leads to their mislocalization and aggregation, which disrupts nucleocytoplasmic transport and causes arsenic sensitivity.\n\nID: 40535610\nTitle: Identification of actin mutants with neurodegenerative disease-like phenotypes via mutagenesis of the actin-ATP interface.\nAbstract: Cofilin-actin rods are a well-documented stress response in neuronal cells and their persistence is frequently associated with neurodegenerative disease. However, the role of specific actin residues in promoting the formation of cofilin-actin rods and other anomalous cytoskeletal structures is largely unknown. As it is increasingly suspected that specific mutations and post-translation modifications of actin may promote neurodegenerative disease, characterizing the role of these residues in cytoskeletal dysregulation is highly relevant. In this study, we focus on the actin-ATP interface, which has been proposed as a key mediator of cofilin-actin rod formation and the propensity of actin to respond to cellular stress. Using a light and stress-gated reporter of cofilin-actin cluster formation, we determine the impact of mutants associated with Actin-ATP binding on the propensity of actin to form anomalous structures in the presence and absence of applied cellular stress. This study identifies actin mutants that promote anomalous actin inclusions in HeLa cells and characterizes the manifestation of these phenotypes in cortical neurons. Mutations to the ATP phosphate tail-binding region of actin (K18A, D154A, G158L, K213A) were found to be particularly disruptive to actin phenotypes, and in several instances promote disease-associated actin-rich structures such as cofilin-actin rods and Hirano bodies. We find that these mutant phenotypes are largely consistent between cell types and display highly unusual inclusions in cultured cortical neurons, without leading to nuclear fragmentation and apoptotic death of the transfected cells. These mutants strengthen the association of residue-specific changes in actin with large-scale phenotypic and functional changes in the cytoskeleton, further implicating them in neurodegenerative disease progression.\n\nID: 40475464\nTitle: Tau Oligomerization Drives Neurodegeneration via Nuclear Membrane Invagination and Lamin B Receptor Binding in Alzheimer's disease.\nAbstract: The microtubule-associated protein tau aggregates into oligomeric complexes that highly correlate with Alzheimer's disease (AD) progression. Increasing evidence suggests that nuclear membrane disruption occurs in AD and related tauopathies, but whether this is a cause or consequence of neurodegeneration remains unclear. Using the optogenetically inducible 4R1N Tau::mCherry::Cry2Olig (optoTau) system in iPSC-derived neurons, we demonstrate that tau oligomerization triggers nuclear rupture and nuclear membrane invagination. Pathological tau accumulates at sites of invagination, inducing structural abnormalities in the nuclear envelope and piercing into the nuclear space. These findings were confirmed in the humanized P301S tau (PS19) transgenic mouse model, where nuclear envelope disruption appeared as an early-onset event preceding neurodegeneration. Further validation in post-mortem AD brain tissues revealed nuclear lamina disruption correlating with pathological tau emergence in early-stage patients. Notably, electron microscopy shows that tau-induced nuclear invagination triggers global chromatin reorganization, potentially driving aberrant gene expression and protein translation associated with AD. These findings suggest that nuclear membrane disruption is an early and possibly causative event in tau-mediated neurodegeneration, establishing a mechanistic link between tau oligomerization and nuclear stress. Further investigation into nuclear destabilization could inform clinical strategies for mitigating AD pathogenesis.\n\nID: 40339618\nTitle: Neuroimmune signaling mediates astrocytic nucleocytoplasmic disruptions and stress granule formation associated with TDP-43 pathology.\nAbstract: Alterations in transactivating response region DNA-binding protein 43 (TDP-43) are prevalent in amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), and other neurological disorders. TDP-43 influences neuronal functions and might also affect glial cells. However, specific intracellular effects of TDP-43 alterations on glial cells and underlying mechanisms are not clear. We report that TDP-43 dysregulation in mouse and human cortical astrocytes causes nucleoporin mislocalization, nuclear envelope remodeling, and changes in nucleocytoplasmic protein transport. These effects are dependent on interleukin-1 (IL-1) receptor activity and nuclear factor kappa-light-chain-enhancer of activated B cells (NF-\u03baB) signaling and are associated with the formation of cytoplasmic stress granules. Stimulation of IL-1 receptors and NF-\u03baB signaling are necessary and sufficient to induce astrocytic stress granules and rapid nucleocytoplasmic changes, which are broadly alleviated by inhibition of the integrated stress response. These findings establish that TDP-43 alterations and neuroimmune factors can induce nucleocytoplasmic changes through NF-\u03baB signaling, revealing mechanistic convergence of proteinopathy and neuroimmune pathways onto glial nucleocytoplasmic disruptions that may occur in diverse neurological conditions.\n\nID: 40330856\nTitle: Interventionally targeting somatic CAG expansions can be a rapid disease-modifying therapeutic avenue: Preclinical evidence.\nAbstract: Huntington disease (HD) is caused by inherited CAG expansions, which continue expanding somatically in affected brain regions to hasten disease onset and progression. Therapeutically diminishing somatic expansions is expected to be clinically beneficial. However, it is not known if interventionally modifying somatic CAG expansions will actually modify in vivo clinically-relevant phenotypes, what the therapeutic window is, or which phenotypes will be altered. Here we show that acute (6-week) delivery of the contraction-inducing slipped-CAG DNA ligand naphthyridine-azaquinolone to young (4-week-old) (CAG)120 HD mice, induces contractions throughout brain regions, improves motor function (locomotion, balance, coordination, muscle strength), molecular disease landmarks (mHTT aggregates, nuclear envelope morphology, nucleocytoplasmic mRNA transport, transcriptomic dysregulation, neuroinflammation), and neurodegeneration. Beneficial effects of modifying somatic expansions were also evident in muscle and blood, where blood CAG instability correlated with brain instability and blood serum had diminished levels of neurofilament light (a biomarker for neurodegeneration) - offering blood as having elements of target engagement and efficacy. These data support that targeting somatic repeat expansions can be a rapid disease-modifying therapeutic avenue for HD and possibly other repeat expansion diseases. Our findings support an etiologic pathway interconnected to somatic CAG expansions that will inform the design of clinical trials expecting clinical benefit by modulating somatic expansions.\n\nID: 40254494\nTitle: Emerging roles of cuproptosis in liver diseases.\nAbstract: Intracellular copper levels should be maintained within a controlled range to obtain copper homeostasis. Cuproptosis, a newly discovered form of cell death, occurs when excessive copper ions bind to the lipoylated enzymes in the tricarboxylic acid cycle, which leads to lipoylated protein aggregation, proteotoxic stress, and ultimately cell death. Herein, we summarize the current knowledge regarding copper metabolism, the discovery and molecular mechanism of cuproptosis. In addition, we discuss the implications of cuproptosis in the pathogenesis of various liver diseases, including hepatocellular carcinoma (HCC), Wilson disease (WD), metabolic-associated fatty liver disease (MAFLD), liver fibrosis, hepatic ischemia-reperfusion injury (HIRI) and drug-induced liver injury (DILI). Understanding the mechanism of cuproptosis can not only provide deeper insights into the pathogenesis of liver diseases but also open up new avenues for the development of targeted therapies.\n\nID: 40210858\nTitle: A TLK2-mediated calcium-driven cell death pathway links neuronal degeneration to nuclear envelope disruption.\nAbstract: Calcium overload drives neuronal cell death, but its mechanisms remain unclear. Previous studies in Drosophila implicated tousled-like kinase (TLK) in this process. Here, we investigated TLK2, the mammalian homolog, in calcium overload-induced neuronal death. We found that calcium overload enhances TLK2 expression, multimerization, and phosphorylation, increasing its kinase activity. Inhibiting TLK2 via RNA interference or a small-molecule inhibitor reduced neuronal death, while TLK2 overexpression triggered nuclear envelope (NE) rupture, nuclear enlargement, multinucleation, and cell cycle reentry markers. A protein complex involving TLK2, dynein light chain LC8, and myosin IIA was linked to NE disruption. In mouse models of glaucoma, TLK2 contributed to retinal ganglion cell degeneration, connecting calcium overload to neurodegeneration. We propose \"CaToptosis\" (Calcium-induced Tousled-like kinase-mediated cell death) as a distinct neuronal death pathway.\n\nID: 40157412\nTitle: Nuclear translocation of the LINE-1 encoded ORF1 protein alters nuclear envelope integrity in human neurons.\nAbstract: LINE-1 retrotransposons are increasingly implicated in aging and neurodegenerative diseases, yet the precise pathogenic mechanisms remain elusive. While the endonuclease and reverse transcriptase activities of LINE-1-encoded ORF2p can induce DNA damage and inflammation, a role of LINE-1 ORF1p in cellular dysfunctions stays unassigned. Here we demonstrate, using a neuronal cellular model, that ORF1p translocates into the nucleus upon arsenite-induced stress, directly interacting with nuclear import (KPNB1), nuclear pore complex (NUP153), and nuclear lamina (Lamin B1) proteins. Nuclear translocation of ORF1p disrupts nuclear integrity, nucleocytoplasmic transport, and heterochromatin structure, features linked to neurodegeneration and aging. Elevated nuclear ORF1p levels induced either by arsenite-induced stress, ORF1p overexpression, or as observed in Parkinson's disease post-mortem brain tissues correlate with impaired nuclear envelope (NE) morphology. Stress-induced nuclear alterations are mitigated by blocking ORF1p nuclear import or with the anti-aging drug remodelin. This study thus reveals a pathogenic action of nuclear ORF1p in human neurons driving NE alterations and thereby contributing to LINE-1-mediated cell toxicity.\n\nID: 39945772\nTitle: Loss of ATG7 in microglia impairs UPR, triggers ferroptosis, and weakens amyloid pathology control.\nAbstract: Microglia impact brain development, homeostasis, and pathology. One important microglial function in Alzheimer's disease (AD) is to contain proteotoxic amyloid-\u03b2 (A\u03b2) plaques. Recent studies reported the involvement of autophagy-related (ATG) proteins in this process. Here, we found that microglia-specific deletion of Atg7 in an AD mouse model impaired microglia coverage of A\u03b2 plaques, increasing plaque diffusion and neurotoxicity. Single-cell RNA sequencing, biochemical, and immunofluorescence analyses revealed that Atg7 deficiency reduces unfolded protein response (UPR) while increasing oxidative stress. Cellular assays demonstrated that these changes lead to lipoperoxidation and ferroptosis of microglia. In aged mice without A\u03b2 buildup, UPR reduction and increased oxidative damage induced by Atg7 deletion did not impact microglia numbers. We conclude that reduced UPR and increased oxidative stress in Atg7-deficient microglia lead to ferroptosis when exposed to proteotoxic stress from A\u03b2 plaques. However, these microglia can still manage misfolded protein accumulation and oxidative stress as they age.\n\nID: 39937646\nTitle: Cellular rejuvenation protects neurons from inflammation-mediated cell death.\nAbstract: In multiple sclerosis (MS), inflammation of the central nervous system results in demyelination, neuroaxonal injury, and cell death. However, the molecular signals responsible for injury and cell death in neurons are not fully characterized. Here, we profile the transcriptome of retinal ganglion cells (RGCs) in experimental autoimmune encephalomyelitis (EAE) mice. Pathway analysis identifies a transcriptional signature reminiscent of aged RGCs with some senescent features, with a comparable signature present in neurons from patients with MS. This is supported by immunostaining demonstrating alterations to the nuclear envelope, modifications in chromatin marks, and accumulation of DNA damage. Transduction of RGCs with an Oct4-Sox2-Klf4 adeno-associated virus (AAV) to rejuvenate the transcriptome enhances RGC survival in EAE and improves visual acuity. Collectively, these data reveal an aging-like phenotype in neurons under pathological neuroinflammation and support the possibility that rejuvenation therapies or senotherapeutic agents could offer a direct avenue for neuroprotection in neuroimmune disorders.\n\nID: 39908177\nTitle: Neuronal \u03b1-synuclein toxicity is the key driver of neurodegeneration in multiple system atrophy.\nAbstract: Multiple system atrophy (MSA) is a rare, rapidly progressing neurodegenerative disorder often misdiagnosed as Parkinson's disease (PD). Although both conditions share some clinical features, MSA is distinct in its pathological hallmark: oligodendroglial cytoplasmic \u03b1-synuclein (\u03b1-Syn) inclusions, known as glial cytoplasmic inclusions. These glial cytoplasmic inclusions are pathognomonic for MSA, but they do not lead to significant oligodendroglial cell loss. Instead, MSA is characterized by a substantially greater loss of non-dopaminergic neurons in the nigrostriatal and olivopontocerebellar systems compared with PD. This widespread neuronal degeneration, which is not seen to the same extent in PD, plays a crucial role in the clinical presentation of MSA and is important to consider if PD is to be redefined as a neuronal \u03b1-Syn disease. It also raises the question of differences in the potential toxicity of lesions in MSA and the underlying cause of neuronal death in MSA. By combining an N-terminus \u03b1-Syn antibody that reveals more \u03b1-Syn pathology and super-resolution microscopy, we identified \u03b1-Syn fibrils in MSA neurons penetrating the nucleus from the cytoplasm, leading to nuclear destruction and neuronal death. Our data indicate an early invasion of neuronal nuclei by \u03b1-Syn pathology in MSA, precipitating rapid nuclear envelope destruction, as observed through significant structural damage, including the loss of Lamin integrity. Although the progression of \u03b1-Syn pathology from the cytoplasm to the nucleus might be similar in oligodendroglia and neurons, the aggregation state of the \u03b1-Syn proteoforms involved differs because proteolytic resistance of \u03b1-Syn inclusions is significantly higher in neurons, and the nucleus is destroyed. We describe the progressive impact of \u03b1-Syn nuclear pathology on MSA neurons and show that this is a more detrimental and rapid pathology driving neurodegeneration. Our data suggest that oligodendroglial inclusions contain more soluble, less toxic \u03b1-Syn proteoforms, consistent with two distinct \u03b1-Syn filaments in MSA. We propose renaming MSA as a neuronal nuclear and oligodendroglial \u03b1-synucleinopathy to reflect these two distinct pathologies better.\n\nID: 39868121\nTitle: Direct binding of arsenicals to nuclear transport factors disrupts nucleocytoplasmic transport.\nAbstract: Human exposure to arsenicals is associated with devastating diseases such as cancer and neurodegeneration. At the same time, arsenic-based drugs are used as therapeutic agents. The ability of arsenic to directly bind to proteins is correlated with its toxic and therapeutic effects highlighting the importance of elucidating arsenic-protein interactions. In this study, we took a proteomic approach and identified 174 proteins that bind to arsenic in Saccharomyces cerevisiae. Proteins involved in nucleocytoplasmic transport were markedly enriched among the arsenic-binding proteins, and we demonstrate that arsenic-binding to nuclear import factors results in their relocation from the nuclear envelope and subsequent aggregation in the cytosol. Similarly, nuclear pore proteins that make up the nuclear pore complex mislocalized and aggregated in arsenic-exposed cells. Consequently, arsenic was shown to inhibit nuclear protein import and export. We propose a model in which arsenic-binding to nuclear transport factors leads to their mislocalization and aggregation, which disrupts nucleocytoplasmic transport and causes arsenic sensitivity.\n\nID: 42537460\nTitle: Host autophagy in Staphylococcus aureus infection: Mechanisms of clearance, evasion, and therapeutic intervention.\nAbstract: Staphylococcus aureus is a facultative intracellular pathogen that persists within both professional and non-professional phagocytes, contributing to chronic and antibiotic-resistant infections. Autophagy, particularly xenophagy, serves as a central cell-autonomous defense pathway that can capture intracellular S. aureus and deliver it to lysosomes for degradation. However, the bacterium has evolved multiple strategies to subvert xenophagic clearance, including manipulation of bacteria-containing autophagosome maturation, blockade of autophagosome and lysosome fusion, and co-option of autophagy-related machinery to create intracellular survival niches. Recent studies have also identified host pathways that shape infection outcomes, including reprogramming of cell death cascades to simultaneously sustain host viability and suppress xenophagy, and co-option of mitophagy to eliminate bactericidal mitochondrial ROS. As illustrative examples, caspase-8 reprogramming uncouples host survival from effective xenophagy, and the HDAC11/IL10/mTOR/PINK1-PRKN axis drives mitophagy to suppress mitochondrial ROS. We further address the largely unexplored roles of chaperone-mediated autophagy and endosomal microautophagy in S. aureus infection, drawing on mechanistic paradigms from viral and mycobacterial infections. Since S. aureus can impair autophagosome maturation, lysosomal acidification, and fusion between bacteria-containing autophagosomes and lysosomes, enhancing autophagy initiation alone may not always translate into improved bacterial clearance. We therefore propose, as a testable hypothesis, that host-directed strategies aimed at restoring lysosomal competence, improving degradative flux, or neutralizing bacterial virulence mechanisms may complement or outperform upstream autophagy induction in selected infection contexts. However, this concept remains insufficiently validated, and direct comparative studies in relevant host cell types and animal models are needed before lysosome-directed approaches can be prioritized therapeutically.\n\nID: 42474944\nTitle: Mitochondrial stress-induced cuproptosis: a metabolic bridge to reprogramming the GBM immune microenvironment.\nAbstract: Glioblastoma (GBM) remains the most lethal primary brain malignancy, characterized by profound metabolic heterogeneity and an immunosuppressive tumor immune microenvironment (TIME) that severely limits the efficacy of immune checkpoint blockade. While cuproptosis has recently been defined as a distinct form of regulated cell death driven by copper-induced mitochondrial proteotoxicity, its non-cell-autonomous roles in remodeling the immune landscape remain poorly understood. This review synthesizes emerging evidence to position cuproptosis not merely as a metabolic collapse, but as a potent driver of immunogenic cell death (ICD). We propose a potential \"metabolic-immune\" signaling axis wherein copper-triggered aggregation of lipoylated TCA cycle enzymes leads to mitochondrial membrane rupture and the subsequent leakage of mitochondrial DNA (mtDNA) into the cytosol. This danger signal is sensed by the cyclic GMP-AMP synthase (cGAS), activating the STING pathway to stimulate type I interferon production. We discuss how this cascade orchestrates a systemic immune response, including the recruitment of cytotoxic CD8\u2009+\u2009T cells and the repolarization of tumor-associated macrophages from a pro-tumor M2 to an anti-tumor M1 phenotype. Furthermore, we highlight the translational potential of copper ionophores and bioengineered nanomedicines as next generation immunomodulators. By integrating copper metabolism with innate immunity, this review provides a strategic roadmap for exploiting mitochondrial stress to reverse immune exclusion and overcome therapy resistance in GBM.\n\nID: 42439223\nTitle: A Label-Free Ultraviolet Photoacoustic Microscopy Enables Nuclear Imaging and Toxicity Assessment in an Intact Brain Organoid.\nAbstract: Fetal alcohol spectrum disorders (FASDs) are caused by prenatal exposure to ethanol (EtOH), leading to developmental brain abnormalities. Cortical organoids derived from human-induced pluripotent stem cells provide physiologically relevant models to study such neurotoxic effects. However, accurate imaging of nuclear morphology, a key indicator of cytotoxicity and developmental impairment, remains difficult. Traditional fluorescence-based techniques rely on staining and sectioning, limiting throughput and potentially altering native structures. Herein, we present an ultraviolet photoacoustic microscopy system that targets endogenous nucleic acids at 266\u00a0nm excitation, resulting in a lateral resolution of 278\u00a0nm, which is sufficient to resolve individual nuclei in situ. The system integrates precise z-axis scanning for focal-plane alignment, enabling high-resolution depth-resolved imaging of subvolumes within 3D intact live organoids without physical sectioning. Using EtOH-treated cortical organoids as a model of FASD-associated neurotoxicity, we observed significant reductions in nuclear area, diameter, and circularity by 46.1%, 20.8%, and 6.0%, respectively, indicating structural damage consistent with apoptosis and impaired neurodevelopment. This method is the first to demonstrate label-free nuclear imaging in intact live brain organoids, providing a robust and preparation-free platform for probing disease-relevant phenotypes, accelerating drug screening, and enabling early toxicity assessments in neurodevelopmental disorder models.\n\nID: 42392071\nTitle: Spliceosomal proofreading factors safeguard 3' splice-site fidelity and prevent proteotoxicity and inflammation.\nAbstract: Precise intron removal by RNA splicing is essential for faithful gene expression, yet the mechanisms ensuring splicing fidelity in mammals remain unclear. Using a systematic knockdown RNA sequencing (RNA-seq) screen, we uncover widespread splicing errors and identify AQR, SYF1, and SYF3 as cooperative safeguards of 3' splice-site (3'ss) fidelity in human and mouse. These factors act during spliceosome assembly to correct U2AF-mediated misrecognition of non-canonical 3'ss bearing AG dinucleotides embedded within pyrimidine-rich sequences and lacking canonical branch points (BPs), likely through kinetic proofreading. Their loss triggers pervasive 3'ss mis-splicing, resulting in the accumulation of misfolded proteins, proteotoxic stress, unfolded protein response activation, and ultimately cell death and intestinal inflammation. Together, our study reveals a previously unrecognized layer of splicing fidelity control in mammals that links aberrant splice-site selection to proteostasis and inflammation.\n\nID: 42388635\nTitle: Cuproptosis and prostate cancer: from molecular mechanisms and microenvironment remodeling to precision therapy.\nAbstract: Prostate cancer (PCa) is a leading malignancy, and progression to castration-resistant prostate cancer (CRPC) remains a central therapeutic challenge. Cuproptosis, a copper-dependent cell death mechanism first characterized in 2022, is triggered by copper binding to lipoylated tricarboxylic acid (TCA)-cycle proteins, inducing their aggregation, Fe-S cluster protein instability, and mitochondrial proteotoxic stress. This review critically evaluates the emerging but still heterogeneous evidence linking cuproptosis to PCa, explicitly distinguishing prostate cancer-specific data from pan-cancer,non-prostate, bioinformatic, and preclinical observations. We describe the core machinery, including ferredoxin 1 (FDX1), dihydrolipoamide acetyltransferase (DLAT), protein lipoylation enzymes, and copper transport/chaperone systems, while emphasizing differences from apoptosis and ferroptosis. In PCa, altered copper homeostasis and mitochondrial metabolic rewiring provide a biologically plausible vulnerability, but current evidence does not yet establish cuproptosis as a validated clinical driver or therapeutic target. We therefore summarize cuproptosis-related gene expression profiles and prognostic models as hypothesis-generating biomarkers,\u00a0and provide a prostate cancer-specific evidence table that separates bioinformatic, in vitro, in vivo, and clinical levels of support. We also review potential links with metabolic reprogramming, immune microenvironment modulation, PD-L1 regulation, androgen receptor signaling, PTEN/PI3K pathway activity, epigenetic regulation, and crosstalk with ferroptosis. Therapeutically, copper ionophores such\u00a0as elesclomol and disulfiram/copper, and copper-depleting approaches such as chelators, are discussed as investigational strategies rather than near-clinical solutions. Particular attention is given to toxicity, narrow therapeutic windows, negative or inconclusive clinical data, the absence of validated companion diagnostics in PCa, and the need for patient-selection biomarkers based on copper handling, FDX1/lipoylation status, and mitochondrial dependency. Finally, we outline the experimental and translational studies required before cuproptosis-directed interventions can be rationally tested in advanced PCa.\n\nID: 42352045\nTitle: Aminochrome-Induced Disruption of Autophagosome-Lysosome Fusion: Implications for Protein Aggregation in Parkinson's Disease.\nAbstract: Aminochrome, an endogenous neurotoxin, has been implicated in the loss of neuromelanin-containing dopaminergic neurons in the nigrostriatal system in Parkinson's disease. Although aminochrome-induced oxidative stress and its inhibitory effects on microtubule polymerization are well documented, its impact on protein aggregation remains poorly understood. The aim of this research was to evaluate the effects of aminochrome on protein aggregate accumulation in SH-SY5Y cells differentiated into dopaminergic neurons. While the role of aminochrome in autophagy has been described, its direct effect on autophagosome-lysosome fusion has not been studied. Our findings reveal that aminochrome, like vinblastine, delays autophagosome-lysosome fusion and induces cell death. This inhibitory effect was also observed in the presence of autophagy inducers, which partially attenuated aminochrome-induced cell death. Under these conditions of disruptions in autophagosome-lysosome fusion, a marked accumulation of perinuclear vimentin and ubiquitin aggregates was observed. Aminochrome also increased colocalization between vimentin and ubiquitin. Interestingly, ubiquitin aggregates were also detected within the nucleus. These findings suggest that aminochrome-induced disruption of the microtubule network, particularly its impairment of autophagosome-lysosome fusion and promotion of protein aggregation, may represent a critical mechanism leading to cell death. In addition, inhibition of autophagosome-lysosome fusion may contribute to the accumulation of perinuclear and nuclear protein aggregates, which may be associated with either toxic or non-toxic pathways. Our findings underscore the therapeutic potential of targeting both microtubule stabilization and proteostasis pathways, including autophagy and the ubiquitin-proteasome system (UPS), in Parkinson's disease, highlighting the need for further research into nuclear proteotoxicity mechanisms.\n\nID: 42342297\nTitle: Advances in ferroptosis research and applications.\nAbstract: Ferroptosis is an iron-dependent form of regulated cell death driven by lipid peroxidation and redox imbalance. It has emerged as a pivotal mechanism implicated in various diseases, including cancer, chronic kidney diseases (CKD), neurodegenerative disorders, pulmonary fibrosis, chronic wounds, and viral infections such as COVID-19. This chapter presents a comprehensive overview of the molecular underpinnings of ferroptosis, emphasizing its key regulators-iron metabolism, lipid peroxidation pathways, and antioxidant defenses such as GPX4 and system Xc-. We explore recent advances highlighting the therapeutic potential of ferroptosis modulation across multiple pathological contexts. In cancer, ferroptosis inducers have shown efficacy in overcoming drug resistance and enhancing immunotherapy. In contrast, inhibition of ferroptosis offers protective effects in neurodegenerative diseases, ischemia-reperfusion injury, and chronic inflammatory conditions. Applications in nanomedicine have further enabled targeted delivery of ferroptosis modulators, expanding their clinical relevance. The chapter also discusses emerging roles of ferroptosis in wound healing, CKD and pulmonary fibrosis, with particular attention to COVID-19-related lung injury. Finally, we evaluate current therapeutic strategies, safety considerations, and potential clinical applications, along with future directions including biomarker development and personalized medicine. Our aim is to provide a unified perspective on ferroptosis as a disease-modifying mechanism and to highlight its growing importance as a therapeutic target across diverse clinical disciplines.\n\nID: 42328449\nTitle: Copper-Iron Cell Death Axis: Mechanistic Crosstalk, Disease Implications and an Integrated Metallo-Redox-Metabolic Framework.\nAbstract: Cuproptosis and ferroptosis are two major forms of metal-dependent cell death, characterized by mitochondrial proteotoxicity and lipid peroxidation, respectively, and are broadly implicated in diverse disease contexts. Here, by integrating mechanistic, biological, and disease-associated evidence, we propose the metal-metabolism-redox vulnerability axis, which describes cellular states under metal stress as a continuous space defined by metal homeostasis, mitochondrial metabolism, and redox balance. Within this space, cuproptosis and ferroptosis correspond to distinct execution regions rather than independent processes. Building on this concept, we further establish a metallo-redox-metabolic framework to explain how key state variables and their coupling relationships determine execution bias and drive dynamic transitions between death modalities. This framework reframes metal-dependent cell death as a state-driven system rather than a collection of discrete pathways and provides a unified perspective for understanding its roles in complex diseases. In addition, we outline predictive and testable hypotheses and highlight the importance of multi-omics integration and artificial intelligence based modeling in capturing cellular state and enabling dynamic prediction. Collectively, this work provides a conceptual foundation for understanding metal-driven cell fate decisions and for developing state-oriented therapeutic strategies.\n\nID: 42300786\nTitle: Ubiquitin and ubiquitin-like modifications in the endoplasmic reticulum stress response.\nAbstract: The endoplasmic reticulum (ER) is a cellular organelle frequently subjected to stress under both physiological and pathological circumstances, associated with the accumulation of mis/unfolded proteins in its lumen. To cope with this stress, cells have evolved an adaptive program called the unfolded protein response (UPR), whose primary function is to restore ER proteostasis. When the stress is prolonged, the UPR can also trigger cell death. The UPR controls multiple machineries involved in pre-emptive quality control (QC) of proteins prior to ER entry, ribosome-associated QC, protein folding within the ER, protein degradation through various processes, and export from the ER for secretion. Because the UPR and the machineries it controls play fundamental roles in determining cell fate, they are finely regulated, including through post-translational modifications (PTMs). In this review, we focus on the role of the ubiquitin and ubiquitin-like PTMs in the regulation and mediation of ER proteostasis. We specifically focus on three core processes: the UPR, ER-associated ribosome QC and ER-associated degradation. Lastly, we briefly discuss how Ub and Ubl also control the integrated stress response and the formation of inter-organelle membrane contact sites and thus act as general regulators of responses to cellular stresses beyond ER proteotoxicity.\n\nID: 42298670\nTitle: Methamphetamine hijacks chaperone-mediated autophagy to degrade GPX4, driving ferroptosis-precipitated cognitive decline and addictive pathogenesis.\nAbstract: Methamphetamine (METH) addiction is associated with progressive cognitive decline and maladaptive behaviors, but the molecular mechanisms bridging proteostatic dysfunction to neural circuit degeneration remain poorly defined. We hypothesized that METH hijacks chaperone-mediated autophagy (CMA), a lysosomal quality-control pathway, to drive neurodegeneration through ferroptosis. Using chronic METH self-administration models, hippocampal neurons, and CMA-targeted approaches, we demonstrated that METH coerces CMA components (HSC70-LAMP2A) to recognize a non-canonical 124NVKFD128 degron on glutathione peroxidase 4 (GPX4), resulting in its lysosomal degradation. This CMA-dependent GPX4 depletion disrupted glutathione recycling, unleashing lethal lipid peroxidation and hippocampal ferroptosis. Critically, neuronal CMA ablation rescued spatial memory deficits and reduced compulsive drug-seeking behaviors, establishing CMA hyperactivity as a causal driver of addiction-related neuropathology. Our findings extend the oxidative stress-centric model of METH toxicity by revealing CMA as a pathological switch that converts physiological proteostasis into a self-destructive cascade. The CMA-GPX4 axis, mechanistically linking protein quality control failure, iron-dependent cell death, and behavioral dysfunction, represents a druggable target, with CMA inhibitors showing preclinical efficacy in mitigating METH-induced neuropsychiatric deterioration. By redefining addiction-associated neurodegeneration as a disorder of hijacked proteostasis, this work provides a unified framework for targeting shared mechanisms in substance use disorders and neurodegenerative diseases.\n\nID: 42261159\nTitle: The Pivotal Role of HDAC6 in Amyotrophic Lateral Sclerosis: Neuroprotective Protagonist or Degenerative Adversary?\nAbstract: The review specifically examines the pivotal role of HDAC6 in the pathophysiological pathway of Amyotrophic Lateral Sclerosis (ALS), an escalating neurodegenerative ailment marked by the discerning damage to motor neurons. Several lines of evidence implicate inadequate proteostasis in significantly influencing neuronal degeneration. The accumulation of misfolded proteins and proteotoxicity are highlighted as significant factors in ALS pathophysiology. Key pathological hallmarks include ubiquitin-positive inclusions, disrupted RNA metabolism, cytoskeletal perturbations, and compromised axonal transport systems. HDAC6 dysregulation disrupts axonal transport, impairing mitochondrial function and increasing oxidative stress, leading to rapid motor neuron damage and cell death. The enzyme's aberrant deacetylation of \u03b1-tubulin destabilizes microtubules and impairs intracellular trafficking. Despite HDAC6's participation in these unfavorable processes, it also exerts neuroprotective properties. It deacetylates tubulin, promoting efficient axonal transport and autophagic clearance. HDAC6 helps form aggresomes and stress granules, which are essential for cellular defence against proteotoxic stress. Through its zinc finger ubiquitin-binding domain, HDAC6 interacts with polyubiquitinated proteins, facilitating their autophagic degradation. HDAC6 inhibition can boost autophagic flux and reduce protein aggregation, while its activation may amplify the protective effects. This dichotomous behaviour of HDAC6 may pose an obstacle to the design of targeted therapy. Illuminating the complex mechanisms through which HDAC6 influences neurodegeneration and neuroprotection is important before constructing effective treatments for ALS. The review provides a clear understanding of the complex role of HDAC6 in ALS pathogenesis and highlights potential strategies to improve the prognosis of people affected by this neurological illness.\n\nID: 42240198\nTitle: Plant-Derived Thylakoids Potentiate Copper-Mediated Multimodal Cell Death via Hypoxia Alleviation for Synergistic Antitumor Therapy.\nAbstract: Cuproptosis is a copper-dependent programmed cell death mechanism characterized by mitochondrial copper accumulation, which leads to protein aggregation and proteotoxic stress, offering considerable anti-cancer potential. However, the hypoxic tumor microenvironment (TME) activates HIF-1\u03b1 signaling, promoting glycolytic metabolism and reducing sensitivity to cuproptosis. To overcome this limitation, we designed TC@UN/G, a system comprising a metal-organic framework (UN) for copper delivery, oxygen-generating thylakoids (T) to alleviate hypoxia via photosynthesis, and a thermosensitive F127 hydrogel (G) for localized sustained release through peritumoral injection. Upon peritumoral injection and light illumination, thylakoids produced oxygen, relieving hypoxia and restoring mitochondrial function. This sensitized tumor cells to cuproptosis and concurrently triggered ferroptosis and immunogenic cell death, thereby activating antitumor immunity. In the cancer model, TC@UN/G+IL suppressed tumor growth and remodeled the TME. This approach offers a holistic strategy for solid tumor therapy by modulating the TME, potentiating cuproptosis, and activating the immune response.\n\nID: 42218124\nTitle: CLN7 suppression induces apoptosis via mTOR-regulated and chaperone-mediated autophagy in myeloid leukemia cells.\nAbstract: Refractory disease and relapse continue to impede effective treatment of myeloid leukemia, despite substantial progress in therapeutic approaches. Emerging evidence implicates lysosomal ion channels in the regulation of cell death pathways, highlighting these channels as viable targets for therapeutic intervention. This study identified elevated expression of the lysosomal ion channel CLN7 in myeloid leukemia cells. Suppression of CLN7 triggered apoptosis, inhibited cellular proliferation, and markedly reduced the abundance of oncogenic proteins. Mechanistically, CLN7 inhibition promoted nuclear translocation of TFEB by downregulating mTOR signaling, thereby enhancing lysosomal biogenesis and macroautophagy. Notably, CLN7 suppression selectively accelerated chaperone-mediated autophagic degradation of BCR-ABL through cathepsin B (CTSB) upregulation. In addition, inhibition of CLN7 induced autophagy-mediated apoptosis, which led to significant impairment of leukemogenic potential. Co-treatment with chemotherapeutic agents and CLN7 suppression enhanced therapeutic efficacy in myeloid leukemia cells. Finally, suppression of CLN7 markedly reduced tumor growth in human xenograft models without compromising normal hematopoietic function. These findings establish CLN7 as a critical regulator of leukemic cell survival, representing a promising therapeutic target for myeloid leukemia.\n\nID: 42113991\nTitle: Chaperone-mediated autophagy protects against retinal photoreceptor degeneration by modulating proteostasis of glucose metabolism enzymes.\nAbstract: Defective proteostasis is a hallmark of aging cells and tissues. Among the different components of the proteostasis network, in this study, we focus on a selective form of autophagy known as chaperone-mediated autophagy (CMA), and we set out to understand its physiological role in the retina. Using mice deficient for CMA [knockout for lysosome-associated membrane protein type 2A (Lamp2A)], we have found that CMA blockade leads to impaired visual function, altered retinal proteostasis, and photoreceptor cell death. Conversely, mice that overexpress human LAMP2A show higher resistance to chemically induced photoreceptor degeneration and slower visual function decline. We found a similar protective effect against retinal degeneration upon pharmacological activation of CMA. To start elucidating the mechanisms behind CMA's protective role in the retina, we used comparative proteomics and found elevated levels of enzymes related with glucose metabolism in CMA-deficient retinas that phenocopy those observed in old mice retinas. Overall, our results highlight a cytoprotective role for CMA in retina, in part through proteostatic regulation of enzymes involved in glucose metabolism, and support the feasibility of pharmacologically upregulating CMA against retinal degeneration.\n\nID: 42021324\nTitle: Parkin regulates NLRP3 degradation through chaperone-mediated autophagy to suppress PANoptosis and protect dopaminergic neurons in Parkinson's disease.\nAbstract: Parkinson's Disease (PD) is characterized by selective loss of dopaminergic (DA) neurons in the substantia nigra pars compacta (SNpc). PANoptosis, a programmed inflammatory cell death integrating pyroptosis, apoptosis, and necroptosis, contributes to DA neuron degeneration in PD. The E3 ubiquitin ligase Parkin and the inflammasome sensor NOD-like receptor protein 3 (NLRP3) are known to play critical regulatory roles in DA neuron degeneration. However, whether Parkin modulated NLRP3 via chaperone-mediated autophagy (CMA) to inhibit PANoptosis remained unclear. To verify the above hypothesis, SN4741 cells and C57BL/6 mice were treated with rotenone to establish PD models. PANoptosis activation and DA neurons degeneration were observed in PD models, and these pathological manifestations were mitigated by the NLRP3 inhibitor MCC950. Besides, Parkin interacted with NLRP3, ubiquitinated its K353 residue, and then promoted NLRP3 degradation via CMA. Parkin overexpression or CMA activation alleviated DA neuron damage and PANoptosis, while K353R mutation abolished these effects. It was revealed that Parkin mediated CMA-dependent degradation of NLRP3 (targeting K353) to suppress PANoptosis and protect DA neurons in PD. CMA activators or NLRP3 inhibitors may serve as disease-modifying therapies for PD.\n\nID: 41968682\nTitle: Molecular Mechanisms of Dopaminergic Neuron Degeneration in Parkinson's disease: A Comprehensive Review.\nAbstract: Parkinson's disease (PD) is a neurological condition that starts with the degeneration of neurons. Neurons play a crucial role in producing dopamine (DA), a type of neurotransmitter that primarily regulates bodily functions such as motor control, posture, motivation, reward, pleasure, cognition, and memory. Other variables that contribute to the disorder include the buildup of Lewy bodies and Lewy neurites, which are composed of increased \u03b1-synuclein (\u03b1-syn). Depletion of DA in the striatal area and the death of DA-producing neurons are often considered the basis for the mo-tor impairments seen in PD. In addition, both genetic and environmental factors may play a role in PD etiology; specifically, genetic variations and exposure to toxins may contribute to the development of brain lesions. The article aims to outline the current state of knowledge on the dopaminergic pathway and how PD affects DA homeostasis. Various molecular mechanisms are involved in the pathogenesis of PD, including \u03b1-syn aggregation, lysosomal and chaperone-mediated autophagy, mitochondrial dysfunction, and abnormal regulation of calcium homeostasis. Intrinsic and extrinsic caspase-mediated apoptosis, autophagic cell death, and ferroptosis are also involved in neurodegen-eration that often leads to PD. The occurrence of PD can be controlled by the inclusion of antioxi-dants, such as mitoquinone, which inhibit mitochondrial oxidative damage, as well as modulation of autophagy, proteostasis, gene therapy, and its editing, and stem cell regeneration. Diverse mechanistic pathogenesis and genetic variations make PD a complicated disease to tackle. Potential treatment approaches, such as modulating autophagy-lysosomal pathways and protecting mitochon-dria, may be better understood with deeper insight into these mechanisms. We conclude by highlighting current and upcoming gene and cell therapies.\n\nID: 41941350\nTitle: Dual Energy Depletion by Zinc/Copper Disruptor to Potentiate Cuproptosis and Pyroptosis for Enhanced Tumor Immunotherapy.\nAbstract: Metal ion interference therapy disrupts ion homeostasis to stimulate immunity, but the underlying mechanisms remain poorly elucidated. Here, a hydrazide hyaluronan-decorated copper/zinc disruptor is constructed to inhibit tumoral energy metabolism and activate anticancer immunity. Functionally, Zn2+ acts as a metabolic inhibitor to suppress glycolysis by directly restraining lactate dehydrogenase activity and downregulating the PI3K/Akt/HIF-1\u03b1 axis, thus reducing lactate output and limiting adenosine triphosphate generation. In parallel, Cu2+ triggers cuproptosis via mitochondrial proteotoxicity and lipoylated protein aggregation, thereby blocking the flux of pyruvate into the tricarboxylic acid cycle and aggravating energy exhaustion. This metabolic collapse forms a mechanistic cascade, in which glycolytic inhibition predisposes cells to cuproptotic stress, while cuproptosis further reinforces pyroptotic activation. Ultimately, ion overload, severe energy deficit, and subsequent oxidative perturbation cooperatively amplify pyroptosis-driven inflammatory cytokine release and establish a synergistic metal ion-induced immunogenic cell death pathway. In vitro studies reveal that the anticancer activity of the disruptor involves oxidative stress, mitochondrial dysfunction, and inflammatory responses. In vivo studies demonstrate that it efficiently suppresses primary and distant tumor growth and activates systemic immunity. Collectively, this bimetallic disruption strategy bridges metal therapy with immunotherapy, provides insights into the underlying molecular mechanisms, and highlights the potential of metal-based nanomedicine for tumor immunotherapy.\n\nID: 41828458\nTitle: Crosstalk Between Autophagy and Paraptosis: A New Frontier in Cancer Therapy.\nAbstract: Autophagy and paraptosis are two distinct physiological mechanisms involved in regulating cell fate in cancer. Recent studies have demonstrated that autophagy is a crucial process for maintaining cellular homeostasis by facilitating the removal of misfolded proteins and damaged organelles. However, autophagy is found to play a dual role in cancer. Severe ER and mitochondrial dysfunction can trigger different forms of programmed cell death, including autophagic cell death. In cancer cells that evade apoptosis, paraptosis, a caspase-independent alternate death pathway, is triggered by ER and mitochondrial swelling, leading to extensive cytoplasmic vacuolation. It can be induced by natural compounds, metallic complexes, nanoparticles, or chemotherapeutic agents, primarily through excessive ROS production and disruption of protein, thiol, and calcium/ion homeostasis. Autophagy and paraptosis have been found to be connected through crosstalk. While MAPK activation drives paraptosis, ER stress and the unfolded protein response (UPR) can initiate both paraptosis and autophagy. UPR-mediated PERK activation promotes survival autophagy in ER-stressed melanoma, whereas PERK elimination triggers paraptosis via sec61\u03b2 with unresolved ER stress. Similarly, CHOP and DDIT4 can enhance ER stress and proteotoxicity, thereby favouring paraptosis. This review is unique in exploring the dynamic interplay between autophagy and paraptosis in cancer cells, highlighting promising therapeutic targets for chemotherapy-resistant cancers.\n\nID: 41766674\nTitle: STING1 exacerbates iodinated contrast-induced acute kidney injury by promoting ferroptosis through chaperone-mediated autophagic degradation of FTH1.\nAbstract: Iodinated contrast-induced acute kidney injury (CI-AKI) is a common clinical complication with poor prognostic outcomes, yet its molecular mechanisms remain incompletely understood. Ferroptosis, a regulated form of cell death driven by iron overload and lipid peroxidation, has been implicated in CI-AKI. However, its involvement and precise regulation in CI-AKI remain unclear. Here, we identify STING1 (stimulator of interferon response cGAMP interactor 1) as a key mediator of ferroptosis in renal proximal tubular cells (RPTCs). We demonstrate that iodinated contrast media (ICM) activate STING1, triggering ferroptosis. Using proximal tubule-specific sting1 knockout mice and primary RPTCs, we show that Sting1 deficiency mitigates ferroptosis and alleviates CI-AKI. Mechanistically, STING1 interacts with HSPA8/HSC70 (heat shock protein family A (Hsp70) member 8) in patients with acute tubular necrosis and experimental CI-AKI models, facilitating the chaperone-mediated autophagic degradation of FTH1 (ferritin heavy chain 1) and GPX4 (glutathione peroxidase 4). Notably, inhibition of chaperone-mediated autophagy (CMA) via LAMP2A (lysosomal associated membrane protein 2A) knockdown inhibits FTH1 and GPX4 degradation, and attenuates ferroptosis. These findings uncover a novel STING1-driven mechanism linking CMA to ferroptosis in CI-AKI and highlight the STING1 pathway as a potential therapeutic target for contrast-induced renal injury.Abbreviations: 3-MA: 3-methyladenine; AIFM2/FSP1: AIF family member 2, ferroptosis suppressor; CLBD: cytoplasmic ligand-binding domain; CGAS: cyclic GMP-AMP synthase; CI-AKI: contrast-induced acute kidney injury; CMA: chaperone-mediated autophagy; CQ: chloroquine; CTT: C-terminal tail; DHE: dihydroethidium; FTH1: ferritin heavy chain 1; GAPDH: glyceraldehyde-3-phosphate dehydrogenase; GPX4: glutathione peroxidase 4; GSH/GSSG: glutathione/glutathione oxidized; KO: knockout; HK-2 cell: human renal proximal tubular epithelial cell; HSPA8/HSC70: heat shock protein family A (Hsp70) member 8; IRI: ischemia-reperfusion injury; KFERQ: CMA recognition pentapeptide; LAMP2A: lysosomal associated membrane protein 2A; MDA: malondialdehyde; NCOA4: nuclear receptor coactivator 4; PT: proximal tubule; RPTCs: renal proximal tubule cells; ROS: reactive oxygen species; STING1: stimulator of interferon response cGAMP interactor 1; TMD: transmembrane domain; WT: wild-type.\n\nID: 41544689\nTitle: Regulated cell death in COPD: Modulators, crosstalk mechanisms, and therapeutic opportunities.\nAbstract: Chronic obstructive pulmonary disease (COPD) is a progressive inflammatory airway disorder, with emerging evidence highlighting the central role of regulated cell death (RCD) in its pathogenesis. However, the regulatory mechanisms, crosstalk between different RCD pathways, and their role in intercellular communication remain poorly understood. This review examines major forms of RCD (apoptosis, necroptosis, ferroptosis, pyroptosis, NETosis, and PANoptosis) in COPD, exploring their regulation, crosstalk, role in intercellular signaling, and potential as therapeutic targets. Mechanistically, RCD is regulated through membrane receptors, epigenetic modifications, and post-translational processes. Endoplasmic reticulum (ER) stress, reactive oxygen species, and autophagy serve as common nodes across multiple RCD types. Excessive ER stress triggers apoptosis, while impaired autophagy promotes oxidative stress, cellular senescence, and inflammation. Conversely, excessive autophagy-including mitophagy, ferritinophagy, lysosomal autophagy, ER-phagy, and chaperone-mediated autophagy-can induce apoptosis, necroptosis, and ferroptosis. Regarding inter-pathway crosstalk and RCD-mediated intercellular communication: reduced macrophage apoptosis exacerbates epithelial inflammation and apoptosis; macrophage inflammation or ferroptosis can further promote epithelial ferroptosis or inflammatory responses. Ferroptosis in airway epithelial cells aggravates their own pyroptosis, and pyroptotic epithelial cells secrete exosomes that induce macrophage pyroptosis. NETotic neutrophils release extracellular DNA, driving inflammation in airway epithelia. Therapeutically, current exploratory strategies target these death pathways through diverse approaches, including existing pharmaceuticals, hormones, phytochemicals, recombinant proteins and nucleic acids, stem cell and regenerative therapies, and modulation of the airway microbiome. Deciphering the RCD network in COPD not only enhances our understanding of disease heterogeneity but also paves the way for developing precision therapeutics.\n\nID: 41534263\nTitle: Self-reinforced photothermal-immunomodulation potentiating ISR-ICD cascade against postoperative relapse.\nAbstract: Postoperative liver cancer relapse remains a formidable clinical challenge. Photothermal therapy (PTT) holds promise by eliminating residual malignancies and activating antitumor immunity; notably, tumor cells persistently reconstitute proteostasis and survive by integrated stress response (ISR)-mediated heat shock protein 90 (HSP90) activation to constrain PTT efficacy. To address this limitation, we engineered a self-reinforced photothermal-immunomodulation strategy based on electrospun nanofiber scaffolds co-loaded with black phosphorus nanosheets (BPNSs) and the HSP90 inhibitor 17-DMAG. These nanofiber scaffolds exhibited robust hydrophobicity, efficient photothermal conversion, and near-infrared (NIR) responsive controlled drug release. Under NIR irradiation, the nanofiber scaffolds leveraged BPNSs to generate stable PTT while liberating 17-DMAG to amplify proteotoxicity, forcibly redirecting the ISR from pro-survival adaptation toward robust apoptosis and immunogenic cell death (ICD). Consequently, prominently exposed damage-associated molecular patterns potentiated tumor immunogenicity and remodeled immune microenvironment by dendritic cells maturation, cytotoxic T lymphocytes (CTLs) priming, and immunosuppressive populations reprogramming. Crucially, subsequent synergy with anti-PD-L1 reinvigorated CTLs and established durable immune memory. Systematic validation confirmed this localized strategy uniquely integrates precision photothermal energy conversion with potent ISR-ICD cascade, effectively synergizing with anti-PD-L1 to suppress postoperative liver cancer relapse and metastasis, thereby holding substantial translational potential for clinical oncology.\n\nID: 41495336\nTitle: Chaperone-mediated autophagy ameliorates hyperlipidemia-induced apoptosis in podocytes via attenuating lipid accumulation.\nAbstract: Lipid disorder is an independent risk factor of diabetic kidney disease (DKD). Excess accumulation of lipid in podocytes can cause cell dysfunction and cell death. Chaperone-mediated autophagy (CMA) serves as a critical role in regulating lipid metabolism. However, the exact role of CMA in the podocytes of DKD with dyslipidemia is still uncertain. Herein, we aimed to explore the role of CMA in hyperlipidemia-induced lipid accumulation and apoptosis in podocytes. In the present study, we showed that palmitic acid (PA) treatment induced the activation of CMA, increased lipid accumulation and apoptosis in podocytes. We further found that blocking CMA with inhibitor VER155008 or LAMP-2\u00a0A siRNA significantly upregulated PA-induced increased expression of PLIN2, exacerbated PA-induced lipid accumulation and apoptosis, whereas promoting CMA with Torin1 downregulated the expression of PLIN2, ameliorated lipid accumulation and apoptosis in PA-induced podocytes. Moreover, we also observed the activation of CMA and increased lipid accumulation in the kidney tissue of DKD mice. Taken together, these results suggest that CMA plays a protective role in PA-induced podocytes apoptosis and that the potential protective mechanism of CMA is involved in reducing cellular lipid accumulation through mediating the degradation of PLIN2.\n\nID: 41400098\nTitle: Hyperandrogenemia Induces Trophoblast Ferroptosis and Early Pregnancy Loss in Patients With PCOS via CMA-Dependent FTH1 Degradation.\nAbstract: Polycystic ovary syndrome (PCOS) patients with hyperandrogenemia exhibit an increased risk of early pregnancy loss; however, the underlying mechanisms remain poorly understood. Ferroptosis, an iron-dependent form of cell death driven by phospholipid peroxidation, has been implicated in various diseases. This study identifies significant\u00a0iron homeostasis\u00a0disorders and ferroptosis in PCOS patients with hyperandrogenemia, which is mediated by androgen-induced reduction of ferritin heavy chain 1 (FTH1) protein levels in trophoblasts. Specifically, androgens upregulate FTH1 mRNA and protein synthesis by binding to androgen response elements on the FTH1 promoter via the androgen receptor (AR). Simultaneously, elevated androgen levels enhance chaperone-mediated autophagy (CMA) through upregulating LAMP2A (lysosomal-associated membrane protein 2), thereby promoting FTH1 protein degradation. When androgen levels are excessive or AR is overactivated, this CMA-driven degradation exceeds FTH1 protein synthesis, leading to a reduction in FTH1 level. Furthermore, metformin was found to compete with androgens for AR binding, thereby stabilizing FTH1 and protecting trophoblasts from ferroptosis. In PCOS-model mice, metformin significantly reduced early embryonic absorption. These findings reveal androgen-induced ferroptosis as a key mechanism in placental dysfunction and highlight a potential application of metformin for treatment of early pregnancy loss associated with PCOS.\n\nID: 41317862\nTitle: Goat bone marrow mesenchymal stem cell angiotensin-converting enzyme 2 attenuates Streptococcus uberis-induced ferroptosis in goat mammary epithelial cells by downregulating the reactive oxygen species-chaperone-mediated autophagy pathway.\nAbstract: Streptococcus uberis is a leading cause of environmental mastitis globally. Ferroptosis, a cell death pathway driven by Fe2+-mediated lipid peroxide accumulation, with reactive oxygen species (ROS) participating in this process, is related to the mechanisms of infections caused by other pathogens inducing mastitis, such as Escherichia coli and Staphylococcus aureus. This study aims to investigate whether ferroptosis occurs in S. uberis-induced mastitis and to develop corresponding therapeutic interventions. Goat bone marrow mesenchymal stem cells (GBMSC) were isolated from a 3-mo-old healthy goat. After verification via surface marker analysis and trilineage differentiation, angiotensin-converting enzyme 2 (ACE2)-overexpressing GBMSC (GBMSC-ACE2) were generated using lentiviral vectors. In vitro, a coculture model of GBMSC, GBMSC-GFP, or GBMSC-ACE2 with goat mammary epithelial cells (GMEC) infected by S. uberis was established. Results showed that GBMSC-ACE2 effectively reduced ROS accumulation and inflammatory cytokine secretion, inhibited excessive activation of chaperone-mediated autophagy (CMA), and maintained iron metabolism homeostasis, thus alleviating S. uberis-induced ferroptosis in GMEC better than GBMSC or GBMSC-GFP. The main manifestations were: 1) inhibiting ADAM metallopeptidase domain 17 (ADAM17) and promoting ACE2 expression to suppress the Angiotensin II (Ang II)/Ang II Type 1 Receptor (AT1R)/NADPH oxidase 2 (NOX2) pathway; 2) inhibiting lysosomal associated membrane protein\u20022A (LAMP2A), heat shock cognate protein 70 (Hsc70), heat shock protein 90 (Hsp90) while promoting glutathione peroxidase 4 (GPX4) expression; 3) reducing intracellular Fe2+ accumulation; 4) delaying lipid peroxidation. In vivo, 9 lactating goats were randomly divided into 3 groups (n = 3 each): control, S. uberis-infected, and GBMSC-ACE2-treated. The experiment lasted 7 d. The GBMSC-ACE2 significantly decreased SCC, improved milk yield and quality, inhibited bacterial proliferation, enhanced ACE2 expression in mammary tissue, and alleviated ferroptosis by suppressing CMA-mediated GPX4 degradation, thus reducing damage to the blood-milk barrier and mammary tissue. In conclusion, this study suggests that GBMSC-ACE2 is a novel treatment for S. uberis mastitis, capable of inhibiting ferroptosis in mammary epithelial cells and promoting tissue regeneration.\n\nID: 41262881\nTitle: Compound Tinglizi Decoction-Containing Serum Is Associated with Inhibition of PANoptosis in Cardiomyocytes via SIRT3-Related Chaperone-Mediated Autophagy of AIM2.\nAbstract: Septic cardiomyopathy (SCM) is a life-threatening complication of sepsis with no specific therapeutic options. Recent evidence suggests that PANoptosis, a programmed cell death pathway, contributes to myocardial injury in sepsis. Compound Tinglizi Decoction (CTLZC), a traditional Chinese herbal formula, has shown potential cardioprotective effects, yet the underlying biochemical mechanisms remain unclear. A rat model of SCM was established to investigate the effect of CTLZC-containing serum on myocardial injury. Primary cardiomyocytes were treated with CTLZC-containing serum, and SIRT3 expression was modulated via overexpression and knockdown plasmids. Cell viability, PANoptosis markers, and chaperone-mediated autophagy (CMA) proteins were assessed through CCK-8, TUNEL staining, RT-qPCR, Western blotting, ELISA, and Co-IP assays. CTLZC-containing serum enhanced cardiomyocyte viability and significantly upregulated SIRT3 expression. It inhibited the expression of PANoptosis-related molecules (AIM2, ZBP1, RIPK1, RIPK3, FADD, and caspase-8) and promoted the expression of CMA-related proteins HSC70 and LAMP2A. SIRT3 knockdown reversed these effects and increased the release of biochemical markers of myocardial injury (LDH, CK-MB) and inflammatory cytokines (TNF-\u03b1, IL-1\u03b2, IL-18). Co-IP confirmed that AIM2 interacts with HSC70, indicating lysosomal degradation via CMA. CTLZC-containing serum attenuates inflammatory and cell death responses in septic cardiomyopathy, likely through a SIRT3-associated modulation of chaperone-mediated autophagy and PANoptosis. These findings highlight the biochemical regulatory role of SIRT3 in mediating autophagic and inflammatory pathways during SCM, offering new insights into potential therapeutic targets.\n\nID: 41173434\nTitle: ACE2 mitigates Streptococcus uberis-induced ferroptosis in goat mammary epithelial cells by inhibiting ROS-chaperone-mediated autophagic degradation of GPX4.\nAbstract: Streptococcus uberis (S. uberis), is a prevalent and highly infectious environmental pathogen that exacerbates the pathological process of mastitis in lactating animals by inducing oxidative stress and cell damage. Ferroptosis, a novel form of programmed cell death, has attracted increasing attention for its potential role in the pathogenesis of mastitis caused by pathogens like S. aureus and E. coli. However, whether S. uberis infection exacerbates damage to goat mammary epithelial cells (GMECs) via ferroptosis and its underlying regulatory mechanisms remain unclear. This study found that S. uberis infection induced iron overload and lipid peroxidation, with a significant decrease in GPX4, a key regulator of ferroptosis. Further investigation revealed that S. uberis-mediated over-activation of chaperone-mediated autophagy (CMA) promoted GPX4 degradation in lysosomes, regulated by ROS levels. Additionally, S. uberis infection activated ADAM17, reducing membrane-bound ACE2 expression, and promoting the activation of the Ang II/AT1R/NOX2 pathway to induce oxidative stress. ACE2, by degrading Ang II, decreased intracellular ROS, enhanced GPX4 stability, and reduced CMA activity, alleviating ferroptosis. These findings identify ACE2 as a key regulator of the ROS-CMA-GPX4 axis during S. uberis infection, offering new insights into host defense against S. uberis-induced mastitis and highlighting ferroptosis regulation as a promising therapeutic strategy for bacterial infectious diseases.\n\nID: 41808488\nTitle: Regulated neuronal death in Alzheimer's disease: Crosstalk and convergence of apoptosis, pyroptosis, senescence, and ferroptosis.\nAbstract: Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by memory loss and cognitive impairment. Despite its rapidly increasing global prevalence, effective disease-modifying therapies remain limited. Neuronal loss is a central pathological hallmark of AD, yet classical proteinopathy frameworks centered on amyloid-\u03b2 (A\u03b2) deposition and tau hyperphosphorylation do not fully explain the extent and dynamics of neurodegeneration. Convergent upstream pressures-including A\u03b2/tau-associated proteotoxicity, mitochondrial dysfunction and oxidative stress, glucose hypometabolism/brain insulin resistance, and chronic neuroinflammation-lower the threshold for regulated neuronal death programs. Evidence from human postmortem brains and experimental AD models implicates multiple death modalities, including apoptosis, inflammasome-associated pyroptosis, cellular senescence with a senescence-associated secretory phenotype (SASP), and ferroptosis driven by iron-dependent lipid peroxidation. These signatures are often mixed and show region- and stage-dependent patterns, reflecting context- and model-specific drivers rather than mutually exclusive pathways. A crosstalk-and-convergence view highlights shared hubs-oxidative stress, mitochondrial failure, inflammasome/cytokine signaling, and SASP-mediated chronic inflammation-that connect these modalities through feed-forward loops, helping to explain the limited durability of single-pathway interventions. This review summarizes recent advances across these four pathways, discusses their mechanistic interplay, and outlines translational considerations (blood-brain barrier delivery, target specificity, and limited clinical evidence). We also highlight priorities for future work, including single-cell/spatial profiling, multi-omics integration, and biomarker-guided stratification to enable rational combination strategies.\n\nID: 39394148\nTitle: NAD+-boosting agent nicotinamide mononucleotide potently improves mitochondria stress response in Alzheimer's disease via ATF4-dependent mitochondrial UPR.\nAbstract: Extensive studies indicate that mitochondria dysfunction is pivotal for Alzheimer's disease (AD) pathogenesis; while cumulative evidence suggests that increased mitochondrial stress response (MSR) may mitigate neurodegeneration in AD, explorations to develop a MSR-targeted therapeutic strategy against AD are scarce. We combined cell biology, molecular biology, and pharmacological approaches to unravel a novel molecular pathway by which NAD+-boosting agent nicotinamide mononucleotide (NMN) regulates MSR in AD models. Here, we report dyshomeostasis plasma UPRmt-mitophagy-mediated MSR profiles in AD patient samples. NMN restores NAD+ metabolic profiles and improves MSR through the ATF4-dependent UPRmt pathway in AD-related cross-species models. At the organismal level, NAD+ repletion with NMN supplementation ameliorates mitochondrial proteotoxicity, decreases hippocampal synaptic disruption, decreases neuronal loss, and brain atrophy in mice model of AD. Remarkably, omics features of the hippocampus with NMN show that NMN leads to transcriptional changes of genes and proteins involved in MSR characteristics, principally within the astrocyte unit rather than microglia and oligodendrocytes. In brief, our work provides evidence that MSR has an active role in the pathogenesis of AD, as reducing mitochondrial homeostasis via atf4 depletion in AD mice aggravates the hallmarks of the disease; conversely, bolstering mitochondrial proteostasis by NMN decreases protein aggregation, restores memory performance, and delays disease progression, ultimately translating to increased healthspan.\n\nID: 39317269\nTitle: DMT1 knockout abolishes ferroptosis induced mitochondrial dysfunction in C. elegans amyloid \u03b2 proteotoxicity.\nAbstract: Iron is critical for neuronal activity and metabolism, and iron dysregulation alters these functions in age-related neurodegenerative disorders, such as Alzheimer's disease (AD). AD is a chronic neurodegenerative disease characterized by progressive neuronal dysfunction, memory loss and decreased cognitive function. AD patients exhibit elevated iron levels in the brain compared to age-matched non-AD individuals. However, the degree to which iron overload contributes to AD pathogenesis is unclear. Here, we evaluated the involvement of ferroptosis, an iron-dependent cell death process, in mediating AD-like pathologies in C. elegans. Results showed that iron accumulation occurred prior to the loss of neuronal function as worms age. In addition, energetic imbalance was an early event in iron-induced loss of neuronal function. Furthermore, the loss of neuronal function was, in part, due to increased mitochondrial reactive oxygen species mediated oxidative damage, ultimately resulting in ferroptotic cell death. The mitochondrial redox environment and ferroptosis were modulated by pharmacologic processes that exacerbate or abolish iron accumulation both in wild-type worms and worms with increased levels of neuronal amyloid beta (A\u03b2). However, neuronal A\u03b2 worms were more sensitive to ferroptosis-mediated neuronal loss, and this increased toxicity was ameliorated by limiting the uptake of ferrous iron through knockout of divalent metal transporter 1 (DMT1). In addition, DMT1 knockout completely suppressed phenotypic measures of A\u03b2 toxicity with age. Overall, our findings suggest that iron-induced ferroptosis alters the mitochondrial redox environment to drive oxidative damage when neuronal A\u03b2 is overexpressed. DMT1 knockout abolishes neuronal A\u03b2-associated pathologies by reducing neuronal iron uptake.\n\nID: 39149382\nTitle: DMT1 knockout abolishes ferroptosis induced mitochondrial dysfunction in C. elegans amyloid \u03b2 proteotoxicity.\nAbstract: Iron is critical for neuronal activity and metabolism, and iron dysregulation alters these functions in age-related neurodegenerative disorders, such as Alzheimer's disease (AD). AD is a chronic neurodegenerative disease characterized by progressive neuronal dysfunction, memory loss and decreased cognitive function. AD patients exhibit elevated iron levels in the brain compared to age-matched non-AD individuals. However, the degree to which iron overload contributes to AD pathogenesis is unclear. Here, we evaluated the involvement of ferroptosis, an iron-dependent cell death process, in mediating AD-like pathologies in C. elegans. Results showed that iron accumulation occurred prior to the loss of neuronal function as worms age. In addition, energetic imbalance was an early event in iron-induced loss of neuronal function. Furthermore, the loss of neuronal function was, in part, due to increased mitochondrial reactive oxygen species mediated oxidative damage, ultimately resulting in ferroptotic cell death. The mitochondrial redox environment and ferroptosis were modulated by pharmacologic processes that exacerbate or abolish iron accumulation both in wild-type worms and worms with increased levels of neuronal amyloid beta (A\u03b2). However, neuronal A\u03b2 worms were more sensitive to ferroptosis-mediated neuronal loss, and this increased toxicity was ameliorated by limiting the uptake of ferrous iron through knockout of divalent metal transporter 1 (DMT1). In addition, DMT1 knockout completely suppressed phenotypic measures of A\u03b2 toxicity with age. Overall, our findings suggest that iron-induced ferroptosis alters the mitochondrial redox environment to drive oxidative damage when neuronal A\u03b2 is overexpressed. DMT1 knockout abolishes neuronal A\u03b2-associated pathologies by reducing neuronal iron uptake.\n\nID: 35053188\nTitle: Lipotoxicity Downstream of \u03b1-Synuclein Imbalance: A Relevant Pathomechanism in Synucleinopathies?\nAbstract: Neuronal loss in Parkinson's disease and related brain diseases has been firmly linked to the abundant neuronal protein \u03b1-synuclein (\u03b1S). However, we have gained surprisingly little insight into how exactly \u03b1S exerts toxicity in these diseases. Hypotheses of proteotoxicity, disturbed vesicle trafficking, mitochondrial dysfunction and other toxicity mechanisms have been proposed, and it seems possible that a combination of different mechanisms may drive pathology. A toxicity mechanism that has caught increased attention in the recent years is \u03b1S-related lipotoxicity. Lipotoxicity typically occurs in a cell when fatty acids exceed the metabolic needs, triggering a flux into harmful pathways of non-oxidative metabolism. Genetic and experimental approaches have revealed a significant overlap between lipid storage disorders, most notably Gaucher's disease, and synucleinopathies. There is accumulating evidence for lipid aberrations causing synuclein misfolding as well as for \u03b1S excess and misfolding causing lipid aberration. Does that mean the key problem in synucleinopathies is lipotoxicity, the accumulation of harmful lipid species or alteration in lipid equilibrium? Here, we review the existing literature in an attempt to get closer to an answer.\n\nID: 32707907\nTitle: Rapid Alpha-Synuclein Toxicity in a Neural Cell Model and Its Rescue by a Stearoyl-CoA Desaturase Inhibitor.\nAbstract: Genetic and biochemical evidence attributes neuronal loss in Parkinson's disease (PD) and related brain diseases to dyshomeostasis of the 14 kDa protein \u03b1-synuclein (\u03b1S). There is no consensus on how \u03b1S exerts toxicity. Explanations range from disturbed vesicle biology to proteotoxicity caused by fibrillar aggregates. To probe these mechanisms further, robust cellular toxicity models are needed, but their availability is limited. We previously reported that a shift from dynamic multimers to monomers is an early event in \u03b1S dyshomeostasis, as caused by familial PD (fPD)-linked mutants such as E46K. Excess monomers accumulate in round, lipid-rich inclusions. Engineered \u03b1S '3K' (E35K+E46K+E61K) amplifies E46K, causing a PD-like, L-DOPA-responsive motor phenotype in transgenic mice. Here, we present a cellular model of \u03b1S neurotoxicity after transducing human neuroblastoma cells to express yellow fluorescent protein (YFP)-tagged \u03b1S 3K in a doxycycline-dependent manner. \u03b1S-3K::YFP induction causes pronounced growth defects that accord with cell death. We tested candidate compounds for their ability to restore growth, and stearoyl-CoA desaturase (SCD) inhibitors emerged as a molecule class with growth-restoring capacity, but the therapeutic window varied among compounds. The SCD inhibitor MF-438 fully restored growth while exerting no apparent cytotoxicity. Our \u03b1S bioassay will be useful for elucidating compound mechanisms, for pharmacokinetic studies, and for compound/genetic screens.\n\nID: 30771179\nTitle: Monitoring \u03b1-Synuclein Proteotoxicity in Drosophila Models.\nAbstract: Parkinson's disease is the second most common neurodegenerative disease without cure. It is characterized by \u03b1-synuclein accumulation and aggregation in dopaminergic and other types of neurons. Because \u03b1-synuclein accumulation leads to a toxic gain of function, its ectopic expression in Drosophila has been a useful in vivo model for testing modifiers of its toxicity. This chapter describes four assays: the rapid iterative negative geotaxis, rough eye phenotype, quantification of dopaminergic neuronal loss, and measurements of circadian effects.\n\nID: 30631036\nTitle: Lamin B is a target for selective nuclear PQC by BAG3: implication for nuclear envelopathies.\nAbstract: Nuclear envelopathies are recognized genetic disorders affecting individuals with mutations in their genes encoding members of the lamin family of nuclear envelope proteins that are responsible for maintaining the architectural structure of the nucleus. Irregularity in shape and size of the nuclei, nuclear membrane rupture, and appearance of micronuclei in the cytoplasm are among the pathological features of the syndrome. Here, we demonstrate that Bcl2-associated anthanogene-3 (BAG3), a stress-induced co-chaperone protein that by association with heat-shock protein 70 (HSP70) participates in regulation of autophagy, plays a critical role in the integrity of the nuclear membrane in cardiomyocytes. Cells subjected to proteotoxic stress or BAG3 downregulation show perinuclear accumulation of the aberrant ubiquitinated proteins that are often associated with the appearance of misshapen, enlarged, and elongated nuclei. There were dense accumulations of lamin B in the perinuclear area and distribution of lamin B-positive micronuclei in the cytoplasmic space, indicative of nuclear envelope rupture. Overexpression of BAG3 in cells under proteotoxic stress ameliorated pathological nuclear morphology and reduced cytoplasmic distribution of the micronuclei particles. Subcellular co-localization and co-immunoprecipitation demonstrated interaction of lamin B with the BAG domain of BAG3 and HSP70, suggesting the importance of BAG3 in the selective clearance of a surplus of aggregated lamin B that is generated during stress conditions. Our findings define a novel role for BAG3 in nuclear protein quality control and suggest an alternative pathogenetic pathway that contributes to the development of nuclear envelopathies.\n\nID: 24158851\nTitle: FOXO3 determines the accumulation of \u03b1-synuclein and controls the fate of dopaminergic neurons in the substantia nigra.\nAbstract: Parkinson's disease (PD) is characterized by the selective degeneration of neuronal populations presumably due to pathogenic interactions between aging and predisposing factors such as increased levels of \u03b1-synuclein. Here, we genetically modulate the activity of the transcription factor Forkhead box protein O3 (FOXO3) in adult nigral dopaminergic neurons using viral vectors and explore how this determinant of longevity impacts on neuronal fate in normal and diseased conditions. We find that dopaminergic neurons are particularly vulnerable to changes in FOXO3 activity in the substantia nigra. While constitutive activation has proapoptotic effects leading to neuronal loss, inhibition of FOXO-mediated transcription by a dominant-negative competitor causes oxidative damage and is detrimental at high vector dose. To address the role of FOXO3 in PD, we modulate its activity in dopaminergic neurons overexpressing human \u03b1-synuclein. In this pathogenic condition, we find that FOXO inhibition has protective effects, suggesting that this transcription factor ultimately contributes to neuronal cell death. Nevertheless, mild FOXO3 activity also protects nigral neurons against the accumulation of human \u03b1-synuclein, albeit to a lesser extent. FOXO3 reduces the amount of \u03b1-synuclein present in the soluble protein fraction and promotes the coalescence of dense proteinase K-resistant aggregates, with an accumulation of autophagic vacuoles containing lipofuscin. Consistent with these in vivo observations, we find that FOXO3 controls autophagic flux in neuronal cells. Altogether, these results point to FOXO3 as an important determinant of neuronal survival in the substantia nigra, which may oppose \u03b1-synuclein accumulation and proteotoxicity.\n\nID: 20005808\nTitle: Reduced IGF-1 signaling delays age-associated proteotoxicity in mice.\nAbstract: The insulin/insulin growth factor (IGF) signaling (IIS) pathway is a key regulator of aging of worms, flies, mice, and likely humans. Delayed aging by IIS reduction protects the nematode C. elegans from toxicity associated with the aggregation of the Alzheimer's disease-linked human peptide, Abeta. We reduced IGF signaling in Alzheimer's model mice and discovered that these animals are protected from Alzheimer's-like disease symptoms, including reduced behavioral impairment, neuroinflammation, and neuronal loss. This protection is correlated with the hyperaggregation of Abeta leading to tightly packed, ordered plaques, suggesting that one aspect of the protection conferred by reduced IGF signaling is the sequestration of soluble Abeta oligomers into dense aggregates of lower toxicity. These findings indicate that the IGF signaling-regulated mechanism that protects from Abeta toxicity is conserved from worms to mammals and point to the modulation of this signaling pathway as a promising strategy for the development of Alzheimer's disease therapy.\n\nID: 42379397\nTitle: Combined T-DNA and CRISPR/Cas9 mutagenesis reveals redundant developmental roles of the Arabidopsis BAG family.\nAbstract: BAG (Bcl-2-associated athanogene) genes encode evolutionarily conserved co-chaperones that participate in proteostasis regulation, stress responses, and programmed cell death. However, their collective functions during plant development remain poorly understood. Promoter cis-element analysis revealed multiple hormone-responsive elements in promoters of Arabidopsis thaliana (Arabidopsis) BAG genes, suggesting potential involvement of BAG genes in phytohormone-mediated developmental regulation. To investigate this, we generated a bag-septuple (bag-s) mutant in which all seven Arabidopsis BAG genes were knocked out using a combination of T-DNA insertion alleles and CRISPR/Cas9-mediated mutagenesis. Phenotypic characterization revealed pleiotropic defects, including delayed seed germination, increased seed coat mucilage accumulation, reduced primary root elongation, decreased rosette diameter and plant height, and delayed leaf senescence. Consistent with the delayed leaf senescence phenotype, expression of senescence-associated genes and senescence-promoting transcription factors was downregulated in the bag-s mutant. RT-qPCR analyses further showed that genes involved in auxin biosynthesis and auxin signaling were downregulated in the bag-s mutant. Furthermore, exogenous IAA partially rescued the root elongation defect of the bag-s mutant, supporting a functional association between BAG genes and auxin-dependent root growth. Collectively, these findings indicate that BAG genes redundantly regulate seed germination, vegetative growth, auxin-related root development, and leaf senescence, providing a genetic framework for further dissecting BAG-mediated coordination of proteostasis, hormone signaling, and plant development.\n\nID: 42378815\nTitle: Mechanisms and advances of drug resistance in colorectal cancer: A systematic overview of multi-layered regulatory networks.\nAbstract: Colorectal cancer (CRC) remains a leading cause of cancer-related morbidity and mortality worldwide. Although substantial advances in chemotherapy, molecular targeted therapy, and immunotherapy have improved clinical outcomes in select patient populations, therapeutic resistance remains the major obstacle to durable disease control. Accumulating evidence suggests that drug resistance in CRC does not result from isolated molecular events, but rather reflects a dynamic and adaptive process driven by coordinated tumor intrinsic programs, as well as continuous interactions between tumor cells and their surrounding microenvironment. In this Review, we present a systematic overview of the clinical manifestations and biological foundations of resistance to cytotoxic chemotherapy, targeted therapy, and immune checkpoint blockade in CRC. We summarize tumor intrinsic resistance mechanisms, including oncogenic signaling reprogramming, DNA damage response modulation, metabolic and redox adaptation, ubiquitin-regulated proteostasis, epigenetic and RNA-mediated regulation, evasion of programmed cell death, and the emergence of cancer stem cell and drug-tolerant persister states. In parallel, we examine the contribution of the tumor microenvironment, including cancer-associated fibroblasts, immunosuppressive immune networks, extracellular vesicle-mediated communication, and the gut microbiota, in establishing protective niches that promote resistance and limit therapeutic efficacy. We further discuss how emerging approaches such as single-cell and spatial multi-omics profiling, liquid biopsy, and longitudinal molecular monitoring have reshaped the understanding of drug resistance as a continuous evolutionary process under therapeutic selection pressure. Finally, we highlight therapeutic strategies inspired by systems biology and evolutionary principles, with an emphasis on rational combination and sequencing regimens, targeting adaptive vulnerabilities, and remodeling the tumor ecosystem to enable more durable and precise control of CRC.\n\nID: 42245484\nTitle: Musculoskeletal disorders: does cuproptosis hold the key?\nAbstract: Cuproptosis, a recently identified form of programmed cell death, is triggered by intracellular copper accumulation and executed through mitochondrial metabolic interference and proteostasis disruption. While emerging evidence has elucidated its pathophysiological roles in oncology, neurodegenerative disorders, and metabolic diseases, its mechanistic involvement and therapeutic potential in musculoskeletal disorders-including osteoarthritis, rheumatoid arthritis, osteoporosis, intervertebral disc degeneration, ankylosing spondylitis, bone tumors, skeletal muscle atrophy, and osteonecrosis of the femoral head (ONFH)-remain largely unexplored. This comprehensive review synthesizes current knowledge on the molecular mechanisms underlying cuproptosis in musculoskeletal pathophysiology, its potential as a disease-modifying factor, and the translational challenges that must be addressed before its clinical application. Furthermore, we highlight critical knowledge gaps and propose novel research directions that may help advance this emerging field.\n\nID: 42075383\nTitle: Integrative Transcriptomic and Biochemical Profiling Reveals Bacillus amyloliquefaciens JL54 Primes Larix olgensis Defenses Against Neofusicoccum laricinum Attack.\nAbstract: Larix olgensis, a keystone timber species in Northeast China, is increasingly threatened by Neofusicoccum laricinum-induced shoot blight, a devastating disease that compromises forest health and necessitates sustainable management strategies. Here, we demonstrate that the endophytic bacterium Bacillus amyloliquefaciens JL54 elicits multifaceted defense responses in L. olgensis, enhancing resistance to pathogen infection. Greenhouse assays revealed that JL54 pretreatment reduced disease incidence by 12.5% and achieved 43.75% control efficacy while maintaining host vigor. Histochemical analyses identified JL54-induced rapid hydrogen peroxide (H2O2) accumulation, extensive lignin deposition, and localized programmed cell death (PCD), indicative of a primed immune response. Transcriptomic analyses uncovered distinct temporal defense patterns: early-stage responses (0 h post-inoculation) were characterized by upregulation of cutin, suberin, and wax biosynthesis pathways, reinforcing physical barriers, whereas late-stage responses (12 h post-inoculation) were dominated by ribosome- and proteostasis-related pathways (e.g., heat shock proteins [HSPs], glutathione S-transferases [GSTs]) to mitigate cellular damage. Biochemical assays corroborated these findings, with JL54 colonization reducing membrane lipid peroxidation (27.2% decrease in malondialdehyde content) and significantly elevating the activity of key defense enzymes, including peroxidase (POD), phenylalanine ammonia-lyase (PAL), and GST. Phytohormone profiling implicated jasmonic acid (JA) as the central mediator of induced systemic resistance (ISR), with JL54-potentiated JA signaling preceding pathogen containment. Collectively, these results demonstrate that JL54 contributes to a coordinated defense strategy in L. olgensis, integrating structural reinforcement (cuticle/lignin), oxidative stress management, and JA-mediated immune priming. These insights advance the understanding of endophyte-conferred resistance in conifers and highlight JL54's potential as a biocontrol agent for sustainable forestry.\n\nID: 42068593\nTitle: BAG co-chaperones and phytohormonal signaling in tomato: Molecular regulators of stress resilience, growth, and fruit quality.\nAbstract: Tomato (Solanum lycopersicum) is a major horticultural crop and an important model for studying fruit development and stress adaptation. Climate-induced stresses, including drought, salinity, heat, and oxidative damage, pose significant challenges to tomato productivity, emphasizing the need to understand molecular mechanisms that integrate stress responses with developmental processes. Bcl-2-associated athanogene (BAG) proteins, highly conserved co-chaperones, have emerged as key regulators at the intersection of proteostasis, signaling, and programmed cell death. However, despite their emerging importance, comprehensive studies reviewing BAG co-chaperones in tomato are still limited. In this review, we summarize the current knowledge on BAG proteins in tomato, focusing on their structural features, evolutionary divergence from animal BAGs, and functional roles in development and stress tolerance. We examined how SlBAGs interact with Hsp70 chaperones, MAPK signaling cascades, calcium/calmodulin pathways, and the ubiquitin-proteasome system to coordinate cellular responses under diverse abiotic stresses. Special attention is given to their involvement in reactive oxygen species regulation, programmed cell death, senescence, and fruit ripening. Furthermore, we highlighted the gaps in functional characterization, post-translational regulation, and field-level validation of SlBAGs. Finally, we discussed the emerging strategies, including multi-omics approaches, genome editing, and translational breeding, to harness the genetic potential of SlBAGs for developing climate-resilient, high-yielding, and quality-enhanced tomato cultivars.\n\nID: 42010904\nTitle: Telomere Dysfunction and Proteostasis Decline Define Distinct Pathways of Cellular Senescence in the Human Respiratory Tract.\nAbstract: As the global population ages, cellular senescence contributes increasingly to the burden of age-related diseases. Hallmarks of this process include telomere shortening and loss of proteostasis, frequently linked to DNA damage-associated transcriptional stress. Although telomere dysfunction-induced foci (TIF) have been well documented in lungs from patients with idiopathic pulmonary fibrosis (IPF), their occurrence and role during physiological lung aging remain unclear. Analysis of senescence markers in lung tissue from organ donors aged 16-88\u2009years showed a linear decline in telomere length with age; however, TIF frequency increased significantly in the airway epithelium only in individuals older than 75\u2009years. Similarly, senescence markers such as p16 tended to rise with age but did not reach the levels observed in IPF lungs. To better delineate the early events driving senescence in the human respiratory epithelium and to expand the cohort size, we collected nasal epithelial cells by brushing from 213 healthy volunteers aged 2-97\u2009years. As in the aging lung, telomere shortening was evident, yet TIF were rare and detected almost exclusively in individuals over 80\u2009years of age. In contrast, indicators of impaired proteostasis, including increased senescence-associated \u03b2-galactosidase activity and lysosomal content, were apparent from the age of 40 in nasal epithelial cells and correlated with olfactory decline. Together, these findings suggest that telomere dysfunction is unlikely to be the primary driver of cellular senescence in the human respiratory tract, where proteotoxic stress may instead play a more prominent role.\n\nID: 41964446\nTitle: Unfolding Plant Defence: Endoplasmic Reticulum Stress Signalling at the Plant-Pathogen Interface.\nAbstract: The endoplasmic reticulum (ER) stress response, a conserved proteostasis network, has emerged as a central hub that reprograms plant immunity during pathogen attack. This review synthesises how plants harness ER-stress signalling to mount multilayered defences and how pathogens have evolved counterstrategies to subvert these pathways. We delineate the molecular integration of the unfolded protein response (UPR) with canonical immune layers including pattern-triggered immunity (PTI), effector-triggered immunity (ETI) and systemic defences, highlighting salicylic acid (SA) and jasmonic acid (JA) as rheostats that fine-tune ER stress-immune crosstalk. Functionally, the UPR bolsters immunity by coordinating protein folding and secretion, reprogramming transcription and translation, activating ER-dependent programmed cell death (ER-PCD), and orchestrating ER-associated degradation (ERAD) and selective autophagy. Pathogens such as bacteria, oomycetes and viruses in turn deploy virulence factors that target UPR sensors and transcription factors, thereby attenuating ER-driven immunity. We propose a conceptual framework in which the outcome of UPR activation-resistance versus susceptibility-is determined by pathogen lifestyle, ER stress dynamics, subcellular compartmentalisation and pathogen effector intervention. We also consider biotechnological contexts in which strong transgene expression can itself provoke the UPR, and outline diagnostic experimental strategies to distinguish UPR-mediated effects from intended transgene functions. By integrating molecular mechanisms with pathogen counterstrategies, this review underscores the dynamic interplay between ER stress and immune signalling in plants and highlights opportunities to enhance crop resilience under global climate challenges.\n\nID: 41918530\nTitle: Lon protease reprograms cellular physiology of Streptomyces coelicolor resulting in enhance antibiotic production.\nAbstract: The genus Streptomyces is widely recognized as a rich source of natural compounds, including antibiotics, immunosuppressants, and herbicides. Synthesis of secondary metabolites is initiated by cellular differentiation and is a complex process regulated by intracellular and extracellular signals, as well as numerous regulatory proteins. ATP-dependent Lon protease plays a key role in cellular proteostasis and stress adaptation. Overexpression of this protease has been shown to increase the production of actinorhodin (ACT) and undecylprodigiosin (RED) in Streptomyces coelicolor. However, the systems-level mechanisms underlying this phenotype remain unclear. In this study, we employed a multifaceted approach encompassing whole-genome sequencing (WGS), transcriptomics, and high-resolution imaging to analyze how Lon reprograms the cellular physiology of the hyper-antibiotic-producer recombinant strain, Sco-pRAlon. WGS revealed that the pRAlon recombinant vector, which has a \u03a6C31 int/attP site, integrates not only at the canonical attB site within SCO3798 of Streptomyces species, but also at a previously uncharacterized attB-like locus in SCO3793. Transcriptome profiling at the 24th and 72nd hours of fermentation revealed extensive Lon-dependent remodeling, particularly in key functional categories such as secondary metabolism, stress response, primary metabolism, and morphological differentiation. Confocal microscopy confirmed that lon overexpression shifts programmed cell death dynamics, triggers earlier MII (antibiotic-producing mycelia) formation, and supports sustained viability and homogeneous pellet morphology, even in the later stages of fermentation. These structural features coincide with elevated antibiotic titers. Together, these results position Lon as a systems-level regulator, which couples proteostasis to metabolic flux, nutrient signaling, developmental progression, and secondary metabolism. By mapping Lon-dependent regulatory networks, linking transcriptional signatures to quantitative morphological phenotypes, and identifying a new chromosomal attB-like integration site, this work provides a valuable framework for protease-guided strain engineering and highlights Lon as a promising lever for rational improvement of antibiotic production in Streptomyces. To the best of our knowledge, this is the first comprehensive study investigating the systems-level effects of overexpression of Lon protease gene in Streptomyces.\n\nID: 41911441\nTitle: Incense Aerosol-Induced Neurotoxicity Disrupts \u03b1-Synuclein Homeostasis in a Cellular Parkinson's Disease Model, Distinct from Cigarette Aerosols.\nAbstract: Incense burning is a widespread indoor combustion practice, yet its neurotoxic potential and impact on \u03b1-synuclein (\u03b1-Syn) proteostasis remain poorly defined. Using SH-SY5Y cells overexpressing \u03b1-Syn as a cellular Parkinson's disease model, we exposed cells to size-fractionated incense aerosol extracts (IAE) prepared as organic-phase (OP) or water-soluble phase (WP). \u03b1-Syn overexpression augmented vulnerability to IAE, producing greater losses in viability and pronounced increases in intracellular hydrogen peroxide (H2O2), mitochondrial membrane potential depolarization, and engagement of programmed cell-death pathways. Live-cell fluorescence cross-correlation spectroscopy (FCCS) revealed that both OP-IAE and WP-IAE shifted \u03b1-Syn from oligomeric to monomeric states in the cytosol, indicating disruption of oligomerization equilibrium. Antioxidant intervention revealed mechanistic differences compared with other indoor air pollutants, cigarette smoke. OP-IAE-induced cytotoxicity cannot be mitigated by N-acetylcysteine (NAC) or rutin, whereas WP-IAE-induced toxicity was partially attenuated, with NAC surpassing rutin. By contrast, for cigarette aerosol extracts (CAE), both OP- and WP-CAEs were robustly rescued by NAC and, to a lesser extent, rutin. Together, these results indicate that incense aerosols, particularly OP-IAE, engage reactive oxygen species (ROS)-linked mitochondrial injury and programmed cell-death pathways while uniquely driving \u03b1-Syn monomerization, while exhibiting relative resistance to classical antioxidant intervention compared with cigarette aerosols. This work points out incense smoke as a distinct indoor neurotoxicant with implications for \u03b1-Syn homeostasis and Parkinsonian risk in exposed populations.\n\nID: 41735209\nTitle: Significance of Paraptosis in Cancer Treatment and its Induction by Natural Molecules.\nAbstract: All organisms rely on Programmed Cell Death (PCD) to keep their cells in a constant state of homeostasis and to control their development, health, and illness. PCD is classified by its mechanisms, such as autophagy, apoptosis, paraptosis, and necrosis. Apoptosis, or PCD, is usually avoided by cancer cells due to treatment resistance. Hence, paraptosis, a newly found PCD that causes mitochondria and/or ER hypertrophy, could be a new treatment strategy. Paraptosis is characterized by proteostasis, redox and ion imbalance disruptions, vacuoles, and mitochondrial and ER dysfunction in cancer cells. Paraptosis creates cytoplasmic vacuoles from the ER, distinguishing it from autophagy and apoptosis. It does not require caspase stimulation or undergo morphological changes like apoptosis. Recently, multiple natural compounds, metallic complexes, and novel inducers have been shown to trigger paraptosis in diverse cancer cell lines, enhancing their anticancer effects. Understanding paraptosis will lay the basis for generating innovative smallmolecule cancer treatments. Since paraptosis differs from apoptosis and other PCD in morphology and biochemistry, understanding its regulators is vital. This article covers the routes, inducers, stimuli, and modulators of paraptosis, which causes cell death.\n\nID: 41381957\nTitle: Unveiling crosstalk between abiotic and biotic stress responses in soybean (Glycine max) using integrative RNA-Seq meta-analysis.\nAbstract: Soybean (Glycine max) is a critical world crop, highly valued for its high protein and oil content. However, its yield is increasingly threatened by varied abiotic and biotic stresses. Biotic and abiotic stresses often show antagonistic or synergistic cross-talk, whereby one stress may induce cross-tolerance or cross-susceptibility to another stress. Therefore, investigating the molecular interactions for the identification of key hub genes is essential for development of multistress resilient soybean crop. The current research conducts an extensive meta-analysis of available RNA-Seq data to identify conserved transcriptional responses to major stress conditions. 903 and 1,136 meta-differentially expressed genes (meta-DEGS) were found under abiotic (drought, heat, cold, salt) and biotic (aphids, mites, rust, viruses) stresses, respectively, with 28 genes regulated across both types of stresses. Central to the stress response was co-upregulation of protein kinases and NAC transcription factors, regulation of redox buffers and programmed cell death. Abiotic stresses initiate a proteostasis-centred response, involving elevated protein folding, degradation, and ribosome biogenesis, and repression of energy-expensive pathways like photosynthesis. Contrarily, biotic stress triggers immune responses through upregulation of defence and signalling genes, while suppressing circadian function and growth. Furthermore, network analysis, promoter motif discovery and miRNA profiling revealed key hub genes, such as Bystin, BING4, Nucleolar Protein 6, DOF transcription factors, miR171, and miR172. Briefly, in this research we identified putative converging genes of soybean where abiotic and biotic stresses signalling cross-talk. Candidate miRNAs, DOF and NAC transcription factors, HSP chaperones, and ERAD- and ribosome-related genes as for stress resilience in soybean were identified. This systems-level understanding provides promising targets for functional validation and afterwards developing climate-resilient and pathogen-tolerant soybean cultivars through targeted genetic and breeding strategies.\n\nID: 41330616\nTitle: Age-related immune states and PD-1 blockade: mechanisms and strategies for the elderly.\nAbstract: Aging impairs antitumor immunity and may reduce the efficacy of immune checkpoint inhibitors (ICIs). However, the underlying mechanisms remain unclear. Building on our recent findings, we review three key mechanisms of CD8+ T-cell aging: elevated T-cell receptor (TCR) activation thresholds, mitochondrial dysfunction, and disruption of proteostasis. Studies in aged mice have revealed that aged na\u00efve T cells exhibit defective priming due to increased CD45 expression, which raises the TCR activation threshold and restricts effector differentiation. Aging also impairs mitochondrial metabolism, particularly fatty acid oxidation. Furthermore, we highlight the role of proteostasis collapse, including defective autophagy and increased endoplasmic reticulum stress, as a contributor to T-cell dysfunction. Spermidine, a polyamine that declines with age, has the potential to modulate both mitochondrial function and proteostasis. Its supplementation has been shown to improve programmed cell death-1 blockade responsiveness in aged mice. Although clinical studies in humans have yielded inconsistent results regarding the effect of chronological age on ICI efficacy, identifying patients with \"age-related\" immune microenvironments may enable stratified therapeutic approaches based on insights from preclinical aging models.\n\nID: 41303380\nTitle: New Roles of bZIP-Containing Membrane-Bound Transcription Factors in Chromatin Tethering and Karyoptosis.\nAbstract: The nuclear membrane has emerged as a dynamic regulatory platform coordinating genome organization, mechanotransduction, and regulated cell death (RCD). Beyond its barrier function, the nuclear skeleton-comprising lamins, actin-myosin isoforms, nuclear matrix proteins, and the LINC complex-supports nuclear integrity and gene regulation. Recent evidence shows that type II membrane-bound bZIP transcription factors such as cAMP-responsive element-binding protein 3 (CREB3) and CREB3L1 localize to the inner nuclear membrane (INM), linking chromatin tethering with stress signaling. Their stress-induced cleavage by S1P/S2P disrupts chromatin anchoring and, in some contexts, triggers karyoptosis, a novel form of RCD defined by nuclear rupture. These findings position the nuclear envelope (NE) as a mechanosensitive signaling hub with direct implications for disease and therapy. In this review, we provide a comprehensive discussion on how type II membrane-bound bZIP transcription factors and chromatin acting as a nucleoskeleton cooperate to regulate nuclear membrane integrity.\n\nID: 41224730\nTitle: The structural, functional, and therapeutic potential of metacaspases in fungi and protozoa.\nAbstract: Metacaspases are cysteine proteases found in fungi, protozoa, and plants, where they regulate critical cellular processes such as programmed cell death (PCD), cell cycle progression, and protein homeostasis. Although structurally related to caspases, metacaspases differ in mechanism of activation, substrate specificity, and biological roles. Unlike caspases, metacaspases are monomeric calcium-dependent enzymes that cleave substrates after basic residues such as arginine or lysine. This review provides a comprehensive overview of the structural classification, biochemical regulation, and physiological functions of metacaspases in model eukaryotes. We discuss their roles in stress adaptation, cell death, and proteostasis in organisms such as Saccharomyces cerevisiae, Candida albicans, Trypanosoma brucei, and Trypanosoma cruzi. We highlight recent advances in understanding their activation via calcium binding and autocatalytic processing, and explore their functional diversity across species. In addition, we examine the therapeutic potential of metacaspases as drug targets due to their absence in mammals and essential roles in pathogenic microbes. Challenges in substrate identification, enzymatic characterization, and inhibitor design are also addressed, along with emerging tools that may accelerate metacaspase research. Altogether, this review underscores the growing importance of metacaspases in eukaryotic biology and their promising applications in antifungal and antiparasitic drug development.\n\nID: 40959087\nTitle: NLRP3 and beyond: inflammasomes as central cellular hub and emerging therapeutic target in inflammation and disease.\nAbstract: The NLRP3 inflammasome is a key cytosolic sensor in the innate immune system, activated by diverse danger signals such as metabolic stress, infections, and structural cellular disruptions. Its activation leads to the maturation of IL-1\u03b2 and IL-18 and induces pyroptosis through gasdermin D cleavage. Multiple regulatory mechanisms modulate NLRP3 activation, including BRCC3-mediated deubiquitination, lysine carbamylation, intracellular trafficking to the microtubule-organizing center, and endolysosomal localization via PI4P. Dysregulation of these checkpoints contributes to inflammatory, neurodegenerative, hepatic, metabolic, and infectious diseases. Beyond pathogen defense, inflammasomes influence tissue regeneration, cell death pathways, and sterile inflammation, highlighting their role as integrative immune hubs. Alternative inflammatory pathways involving gasdermin E and caspase-8/3 enable persistent cytokine release in the absence of gasdermin D, revealing redundant effector arms within the inflammasome network. Structural triggers such as potassium efflux and intracellular transport disruptions lower the threshold for inflammasome assembly, while hypoxic conditions link its activation to immunometabolic imbalance. Aggresome-like mechanisms further reflect a convergence between proteostasis and inflammation. While NLRP3 remains the most extensively characterized, other inflammasomes-including NLRP1 in epithelial ribotoxic stress, CARD8 in HIV-1 protease sensing, and AIM2/IFI16 in viral and DNA sensing-highlight the diversity of inflammasome signaling in tissue- and pathogen-specific contexts. Small molecules such as MCC950, thiolutin, HDAC6 inhibitors, and CuET have demonstrated efficacy in preclinical models by selectively modulating inflammasome components or their regulatory pathways. Novel strategies such as carbamylation-mediated suppression and disruption of endocytic dynamics offer additional therapeutic entry points. A deeper understanding of inflammasome biology is essential for advancing precision immunotherapy in inflammatory and infectious diseases.\n\nID: 40752569\nTitle: Symphony of regulated cell death: Unveiling therapeutic horizons in sarcopenia.\nAbstract: Sarcopenia is a progressive musculoskeletal condition associated with aging, marked by a decline in muscle mass, strength, and performance. This condition not only compromises functional independence in older individuals but also contributes to escalating healthcare and economic burdens. Although the underlying mechanisms are complex and multifaceted, recent discoveries have emphasized the regulatory influence of multiple forms of programmed cell death-including apoptosis, ferroptosis, necroptosis, and pyroptosis-on skeletal muscle degeneration. These cell death pathways contribute to key pathological features such as muscle fiber loss, proteostasis imbalance, neuromuscular dysfunction, mitochondrial deficits, and persistent inflammation. This review synthesizes current understanding of the molecular underpinnings of regulated cell death (RCD) in sarcopenia and discusses emerging therapeutic interventions aimed at modulating these pathways. These include pharmacological agents (e.g., ferroptosis inhibitors, polyphenols), structured exercise programs (notably resistance), targeted nutritional support (e.g., amino acids, vitamin D), cell-based therapies, and gene-targeted strategies. Despite growing evidence supporting RCD as a viable therapeutic target, the interplay among different cell death modalities and the translation of mechanistic insights into clinical practice remain insufficiently understood. Advancing sarcopenia treatment will require integrated multi-omics analyses, identification of predictive biomarkers, and rigorously designed clinical studies to support personalized and effective therapeutic approaches.\n\nID: 40701274\nTitle: Endoplasmic reticulum-targeted strategies for programmed cell death in cancer therapy: Approaches and prospects.\nAbstract: The endoplasmic reticulum (ER) plays a dual role in cancer biology, functioning both to preserve cellular homeostasis and to facilitate pathological progression. Rapidly proliferating cancer cells, which exhibit heightened metabolic activity, frequently experience ER stress that activates the unfolded protein response (UPR), a mechanism that promotes cellular adaptation and survival. However, when ER stress is prolonged or excessive, it can shift the balance toward programmed cell death (PCD), including apoptosis, autophagy, ferroptosis, pyroptosis, and necroptosis. Given the ER's central role in regulating proteostasis and stress signaling, therapeutically targeting the ER presents a compelling strategy to disrupt cancer cell survival and overcome treatment resistance. Nanomedicine, particularly the use of nanoparticles (NPs) for precise ER targeting, offers a promising platform to modulate ER function and trigger PCD in cancer cells. In this review, we highlight recent advances in the design guidelines of ER-targeted NPs, with a focus on their capacity to engage and activate PCD pathways in cancer cells. We further discuss the current limitations and emerging opportunities in this field, aiming to inform the development of next-generation ER-targeted delivery platforms for enhanced efficacy in cancer treatment.\n\nID: 40563622\nTitle: Activation of Unfolded Protein Response Pathway in Malignancies: Interplay with Extracellular Matrix and Targeting Perspectives.\nAbstract: Malignant cells exhibit elevated rates of protein synthesis and secretion to facilitate tumor growth, proliferation, and tumorigenesis. Upon malignant transformation, the endoplasmic reticulum (ER) experiences stress due to the accumulation of unfolded or misfolded proteins in the ER lumen, lack of nutrient availability and overall hostile tumor microenvironment conditions. The demand for regulated protein turnover and proteostasis reinstatement results in the activation of the unfolded protein response (UPR) pathway for cellular adaptation and survival. The UPR machinery utilizes the BiP chaperone and three ER-bound sensors, PERK, IRE1, and ATF6, to substantiate signal transduction and orchestrate gene expression associated with protein folding, degradation and recycling, inflammation, autophagy, and programmed cell death. The pleiotropic function of UPR emerges as a central mediator for tumor progression, especially in multiple myeloma and glioblastoma pathologies. Numerous studies have recently pointed out that communication of the extracellular matrix (ECM) with surrounding tumor cells dictates in part UPR activity and vice versa. In the context of this dynamic interplay, ER stress and UPR mechanisms have been proposed as potential targets to elicit novel and effective therapeutic approaches in clinical trials.\n\nID: 40337549\nTitle: SHP2-mediated ROS activation induces chondrocyte paraptosis in osteoarthritis and is attenuated by low-intensity pulsed ultrasound.\nAbstract: Paraptosis is a novel form of programmed cell death, generally caused by disrupted proteostasis or alterations of redox homeostasis. However, its impact and underlying mechanisms on the pathology of osteoarthritis (OA) are still unclear. This study aimed to investigate the role and regulatory mechanism of SHP2 in chondrocyte paraptosis and the effects influenced by low-intensity pulsed ultrasound (LIPUS). SHP2, a MAPK upstream intermediary, has been identified as one of the critical targets of IL-1\u03b2-induced paraptosis in the GEO and GeneCard databases. The expression of SHP2 in chondrocytes was regulated by either siRNA knockdown or plasmid overexpression. Additionally, adeno-associated viruses were injected into the knee joints of rats to explore whether SHP2 plays a role in the development of OA. The impact of LIPUS on paraptosis and OA was examined in IL-1\u03b2-induced chondrocytes and a post-traumatic OA model, with SHP2 regulation assessed at both cellular and animal levels. An increase in cellular reactive oxygen species (ROS) caused by IL-1\u03b2 halts the growth of chondrocytes and induces paraptosis in the chondrocytes. IL-1\u03b2-induced paraptosis, manifested as endoplasmic reticulum (ER)-derived vacuolization, was mediated by ROS-mediated ER stress and MAPK activation. SHP2 facilitates ROS production, thereby exacerbating the chondrocytes paraptosis. SHP2 knockdown and ROS inhibition effectively reduced this process and significantly mitigated inflammation and cartilage degeneration. Furthermore, we discovered that LIPUS delayed OA progression by inhibiting the activation of the MAPK pathway, ER stress, and ER-derived vacuoles in chondrocytes, all of which play critical roles in paraptosis, through the downregulation of SHP2 expression. Results on animals showed that LIPUS inhibited cartilage degeneration and alleviated OA progression. SHP2 exacerbates IL-1\u03b2-induced oxidative stress and the subsequent paraptosis in chondrocytes, promoting OA progression. LIPUS mitigates paraptosis by modulating SHP2, which in turn slows OA progression. This study indicates that a novel SHP2-mediated cell death mechanism, paraptosis, plays a role in post-traumatic OA progression. LIPUS helps maintain cartilage-subchondral bone unit integrity by targeting SHP2 inhibition. SHP2 emerges as a potential therapeutic target, while LIPUS provides a promising non-invasive approach for treating trauma-related OA.\n\nID: 39940964\nTitle: Retinal Pigment Epithelium Under Oxidative Stress: Chaperoning Autophagy and Beyond.\nAbstract: The structural and functional integrity of the retinal pigment epithelium (RPE) plays a key role in the normal functioning of the visual system. RPE cells are characterized by an efficient system of photoreceptor outer segment phagocytosis, high metabolic activity, and risk of oxidative damage. RPE dysfunction is a common pathological feature in various retinal diseases. Dysregulation of RPE cell proteostasis and redox homeostasis is accompanied by increased reactive oxygen species generation during the impairment of phagocytosis, lysosomal and mitochondrial failure, and an accumulation of waste lipidic and protein aggregates. They are the inducers of RPE dysfunction and can trigger specific pathways of cell death. Autophagy serves as important mechanism in the endogenous defense system, controlling RPE homeostasis and survival under normal conditions and cellular responses under stress conditions through the degradation of intracellular components. Impairment of the autophagy process itself can result in cell death. In this review, we summarize the classical types of oxidative stress-induced autophagy in the RPE with an emphasis on autophagy mediated by molecular chaperones. Heat shock proteins, which represent hubs connecting the life supporting pathways of RPE cells, play a special role in these mechanisms. Regulation of oxidative stress-counteracting autophagy is an essential strategy for protecting the RPE against pathological damage when preventing retinal degenerative disease progression.\n\nID: 39822064\nTitle: Unfolded protein response: An essential element of intestinal homeostasis and a potential therapeutic target for inflammatory bowel disease.\nAbstract: Different physiological and pathological situations can produce alterations in the cell's endoplasmic reticulum (ER), leading to a condition known as ER stress, which can trigger an intricate intracellular signal transduction system known as the unfolded protein response (UPR). UPR is primarily tailored to restore proteostasis and ER equilibrium; otherwise, if ER stress persists, it can cause programmed cell death as a cytoprotective mechanism and drive inflammatory processes. Therefore, since intestinal cells strongly rely on UPR for their biological functions and unbalanced UPR has been linked to inflammatory, metabolic, and immune disorders, here we discussed the role of the UPR within the intestinal tract, focusing on the UPR contribution to inflammatory bowel disease development. Importantly, we also highlighted the promising potential of UPR components as therapeutic targets for intestinal inflammatory diseases.\n\nID: 39769480\nTitle: Comparison of the Effects of UV-C Light in the Form of Flash or Continuous Exposure: A Transcriptomic Analysis on Arabidopsis thaliana L.\nAbstract: Ultraviolet C (UV-C) flash treatment represents a promising method for priming plants. This study compared the effects of 1 s (flash) and 60 s (60 s) UV-C exposures on the transcriptome of Arabidopsis thaliana L. plants. A dose of 200 J m-2 delivered in one second was observed to effectively stimulate plant defenses without causing any adverse effects on plant health. A total of 3054 and 1865 differentially expressed genes (DEGs) were identified in the flash and 60 s treatments, respectively, in comparison to the control plants. Of these, 1131 were common to both treatments. The flash treatment affected a greater number of transcription factors (415 genes) than the 60 s treatment (254 genes), indicating more pronounced alterations in gene expression. The flash treatment resulted in a significant overexpression of heat shock proteins (HSPs), heat shock factors (HSFs), and their associated genes, which impacted oxidative stress, proteostasis, genome stability, cell survival, and thermotolerance. The majority of mitochondrial genes were found to be upregulated, while photosynthetic genes exhibited a downregulation. These expression patterns coordinate electron transport and crosstalk between the nucleus, chloroplasts, and mitochondria, eliciting an adaptive protective response to UV-C flash. Additionally, the flash treatment resulted in alterations to several genes involved in cell cycle regulation, division, and DNA replication. These included ATP BMMs, BRCA2 s, IQDs, kinesin complex, MCM complex, CYCs, and CDKs, which ultimately led to cell cycle arrest as a temporary preparation for subsequent conditions. The present study demonstrates that a 1 s exposure to UV-C induces distinctive plant responses through coordinated gene expression. The findings suggest that the flash treatment is an innovative method that triggers a unique cellular response, prioritizing repair mechanisms and potentially enhancing plant immunity, resilience, and priming. It can be used as a plant resistance inducer and stimulator.\n\nID: 39761770\nTitle: The interplay between gut microbiota and the unfolded protein response: Implications for intestinal homeostasis preservation and dysbiosis-related diseases.\nAbstract: The unfolded protein response (UPR) is a complex intracellular signal transduction system that orchestrates the cellular response during Endoplasmic Reticulum (ER) stress conditions to reestablish cellular proteostasis. If, on one side, prolonged ER stress conditions can lead to programmed cell death and autophagy as a cytoprotective mechanism, on the other, unresolved ER stress and improper UPR activation represent a perilous condition able to trigger or exacerbate inflammatory responses. Notably, intestinal and immune cells experience ER stress physiologically due to their high protein secretory rate. Indeed, there is evidence of UPR's involvement in both physiological and pathological intestinal conditions, while less is known about its bidirectional interaction with gut microbiota. However, gut microbes and their metabolites can influence ER stress and UPR pathways, and, in turn, ER stress conditions can shape gut microbiota composition, with important implications for overall intestinal health. Thus, targeting UPR components is an intriguing strategy for treating ER stress-linked dysbiosis and diseases, particularly intestinal inflammation.\n\nID: 39757486\nTitle: Light-Controlled Intracellular Synthesis of Poly(luciferin) Polymers Induces Cell Paraptosis.\nAbstract: Accumulation of misfolded proteins challenges cellular proteostasis and is implicated in aging and chronic disorders. Cancer cells, moreover, face an elevated level of basal proteotoxic stress; hence, exacerbating endoplasmic reticulum (ER) stress has been shown to induce programmed cell death while enhancing anticancer immunogenicity. We hypothesize that hydrophobic abiotic macromolecules can trigger a similar stress response. Most polymers and nanoparticles, however, are sequestered in endo/lysosomes after endocytosis, which prevents their interaction with the proteostasis machinery. We adopted an in situ polymerization approach to synthesize polymers in cells with cell-permeable monomers. Specifically, we developed a biocompatible polycondensation between l-cysteine and 2-cyanobenzothiazole (CBT) with photochemical control to form insoluble poly(luciferin) aggregates. We identified that in situ polymerization activates the BiP-PERK-CHOP pathway of the unfolded protein response and that the unresolved ER stress initiates a form of regulated cell death consistent with paraptosis. In addition, the dying cells emit damage-associated molecular patterns (DAMPs), indicating an immunogenic cell death that could potentiate antitumor immunity. Our results show that in situ polymerization mimics misfolded protein aggregates to induce proteotoxic stress and cancer cell death, offering a novel therapeutic strategy to exploit cancer vulnerability.\n\nID: 39625813\nTitle: Karyoptosis as a novel type of UVB-induced regulated cell death.\nAbstract: Karyoptosis is a type of regulated cell death (RCD) characterized by explosive nuclear rupture caused by a loss of nuclear membrane integrity, resulting in the release of genomic DNA and other nuclear components into the cytosol and extracellular environment. The mechanism underlying karyoptosis involves a delicate balance between the following forces: the expansion force exerted by the tightly packed DNA in the nucleus, the resistance provided by the nuclear lamina at the inner nuclear membrane (INM), and the tensile force from the cytoskeleton that helps position the nucleus at the center of the cytoplasm, allowing it to remain maximally expanded. In addition, CREB3, a type II integral membrane protein with DNA-binding ability, tethers chromatin to the INM, providing a tightening force through chromatin interactions that prevent nuclear membrane rupture. UVB radiation can trigger this process, inducing CREB3-FL cleavage and producing CREB3-CF. Therefore, UVB acts as an intrinsic factor in the induction of karyoptosis. Importantly, biochemical analysis of RCD markers shows that karyoptosis is distinct from other forms of cell death, such as apoptosis, autophagy, necroptosis, and pyroptosis. This review explores the mechanisms involved in maintaining nuclear membrane integrity and the role of CREB3 in triggering karyoptosis and provides brief suggestions on the potential implications for targeting cancer cells.\n\nID: 39596399\nTitle: The Mechanistic Link Between Tau-Driven Proteotoxic Stress and Cellular Senescence in Alzheimer's Disease.\nAbstract: In Alzheimer's disease (AD), tau dissociates from microtubules (MTs) due to hyperphosphorylation and misfolding. It is degraded by various mechanisms, including the 20S proteasome, chaperone-mediated autophagy (CMA), 26S proteasome, macroautophagy, and aggrephagy. Neurofibrillary tangles (NFTs) form upon the impairment of aggrephagy, and eventually, the ubiquitin chaperone valosin-containing protein (VCP) and heat shock 70 kDa protein (HSP70) are recruited to the sites of NFTs for the extraction of tau for the ubiquitin-proteasome system (UPS)-mediated degradation. However, the impairment of tau degradation in neurons allows tau to be secreted into the extracellular space. Secreted tau can be monomers, oligomers, and paired helical filaments (PHFs), which are seeding competent pathological tau that can be endocytosed/phagocytosed by healthy neurons, microglia, astrocytes, oligodendrocyte progenitor cells (OPCs), and oligodendrocytes, often causing proteotoxic stress and eventually triggers senescence. Senescent cells secrete various senescence-associated secretory phenotype (SASP) factors, which trigger cellular atrophy, causing decreased brain volume in human AD. However, the molecular mechanisms of proteotoxic stress and cellular senescence are not entirely understood and are an emerging area of research. Therefore, this comprehensive review summarizes pertinent studies that provided evidence for the sequential tau degradation, failure, and the mechanistic link between tau-driven proteotoxic stress and cellular senescence in AD.\n\nID: 29388501\nTitle: Karyoptosis: A novel type of cell death caused by chronic autophagy inhibition.\nAbstract: Macroautophagy/autophagy influences onset and progression of several human neurodegenerative diseases, because of its critical role as a regulator of neuronal proteostasis and organelle quality control. In many neurodegenerative diseases, impairment in autophagy is thought to play a fundamental part in the terminal phases of cellular degeneration and death. However, the ultimate mechanism of neuronal cell death remains elusive. In a recent study we have identified a new form of regulated cell death, which arises upon autophagy inhibition.\n=======================================================\n\n### [CUSTOM DATAPOINTS]\nCRITICAL EXTRACTION DIRECTIVE: You MUST extract the following custom datapoints as root-level key/value pairs inside your final JSON block:\n- \"suggested_experiments\": generate 1-3 suggested experiments\n- \"suggested_studies\": generate 1-3 suggested studies\n- \"swansons_literature_based_discovery_candidates\": You are an advanced Literature-Based Discovery (LBD) system executing Swanson\u2019s complementary-but-disjoint (A-B-C) model. Your goal is to find hidden, unpublished connections across the provided dataset. Strict Discovery Protocol: 1. Identify distinct, isolated sub-literatures (Domain A and Domain C) within the dataset that share NO direct citations, co-mentions, or common contextual paragraphs. 2. Find an intermediate biological mechanism, protein, path, or entity (Bridge B) that appears independently in both isolated domains (A-to-B and B-to-C). 3. Synthesize a novel, unstated hypothesis (A-to-C). Negative Constraint (Crucial): DO NOT output any connection if the relationship between Concept A and Concept C is explicitly mentioned, paired, or summarized anywhere in the source text. If a connection (like \"OMN resilience to SMN stabilization\") is already explicitly stated or grouped as a concept in the data, it is considered \"already known\" and must be disqualified. Format your output exactly as follows: - Discovered Hypothesis (A to C): [Clear, novel statement] - Literature A (Origin): [Entity/Concept and source context] - Literature C (Target): [Entity/Concept and source context] - The Intersecting Bridge B: [The shared mechanism/protein linking them] - Biological Rationale: [1-2 sentences explaining why this hidden connection is mechanistically plausible]\n- \"contradictions_between_evidences\": Identify conflicting evidence within the evidence set (if any) and flag the dispute here\n- \"repurposed_solutions\": identify and explain repurposed Solution potentials\n\n\nFormat Requirement:\nRAG AMNESIA IS ACTIVE: You must ONLY use the provided context literature. Do not use outside prior knowledge. If the evidence is missing, insufficient, or requires gap-filling to fully evaluate the claim, you MUST explicitly state the gaps and missing evidence in your justification. Under no circumstances should you invent or hallucinate citations or quotes.\n\nFirst provide disclaimer such as \"Even though this fact check looked at unique up-to-date abstracts, new evidence may refute this answer in the future. Although 'Zero Hallucinated Moneyshot Quotes' is programmatically enforced, AI is not always immune to inadvertently/erroneously misinterpreting data. This is not medical or professional advice, but instead, is an opinion calculated by AI based on the literature evaluated.\"\n---\nWrite in a highly academic, formal thesis tone.\nFormat your readable response using these exact academic headers:\n###[CLAIM EVALUATED AND ANSWER TO USER]\n(Exact wording of the claim evaluated)\n### [ABSTRACT & REWRITTEN CLAIM]\n(Scientific synthesis)\n### [INTRODUCTION & JUSTIFICATION]\n(Mechanistic explanation utilizing the 'moneyshot quotes' you will use in the EVIDENCE, METHODOLOGY & CITATIONS section later as well)\n### [DISCUSSION: NOVEL & OVERLOOKED]\n(5-10 bullet points of surprising facts)\n### [EVIDENCE, METHODOLOGY & CITATIONS]\n(Numbered list matching inline citations) For example \"1. ID: 12345 - Application: The text discusses ... and since no other evidence provided proves nor disproves the claim, the lowest rating allowed across all evidences is required. ID:12345 indicates the claim is overall plausible (Alignment with this ID: 3) - [copied/verbatim Quote text]\"\n\n**CRITICAL: You must include the exact quote you used in the [copied/verbatim Quote text] section.\n\nIf the prompt says \"at least 20 quotes\" then there must be at least 20 matching citations. You must actually use the quotes you select within the conext of the preprint publication you write.\n\nEvaluation Schema:\nRAG AMNESIA IS ACTIVE: You must ONLY use the provided context literature. Do not use outside prior knowledge. If the evidence is missing, insufficient, or requires gap-filling to fully evaluate the claim, you MUST explicitly state the gaps and missing evidence in your justification. Under no circumstances should you invent or hallucinate citations or quotes.\n\n###critical: WRAP YOUR THOUGHTS WITH ... tags at the very beginning of your response.\n\n=======================================================\nCONTEXT LITERATURE (STATIC CACHE):\nID: 42350373\nTitle: Karyoptosis mediates cell death and neurodegeneration upon proteotoxic stress.\nAbstract: Neurodegenerative diseases are frequently associated with proteotoxic stress linked to disease specific proteins. The autophagy-lysosome system provides essential control of proteotoxic stress and its failure can lead to initiation of apoptosis. However, in aging and neurodegenerative diseases apoptosis is insufficient to account for all neuronal death, and several different cell death types have been reported in these contexts. Here we show that karyoptosis, a distinct form of cell death, can be induced by proteotoxic stress and then develops through nuclear degeneration and cellular expulsion of nuclear material. We establish that karyoptosis is regulated by the p38 kinase signalling pathway, which controls stability of the nuclear lamina protein LaminB1 via direct phosphorylation. We demonstrate that karyoptosis affects neurons in models of amyotrophic lateral sclerosis/frontotemporal dementia (ALS/FTD) pathology. Finally, we identify karyoptotic features in post-mortem frontal cortex of FTD and Alzheimer's disease (AD) patients. Together these findings characterise a form of cell death directly linked to proteotoxic stress and nuclear lamina stability that is associated with neurodegeneration.\n\nID: 42296779\nTitle: Artemisinin and quercetin attenuate hydrogen peroxide-induced oxi-inflammatory-mitochondrial dysfunction-SASP axis mediated lung epithelial cell premature senescence via targeting Stat-1/Atm-p53/p16/p21/Bcl2, NOD-1/MAPKs/NF-\u03baB/ signalling cascades.\nAbstract: The senescence of lung epithelial cells impairs self-repair and exacerbates lung damage in idiopathic pulmonary fibrosis. The potential of natural phytochemicals to reverse premature senescence warrants investigation. Information regarding the independent multifaceted effect of quercetin and artemisinin on epithelial senescence has not been delineated yet. The present investigation aimed to comprehend their attributes on H2O2-induced hallmark of premature senescence via controlling the vicious circle of oxidative-inflammatory stress, impaired cell proliferation, apoptosis, DNA damage, and inflammatory senescence cascades. An in vitro model of H2O2-exposed BEAS-2B cells was used to explore senescence using microscopy, qRT-PCR, immunoblotting, flow cytometry, and NMR\u00b7 H2O2 (100\u202f\u00b5M) treatment induced cellular senescence-associated features without significant cytotoxicity, as evidenced by enhanced SA-\u03b2-galactosidase activity, irreversible irregular enlargement, shrinking, and flattened cell appearance, which was reversed by quercetin and artemisinin at varying degree. Results revealed that quercetin and artemisinin restored disrupted mitochondrial function in senescent cells, as evidenced by reduced MMP, GLS, ARRDC4, TXNIP, creatine, and increased NRF-2, HO-1, NQO-1, Sirt-1/5, and glycine levels. Furthermore, quercetin and artemisinin promoted proliferative ability, DNA repair, S-phase cell cycle transition, apoptosis, and suppressed SASP, as evidenced by enhanced Ki67 expression, annexin-V-positive cells, and diminished expression of interleukins, COX-2, MMPs, and the Atm/p53/p16/p21/Bcl-2 axis. Subsequently, activation of NOD-1, Stat-1, NF-\u03baB, ERK1/2, p38, and JNK was decisively thwarted by quercetin and artemisinin. Intriguingly, Lamin B1 restoration and ROS inhibition were only noticed in quercetin, indicating both are effective in halting senescence through an alternative pathway. Overall, the present investigation emphasizes that quercetin and artemisinin exhibit both senolytic and senomorphic properties and could be valuable senotherapeutics for stress-induced premature senescence.\n\nID: 42117871\nTitle: Rapalink-1 Attenuates Oxidative-Stress-Induced Senescence in Vascular Cells in Association with Reduced NF-\u03baB and MAPK Signaling.\nAbstract: Oxidative stress contributes to vascular dysfunction and senescence-associated changes through activation of inflammatory and stress-responsive signaling pathways. Although the mammalian target of rapamycin (mTOR) integrates metabolic and redox-related signals, its role in vascular stress responses remains incompletely understood. In this study, we investigated the effects of Rapalink-1, an mTOR inhibitor, on H2O2-induced injury responses in human vascular endothelial cells (HUVECs) and vascular smooth muscle cells (SMCs). Oxidative stress-associated changes were assessed using oxidation-sensitive fluorescence, DNA damage markers (\u03b3-H2AX and 8-OHDG), and senescence-associated readouts (SA-\u03b2-gal, Lamin B1, and p21). Senescence-associated secretory phenotype (SASP)-related factors were analyzed by qPCR and Western blot, and mTOR-, NF-\u03baB-, and MAPK-related signaling was evaluated by Western blotting. H2O2 exposure reduced cell viability and increased oxidative stress-associated readouts, DNA damage markers, senescence-associated changes, and SASP-related factor expression in both HUVECs and SMCs. Rapalink-1 attenuated many of these responses, including oxidation-sensitive fluorescence, \u03b3-H2AX and 8-OHDG staining, SA-\u03b2-gal positivity, Lamin B1 loss, p21 upregulation, and the expression of inflammatory and matrix-remodeling factors. These effects were accompanied by reduced phosphorylation of p65, p38, ERK1/2, S6, and 4EBP1. Overall, Rapalink-1 is associated with attenuation of oxidative stress-induced injury responses in vascular endothelial and smooth muscle cells, together with reduced NF-\u03baB-, MAPK-, and mTOR-related signaling. These findings support further investigation of mTOR-targeted approaches in vascular aging and oxidative stress-related vascular dysfunction.\n\nID: 42059427\nTitle: Tranexamic acid protects human dermal fibroblasts from D-galactose-induced senescence via the GPR30/MAPK pathway.\nAbstract: Tranexamic acid (TXA) is widely used for pigmentary disorders, but its anti-ageing potential remains unclear. This study aimed to evaluate whether topical 3% TXA improves early periorbital wrinkles in women with facial melasma and to investigate whether TXA protects human dermal fibroblasts from D-galactose-induced senescence via the GPR30/MAPK pathway. Fifty women with melasma were randomized to 3% TXA serum plus moisturizer or moisturizer alone for 8\u2009weeks, with follow-up to week 12. Periorbital wrinkles were graded using a modified Fitzpatrick Wrinkle Scale (MFWS). Separately, D-gal-induced senescence in HDFs was assessed via viability, SA-\u03b2-gal activity, senescence markers, ROS, antioxidant enzymes, SASP/ECM gene expression, and MAPK activation. GPR30 involvement was examined using antagonist G15, shRNA knockdown, and molecular docking. Topical TXA produced significantly greater MFWS reductions versus moisturizer alone at weeks 4, 8, and 12, with benefit persisting post-treatment. In HDFs, TXA preserved viability, reduced SA-\u03b2-gal positivity, attenuated p21/p16, restored Lamin B1, decreased ROS, and rescued antioxidant activities. TXA downregulated IL-6, IL-8, MMP1, and MMP3, and suppressed D-gal-induced ERK, JNK, and p38 phosphorylation. These effects were weakened by G15 or GPR30 knockdown; docking supported a stable TXA-GPR30 interaction. TXA showed clinical anti-wrinkle activity in melasma patients and protected HDFs from D-gal-induced senescence, partly via GPR30-dependent modulation of oxidative stress, SASP/ECM expression, and MAPK signalling. TXA is a promising candidate for skin ageing intervention.\n\nID: 41858764\nTitle: Organelle homeostasis disruption: A driving force in the progression of cardiomyopathy (Review).\nAbstract: Cardiomyopathy is a complex heart disease with structural and functional defects of the myocardium, often leading to poor clinical outcomes. While traditional research has focused on myofibrillar pathology and ion channel dysfunction, emerging evidence indicates that organelle homeostasis serves a central role in the pathogenesis of the disease. Mitochondrial dysfunction disrupts energy metabolism, calcium handling, dynamics and mitophagy. Golgi fragmentation, impaired glycosylation and abnormal vesicular trafficking jeopardize protein maturation and secretion. Endoplasmic reticulum stress causes myocardial injury via unfolded protein response, calcium dyshomeostasis and disruptions of lipid metabolism. Lysosomal degradation is disrupted by autophagic dysfunction, enzyme dysregulation and calcium signaling abnormalities. Ribosomes regulate proteostasis by defective biogenesis, quality control and translational dysregulation. Nuclear envelope instability and intercalated disc dysfunction disrupt normal mechanical and gene regulation in the development of cardiomyopathy. In combination, these findings support the concept of cardiomyopathy as a multi-organelle network disease driven by coordinated dysfunction of interconnected organelles. This review systematically summarizes current evidence on organelle-specific and inter-organelle mechanisms underlying cardiomyopathy, highlighting how disrupted organelle homeostasis collectively contributes to disease initiation and progression.\n\nID: 41550140\nTitle: Oxidative stress-driven transcriptomic remodeling in human astrocytes reveals network signatures associated with neurodegenerative and cardiovascular processes.\nAbstract: Astrocytes are central to brain homeostasis, supporting neuronal metabolism, synaptic activity, and the blood-brain barrier. With aging, these glial cells undergo molecular and functional changes that weaken support functions and promote neuroinflammation, contributing to neurodegeneration. Yet the systems-level mechanisms by which astrocytes respond to aging-related stressors remain poorly defined in human models. Because aging also heightens risk for cardiovascular disease, cognitive impairment, type 2 diabetes, and systemic inflammation, clarifying shared astrocytic pathways is critical for understanding brain-body crosstalk. Using an in vitro human astrocyte model exposed to sublethal oxidative stress (10\u202f\u00b5M H\u2082O\u2082) as a proxy for age-related cellular stress, we profiled transcriptomic changes and identified differentially expressed genes across antioxidant defenses, proteostasis, transcriptional regulation, vesicular trafficking, and inflammatory signaling. We then performed network-prioritization analyses on a curated human protein-protein interactome: one seeded with the astrocyte oxidative stress responsive genes and six with phenotype-associated gene sets (Alzheimer's disease, cardiovascular disease, cognitive impairment, type 2 diabetes, oxidative stress, and inflammation). Intersecting the top 5\u202f% scoring genes from each run yielded a 127-gene core shared across all seven, enriched for proteostasis, DNA repair, mitochondrial regulation, and telomere and nuclear envelope maintenance. Structure-guided analyses highlighted vulnerable interfaces, including lamin A/C-lamin B1, \u03b1-actinin-filamins, 14-3-3 dimers, and aminoacyl-tRNA synthetase assemblies, where pathogenic variants are predicted to destabilize or aberrantly stabilize protein interactions. Structure-based interface predictions also highlight potential interactions between amyloid precursor protein (APP) and valosin-containing protein (VCP), and between p53 and 14-3-3\u03b6, potentially linking proteostasis and stress signaling. Together, these analyses identify a conserved astrocyte-centered network signature that may relate neurodegenerative and cardiovascular processes, and prioritize structurally testable candidates for biomarker and intervention hypothesis testing.\n\nID: 41382302\nTitle: A Multi-PTM omics atlas uncovers novel aging regulators in colorectal cancer.\nAbstract: Aging is a key driver of colorectal cancer (CRC) progression, yet the post-translational modification (PTM) landscape associated with aging in CRC remains largely uncharacterized. In particular, the coordinated influence of multiple PTMs-such as phosphorylation, ubiquitination, and malonylation-on aging-related pathways has not been systematically explored. In this study, we established a CRC-specific multiomics framework by profiling phosphorylation, malonylation, and ubiquitination in matched tumor and adjacent normal tissues (n\u2009=\u20098 pairs). The differentially modified proteins were subjected to functional enrichment, protein-protein interaction (PPI) network construction, structural mapping, and aging pathway annotation. Key regulatory axes were reconstructed through integration of GO, KEGG, and literature-based evidence. Aging-related PTMs were extensively dysregulated in CRC, with 162 ubiquitination sites, 64 phosphorylation sites, and 68 malonylation sites altered. LMNB1 has emerged as a multi-PTM protein, indicating coordinated control of the nuclear structure during senescence. PPI network analysis highlighted CDK1, SOD2, and MAPK1 as potential hub PTM-regulated nodes involved in the aging program of CRC. An integrated signaling model further demonstrated how PTM-mediated suppression of the EGFR-RAS axis, along with activation of the p38 and p53 pathways, collectively contributes to shaping the aging phenotype in CRC. This study presents the first integrative network map of aging regulation in CRC based on multiple PTMs. Notably, hub proteins such as LMNB1 have emerged as key regulatory targets. These findings provide a theoretical foundation for the development of aging-cancer axis-related biomarkers and therapeutic strategies for CRC.\n\nID: 41187062\nTitle: Stra8 links neuronal activity to inhibitory circuit protection in the adult mouse brain.\nAbstract: While neuronal activity is essential for brain function, it also poses threats to neuronal integrity. Here, we show that activity-induced expression of stimulated by retinoic acid gene 8 (Stra8) protects neurons from degeneration. Previously considered germline specific, Stra8 is expressed in the adult mouse brain and is induced by neuronal activity via calcium influx and N-methyl-D-aspartate (NMDA) receptor signaling. Neuron-specific Stra8 knockout mice display hallmark features of neurodegeneration, including DNA damage, impaired proteostasis, inflammation, nuclear envelope erosion, reduced dendritic plasticity, memory deficits, and heightened excitotoxic vulnerability. Electrophysiological studies reveal disrupted inhibitory circuit function. Mechanistically, Stra8 binds regulatory regions of neuromodulator genes and regulates their expression. Notably, Stra8 loss upregulates the expression of Npas4, an immediate-early gene critical for inhibitory circuits, but the aberrant protein is mislocalized to the nuclear periphery. These findings identify Stra8 as an activity-dependent transcriptional regulator that safeguards neuronal structure and function.\n\nID: 41169507\nTitle: Endolysosomal dysfunction impairs proteostasis and induces neurodegeneration in vivo.\nAbstract: Transactive response (TAR) DNA-binding protein 43 (TDP-43) inclusions are a pathological hallmark of the frontotemporal dementia (FTD)-amyotrophic lateral sclerosis (ALS) spectrum. Dysfunction of the endolysosomal system, which plays a crucial role in protein trafficking and maintaining proteostasis, has been implicated in FTD-ALS pathogenesis. While the impact of endolysosomal dysfunction on TDP-43 pathology remains unclear, we demonstrated that disrupting the endolysosomal pathway by expressing the constitutively active endosomal protein, Rab5Q79L, induces TDP-43 aggregation in cultured cells. Here, we generated a mouse model expressing GFP-tagged Rab5Q79L, demonstrating that GFP-Rab5Q79L mice exhibit early motor deficits and endolysosomal dysfunction, including enlarged endosomes, abnormal lysosome morphology, and p62- or ubiquitin-positive inclusions. These mice also developed significant neuronal loss, neuroinflammation, phosphorylated TDP-43 (pTDP-43) inclusions, and nuclear envelope and nuclear pore structural defects reminiscent of FTD-ALS. Accordingly, GFP-Rab5Q79L mice will prove useful in expanding our understanding of endolysosomal dysfunction in proteostasis and pTDP-43 pathology.\n\nID: 40574397\nTitle: Assessing the Efficacy of Small Molecule Drugs in Hutchinson-Gilford Progeria Syndrome: A Review of Clinical Trials.\nAbstract: Hutchinson-Gilford Progeria Syndrome (HGPS), or progeria, is an exceptionally rare disorder characterized by premature aging. It is primarily caused by a c.1824C>T point mutation in exon 11 of the LMNA gene, though other rare pathogenic variants have also been reported. This mutation leads to aberrant splicing, producing a farnesylated mutant form of lamin A known as progerin. Progerin accumulates abnormally in the nuclear lamina, triggering numerous cellular dysfunctions, including nuclear deformation, disrupted proteostasis, endoplasmic reticulum (ER) stress, replicative stress, increased reactive oxygen species (ROS) production, impaired DNA endjoining repair, mitochondrial dysfunction, and cellular senescence. These disruptions collectively manifest as a multisystem disorder characterized by failure to thrive, accelerated atherosclerosis, and severe complications such as myocardial infarction, heart failure, stroke, and risks associated with head trauma or surgical interventions. Farnesyltransferase inhibitors (FTIs) have shown potential in mitigating disease phenotypes in preclinical models, with lonafarnib achieving FDA approval in 2020 as the first-and currently only-drug for progeria treatment. This review focuses on the clinical trial outcomes of small-molecule therapeutics for progeria, with particular emphasis on emerging small molecules from recent research. These novel compounds, with their unique mechanisms of action, hold promise not only for improving disease management but potentially offering a cure for this devastating condition.\n\nID: 40099196\nTitle: Proteasome dynamics in response to metabolic changes.\nAbstract: Proteasomes, essential protease complexes in protein homeostasis, adapt to metabolic changes through intracellular movements. As the executive arm of the ubiquitin-proteasome system, they selectively degrade poly-ubiquitinated proteins in an ATP-dependent process. The primary proteasome configuration involved in this degradation is the 26S proteasome, which is composed of a proteolytically active core particle flanked by two regulatory particles. In metabolically active cells, such as proliferating yeast and mammalian cancer cells, 26S proteasomes are predominantly nuclear and actively engaged in protein degradation. However, during nutrient deprivation or stress-induced quiescence, proteasome localization changes. In quiescent yeast, proteasomes initially accumulate at the nuclear envelope. During prolonged quiescence with decreased ATP levels, proteasomes exit the nucleus and are sequestered into cytoplasmic membraneless organelles, so-called proteasome storage granules (PSGs). In mammalian cells, starvation and stress trigger formation of membraneless organelles containing proteasomes and poly-ubiquitinated substrates. The proteasome condensates are motile, reversible, and contribute to stress resistance and improved fitness during aging. Proteasome condensation may involve liquid-liquid phase separation, a mechanism underlying the assembly of membraneless organelles.\n\nID: 39984468\nTitle: Characterization of senescence and nuclear reorganization in aging gingival cells.\nAbstract: Cellular senescence is a stress response that limits tumor formation by promoting the removal of damaged cells through the immune system. In this study, we observed accumulation of senescent cells during human aging gingival tissue, by increased levels of \u03b3H2A.X, 53BP1, and SAHF, along with a greater distance of H3K9me3 from the nuclear periphery. Additionally, primary gingival fibroblasts from older individuals displayed an enlarged nuclear area and perimeter, accompanied by DNA damage responses and increased Lamin B1 invaginations. The combination of phospho-p38 (Thr180/Tyr182) foci with form factor demonstrated an 79.27% predictive accuracy for aging in gingival fibroblasts, with an AUC of 0.83. In co-culture experiments, our findings revealed that senescent fibroblasts from aged donors exhibit slower and fewer recruitment of PBMCs and decreased levels of the Natural Killer cell receptor ligand MICA/B and the CD112R ligand Nectin-2, suggesting potential impairment in immune surveillance mechanisms during aging.\n\nID: 39769001\nTitle: LAP1 Interactome Profiling Provides New Insights into LAP1's Physiological Functions.\nAbstract: The nuclear envelope (NE), a protective membrane bordering the nucleus, is composed of highly specialized proteins that are indispensable for normal cellular activity. Lamina-associated polypeptide 1 (LAP1) is a NE protein whose functions are just beginning to be unveiled. The fact that mutations causing LAP1 deficiency are extremely rare and pathogenic is indicative of its paramount importance to preserving human health, anticipating that LAP1 might have a multifaceted role in the cell. Mapping the LAP1 protein interactome is, thus, imperative to achieve an integrated view of its potential biological properties. To this end, we employed in silico- and mass spectrometry-based approaches to identify candidate LAP1-interacting proteins, whose functional attributes were subsequently characterized using bioinformatics tools. Our results reveal the complex and multifunctional network of protein-protein interactions associated to LAP1, evidencing a strong interconnection between LAP1 and cellular processes as diverse as chromatin and cytoskeleton organization, DNA repair, RNA processing and translation, as well as protein biogenesis and turnover, among others. Novel interactions between LAP1 and DNA repair proteins were additionally validated, strengthening the previously proposed involvement of LAP1 in the maintenance of genomic stability. Overall, this study reaffirms the biological relevance of LAP1 and the need to deepen our knowledge about this NE protein, providing new insights about its potential functional partners that will help guiding future research towards a mechanistic understanding of LAP1's functioning.\n\nID: 39202453\nTitle: Genetic and Pathophysiological Basis of Cardiac and Skeletal Muscle Laminopathies.\nAbstract: Nuclear lamins, a type V intermediate filament, are crucial components of the nuclear envelope's inner layer, maintaining nuclear integrity and mediating interactions between the nucleus and cytoplasm. Research on human iPSC-derived cells and animal models has demonstrated the importance of lamins in cardiac and skeletal muscle development and function. Mutations in lamins result in laminopathies, a group of diseases including muscular dystrophies, Hutchison-Gilford progeria syndrome, and cardiomyopathies with conduction defects. These conditions have been linked to disrupted autophagy, mTOR, Nrf2-Keap, and proteostasis signaling pathways, indicating complex interactions between the nucleus and cytoplasm. Despite progress in understanding these pathways, many questions remain about the mechanisms driving lamin-induced pathologies, leading to limited therapeutic options. This review examines the current literature on dysregulated pathways in cardiac and skeletal muscle laminopathies and explores potential therapeutic strategies for these conditions.\n\nID: 39035020\nTitle: Quantitative proteome analysis of LAP1-deficient human fibroblasts: A pilot approach for predicting the signaling pathways deregulated in LAP1-associated diseases.\nAbstract: Lamina-associated polypeptide 1 (LAP1), a ubiquitously expressed nuclear envelope protein, appears to be essential for the maintenance of cell homeostasis. Although rare, mutations in the human LAP1-encoding TOR1AIP1 gene cause severe diseases and can culminate in the premature death of affected individuals. Despite there is increasing evidence of the pathogenicity of TOR1AIP1 mutations, the current knowledge on LAP1's physiological roles in humans is limited; hence, investigation is required to elucidate the critical functions of this protein, which can be achieved by uncovering the molecular consequences of LAP1 depletion, a topic that remains largely unexplored. In this work, the proteome of patient-derived LAP1-deficient fibroblasts carrying a pathological TOR1AIP1 mutation (LAP1 E482A) was quantitatively analyzed to identify global changes in protein abundance levels relatively to control fibroblasts. An in silico functional enrichment analysis of the mass spectrometry-identified differentially expressed proteins was also performed, along with additional in vitro functional assays, to unveil the biological processes that are potentially dysfunctional in LAP1 E482A fibroblasts. Collectively, our findings suggest that LAP1 deficiency may induce significant alterations in various cellular activities, including DNA repair, messenger RNA degradation/translation, proteostasis and glutathione metabolism/antioxidant response. This study sheds light on possible new functions of human LAP1 and could set the basis for subsequent in-depth mechanistic investigations. Moreover, by identifying deregulated signaling pathways in LAP1-deficient cells, our work may offer valuable molecular targets for future disease-modifying therapies for TOR1AIP1-associated nuclear envelopathies.\n\nID: 38757366\nTitle: The Drosophila Nesprin-1 homolog MSP300 is required for muscle autophagy and proteostasis.\nAbstract: Nesprin proteins, which are components of the linker of nucleoskeleton and cytoskeleton (LINC) complex, are located within the nuclear envelope and play prominent roles in nuclear architecture. For example, LINC complex proteins interact with both chromatin and the cytoskeleton. Here, we report that the Drosophila Nesprin MSP300 has an additional function in autophagy within larval body wall muscles. RNAi-mediated MSP300 knockdown in larval body wall muscles resulted in defects in the contractile apparatus, muscle degeneration and defective autophagy. In particular, MSP300 knockdown caused accumulation of cytoplasmic aggregates that contained poly-ubiquitylated cargo, as well as the autophagy receptor ref(2)P (the fly homolog of p62 or SQSTM) and Atg8a. Furthermore, MSP300 knockdown larvae expressing an mCherry-GFP-tagged Atg8a transgene exhibited aberrant persistence of the GFP signal within these aggregates, indicating failure of autophagosome maturation. These autophagy deficits were similar to those exhibited by loss of the endoplasmic reticulum (ER) fusion protein Atlastin (Atl), raising the possibility that Atl and MSP300 might function in the same pathway. In support of this possibility, we found that a GFP-tagged MSP300 protein trap exhibited extensive localization to the ER. Alteration of ER-directed MSP300 might abrogate important cytoskeletal contacts necessary for autophagosome completion.\n\nID: 38570838\nTitle: Tobacco smoke condensate-induced senescence in endothelial cells was ameliorated by colchicine treatment via suppression of NF-\u03baB and MAPKs P38 and ERK pathways activation.\nAbstract: Smoking is the major cause of cardiovascular diseases and cancer. It induces oxidative stress, leading to DNA damage and cellular senescence. Senescent cells increase the expression and release of pro-inflammatory molecules and matrix metalloproteinase, which are known to play a vital role in the initiation and progression of cardiovascular diseases and metastasis in cancer. The current study investigated the smoking induced cellular senescence and employed colchicine that blocked senescence in endothelial cells exposed to tobacco smoke condensate. Colchicine prevented oxidative stress and DNA damage in tobacco smoke-condensate-treated endothelial cells. Colchicin reduced \u03b2-gal activity, improved Lamin B1, and attenuated cell growth arrest markers P21 and P53. Colchicine also ameliorated the expression of SASP factors and inhibited the activation of NF-kB and MAPKs P38 and ERK. In summary, colchicine inhibited tobacco smoke condensate-induced senescence in endothelial cells by blocking the activation of NF-kB and MAPKs P38 and ERK.\n\nID: 38477372\nTitle: Widespread nuclear lamina injuries defeat proteostatic purposes of \u03b1-synuclein amyloid inclusions.\nAbstract: Biogenesis of inclusion bodies (IBs) facilitates protein quality control (PQC). Canonical aggresomes execute degradation of misfolded proteins while non-degradable amyloids sequester into insoluble protein deposits. Lewy bodies (LBs) are filamentous amyloid inclusions of \u03b1-synuclein, but PQC benefits and drawbacks associated with LB-like IBs remain underexplored. Here, we report that crosstalk between filamentous LB-like IBs and aggresome-like IBs of \u03b1-synuclein (Syn-aggresomes) buffer the load, aggregation state, and turnover of the amyloidogenic protein in mouse primary neurons and HEK293T cells. Filamentous LB-like IBs possess unorthodox PQC capacities of self-quarantining \u03b1-synuclein amyloids and being degradable upon receding fresh amyloidogenesis. Syn-aggresomes equilibrate biogenesis of filamentous LB-like IBs by facilitating spontaneous degradation of \u03b1-synuclein and conditional turnover of disintegrated \u03b1-synuclein amyloids. Thus, both types of IB primarily contribute to PQC. Incidentally, the overgrown perinuclear LB-like IBs become degenerative once these are misidentified by BICD2, a cargo-adapter for the cytosolic motor-protein dynein. Microscopy indicates that microtubules surrounding the perinuclear filamentous inclusions are also distorted, misbalancing the cytoskeleton-nucleoskeleton tension leading to widespread lamina injuries. Together, nucleocytoplasmic mixing, DNA damage, and deregulated transcription of stress chaperones defeat the proteostatic purposes of the filamentous amyloids of \u03b1-synuclein.\n\nID: 38074322\nTitle: The role of cellular senescence in skin aging and age-related skin pathologies.\nAbstract: Aging is the result of a gradual functional decline at the cellular, and ultimately, organismal level, resulting in an increased risk of developing a variety of chronic illnesses, such as cardiovascular disease, stroke, cancer and diabetes. The skin is the largest organ of the human body, and the site where signs of aging are most visible. These signs include thin and dry skin, sagging, loss of elasticity, wrinkles, as well as aberrant pigmentation. The appearance of these features is accelerated by exposure to extrinsic factors such as ultraviolet (UV) radiation or pollution, as well as intrinsic factors including time, genetics, and hormonal changes. At the cellular level, aging is associated with impaired proteostasis and an accumulation of macromolecular damage, genomic instability, chromatin reorganization, telomere shortening, remodelling of the nuclear lamina, proliferation defects and premature senescence. Cellular senescence is a state of permanent growth arrest and a key hallmark of aging in many tissues. Due to their inability to proliferate, senescent cells no longer contribute to tissue repair or regeneration. Moreover, senescent cells impair tissue homeostasis, promote inflammation and extracellular matrix (ECM) degradation by secreting molecules collectively known as the \"senescence-associated secretory phenotype\" (SASP). Senescence can be triggered by a number of different stimuli such as telomere shortening, oncogene expression, or persistent activation of DNA damage checkpoints. As a result, these cells accumulate in aging tissues, including human skin. In this review, we focus on the role of cellular senescence during skin aging and the development of age-related skin pathologies, and discuss potential strategies to rejuvenate aged skin.\n\nID: 37998344\nTitle: mTOR Inhibitor Rapalink-1 Prevents Ethanol-Induced Senescence in Endothelial Cells.\nAbstract: The cardiovascular risk factors, including smoking, ethanol, and oxidative stress, can induce cellular senescence. The senescent cells increase the expression and release of pro-inflammatory molecules and matrix metalloproteinase (MMPs). These pro-inflammatory molecules and MMPs promote the infiltration and accumulation of inflammatory cells in the vascular tissue, exacerbating vascular tissue inflammation. MMPs damage vascular tissue by degenerating the extracellular matrix. Consequently, these cellular and molecular events promote the initiation and progression of cardiovascular diseases. We used Rapalink-1, an mTOR inhibitor, to block ethanol-induced senescence. Rapalink-1 inhibited oxidative-stress-induced DNA damage and senescence in endothelial cells exposed to ethanol. It attenuated the relative protein expression of senescence marker P21 and improved the relative protein expression of DNA repair protein KU70 and aging marker Lamin B1. It inhibited the activation of NF-\u03baB, MAPKs (P38 and ERK), and mTOR pathway proteins (mTOR, 4EBP-1, and S6). Moreover, Rapalink-1 suppressed ethanol-induced mRNA expression of ICAM-1, E-selectin, MCP-1, IL-8, MMP-2, and TIMP-2. Rapalink-1 also reduced the relative protein expression of MMP-2. In summary, Rapalink-1 prevented senescence, inhibited pro-inflammatory pathway activation, and ameliorated pro-inflammatory molecule expression and MMP-2.\n\nID: 37715940\nTitle: Changing the guard-nuclear pore complex quality control.\nAbstract: The integrity of the nuclear envelope depends on the function of nuclear pore complexes (NPCs), transport channels that control macromolecular traffic between the nucleus and cytosol. The central importance of NPCs suggests the existence of quality control (QC) mechanisms that oversee their assembly and function. In this perspective, we emphasize the challenges associated with NPC assembly and the need for QC mechanisms that operate at various stages of an NPC's life. This includes cytosolic preassembly QC that helps enforce key nucleoporin-nucleoporin interactions and their ultimate stoichiometry in the NPC in addition to mechanisms that monitor aberrant fusion of the inner and outer nuclear membranes. Furthermore, we discuss whether and how these QC mechanisms may operate to sense faulty mature NPCs to facilitate their repair or removal. The so far uncovered mechanisms for NPC QC provide fertile ground for future research that not only benefits a better understanding of the vital role that NPCs play in cellular physiology but also how loss of NPC function and/or these QC mechanisms might be an input to aging and disease.\n\nID: 37498235\nTitle: Nuclear proteostasis imbalance in laminopathy-associated premature aging diseases.\nAbstract: Laminopathies are a group of rare genetic disorders with heterogeneous clinical phenotypes such as premature aging, cardiomyopathy, lipodystrophy, muscular dystrophy, microcephaly, epilepsy, and so on. The cellular phenomena associated with laminopathy invariably show disruption of nucleoskeleton of lamina due to deregulated expression, localization, function, and interaction of mutant lamin proteins. Impaired spatial and temporal tethering of lamin proteins to the lamina or nucleoplasmic aggregation of lamins are the primary molecular events that can trigger nuclear proteotoxicity by modulating differential protein-protein interactions, sequestering quality control proteins, and initiating a cascade of abnormal post-translational modifications. Clearly, laminopathic cells exhibit moderate to high nuclear proteotoxicity, raising the question of whether an imbalance in nuclear proteostasis is involved in laminopathic diseases, particularly in diseases of early aging such as HGPS and laminopathy-associated premature aging. Here, we review nuclear proteostasis and its deregulation in the context of lamin proteins and laminopathies.\n\nID: 37193048\nTitle: Activation of \u03b17 nicotinic acetylcholine receptor promotes HIV-1 transcription.\nAbstract: Alpha7 nicotinic acetylcholine receptor (\u03b17 nAChR), a hub of the cholinergic anti-inflammatory pathway (CAP), is required for the treatment of inflammatory diseases. HIV-1 infection can upregulate the expression of \u03b17 nAChR in T lymphocytes and affect the role of CAP. However, whether \u03b17 nAChR regulates HIV-1 infection in CD4+ T cells is unclear. In this study, we first found that activation of \u03b17 nAChR by GTS-21 (an \u03b17 nAChR agonist) can promote the transcription of HIV-1 proviral DNA. Then, through transcriptome sequencing analysis, we found that p38 MAPK signaling was enriched in GTS-21 treated HIV-latent T cells. Mechanistically, activation of \u03b17 nAChR could increase reactive oxygen species (ROS), reduce DUSP1 and DUSP6, and consequently enhance the phosphorylation of p38 MAPK. By co-immunoprecipitation and liquid chromatography tandem mass spectrometry, we found that p-p38 MAPK interacted with Lamin B1 (LMNB1). Activation of \u03b17 nAChR increased the binding between p-p38 MAPK and LMNB1. We confirmed that knockdown of MAPK14 significantly downregulated NFATC4, a key activator of HIV-1 transcription. Taken together, activation of the \u03b17 nAChR could trigger ROS/p-p38 MAPK/LMNB1/NFATC4 signaling pathway enhancing HIV-1 transcription. We have revealed an unrecognized mechanism of \u03b17 nAChR-mediated neuroimmune regulation of HIV infection.\n\nID: 37081164\nTitle: Nuclear and cytoplasmic spatial protein quality control is coordinated by nuclear-vacuolar junctions and perinuclear ESCRT.\nAbstract: Effective protein quality control (PQC), essential for cellular health, relies on spatial sequestration of misfolded proteins into defined inclusions. Here we reveal the coordination of nuclear and cytoplasmic spatial PQC. Cytoplasmic misfolded proteins concentrate in a cytoplasmic juxtanuclear quality control compartment, while nuclear misfolded proteins sequester into an intranuclear quality control compartment (INQ). Particle tracking reveals that INQ and the juxtanuclear quality control compartment converge to face each other across the nuclear envelope at a site proximal to the nuclear-vacuolar junction marked by perinuclear ESCRT-II/III protein Chm7. Strikingly, convergence at nuclear-vacuolar junction contacts facilitates VPS4-dependent vacuolar clearance of misfolded cytoplasmic and nuclear proteins, the latter entailing extrusion of nuclear INQ into the vacuole. Finding that nuclear-vacuolar contact sites are cellular hubs of spatial PQC to facilitate vacuolar clearance of nuclear and cytoplasmic inclusions highlights the role of cellular architecture in proteostasis maintenance.\n\nID: 36556471\nTitle: Amentoflavone-Enriched Selaginella rossii Protects against Ultraviolet- and Oxidative Stress-Induced Aging in Skin Cells.\nAbstract: Selaginellaceae plants are used in cosmetics to limit skin aging. This study is the first to investigate the anti-aging effects of Selaginella rossii (SR) on ultraviolet B (UVB)- and oxidative stress-induced skin cells. The 95% ethanol extract of Selaginella rossii (SR95E) contained much higher amounts of amentoflavone (AMF), an active compound, than other Selaginellaceae plants and was more effective in inhibiting matrix metalloproteinase (MMP)-1 expression in CCD-986sk fibroblasts. SR95E significantly decreased UVB-induced MMP-1, MMP-2, MMP-3 and MMP-9 expression and enhanced procollagen type I C-peptide content and mRNA expression of collagen type I alpha (COL1A)1 and COL1A2 in CCD-986sk fibroblasts. In HaCaT keratinocytes, SR95E treatment also dose-dependently decreased UVB-induced MMP-1 concentration and MMP-1, MMP-2, MMP-3 and MMP-9 mRNA expression. Moreover, SR95E treatment markedly inhibited UVB-induced c-Jun N-terminal kinase and p38 mitogen-activated protein kinase signaling and nuclear factor kappa-B signaling in HaCaT cells. Furthermore, SR95E and AMF markedly regulated the 2,2'-azobis(2-amidinopropane) dihydrochloride (AAPH)-induced expression of cellular senescence-related markers, including p16, p21 and LMNB1, in HaCaT cells. Overall, this study indicates that SR may have potential as a functional material on preventing UVB- and AAPH-induced skin aging and wrinkles.\n\nID: 36417855\nTitle: Dynamic quality control machinery that operates across compartmental borders mediates the degradation of mammalian nuclear membrane proteins.\nAbstract: Many human diseases are caused by mutations in nuclear envelope (NE) proteins. How protein homeostasis and disease etiology are interconnected at the NE is poorly understood. Specifically, the identity of local ubiquitin ligases that facilitate ubiquitin-proteasome-dependent NE protein turnover is presently unknown. Here, we employ a short-lived, Lamin B receptor disease variant as a model substrate in a genetic screen to uncover key elements of NE protein turnover. We identify the ubiquitin-conjugating enzymes (E2s) Ube2G2 and Ube2D3, the membrane-resident ubiquitin ligases (E3s) RNF5 and HRD1, and the poorly understood protein TMEM33. RNF5, but not HRD1, requires TMEM33 both for efficient biosynthesis and function. Once synthesized, RNF5 responds dynamically to increased substrate levels at the NE by departing from the endoplasmic reticulum, where HRD1 remains confined. Thus, mammalian protein quality control machinery partitions between distinct cellular compartments to address locally changing substrate loads, establishing a robust cellular quality control system.\n\nID: 36321451\nTitle: Pathogenesis of Cardiomyopathy Caused by Variants in ALPK3, an Essential Pseudokinase in the Cardiomyocyte Nucleus and Sarcomere.\nAbstract: ALPK3 encodes \u03b1-kinase 3, a muscle-specific protein of unknown function. ALPK3 loss-of-function variants cause cardiomyopathy with distinctive clinical manifestations in both children and adults, but the molecular functions of ALPK3 remain poorly understood. We explored the putative kinase activity of ALPK3 and the consequences of damaging variants using isogenic human induced pluripotent stem cell-derived cardiomyocytes, mice, and human patient tissues. Multiple sequence alignment of all human \u03b1-kinase domains and their orthologs revealed 4 conserved residues that were variant only in ALPK3, demonstrating evolutionary divergence of the ALPK3 \u03b1-kinase domain sequence. Phosphoproteomic evaluation of both ALPK3 kinase domain inhibition and overexpression failed to detect significant changes in catalytic activity, establishing ALPK3 as a pseudokinase. Investigations into alternative functions revealed that ALPK3 colocalized with myomesin proteins (MYOM1, MYOM2) at both the nuclear envelope and the sarcomere M-band. ALPK3 loss-of-function variants caused myomesin proteins to mislocalize and also dysregulated several additional M-band proteins involved in sarcomere protein turnover, which ultimately impaired cardiomyocyte structure and function. ALPK3 is an essential cardiac pseudokinase that inserts in the nuclear envelope and the sarcomere M-band. Loss of ALPK3 causes mislocalization of myomesins, critical force-buffering proteins in cardiomyocytes, and also dysregulates M-band proteins necessary for sarcomere protein turnover. We conclude that ALPK3 cardiomyopathy induces ventricular dilatation caused by insufficient myomesin-mediated force buffering and hypertrophy by impairment of sarcomere proteostasis.\n\nID: 35940911\nTitle: Endoplasmic Reticulum Architecture and Inter-Organelle Communication in Metabolic Health and Disease.\nAbstract: The endoplasmic reticulum (ER) is a key organelle involved in the regulation of lipid and glucose metabolism, proteostasis, Ca2+ signaling, and detoxification. The structural organization of the ER is very dynamic and complex, with distinct subdomains such as the nuclear envelope and the peripheral ER organized into ER sheets and tubules. ER also forms physical contact sites with all other cellular organelles and with the plasma membrane. Both form and function of the ER are highly adaptive, with a potent capacity to respond to transient changes in environmental cues such as nutritional fluctuations. However, under obesity-induced chronic stress, the ER fails to adapt, leading to ER dysfunction and the development of metabolic pathologies such as insulin resistance and fatty liver disease. Here, we discuss how the remodeling of ER structure and contact sites with other organelles results in diversification of metabolic function and how perturbations to this structural flexibility by chronic overnutrition contribute to ER dysfunction and metabolic pathologies in obesity.\n\nID: 35778326\nTitle: Maintaining soluble protein homeostasis between nuclear and cytoplasmic compartments across mitosis.\nAbstract: The nuclear envelope (NE) is central to the architecture of eukaryotic cells, both as a physical barrier separating the nucleus from the cytoplasm and as gatekeeper of selective transport between them. However, in open mitosis, the NE fragments to allow for spindle formation and segregation of chromosomes, resulting in intermixing of nuclear and cytoplasmic soluble fractions. Recent studies have shed new light on the mechanisms driving reinstatement of soluble proteome homeostasis following NE reformation in daughter cells. Here, we provide an overview of how mitotic cells confront this challenge to ensure continuity of basic cellular functions across generations and elaborate on the implications for the proteasome - a macromolecular machine that functions in both cytoplasmic and nuclear compartments.\n\nID: 35150241\nTitle: Proteasome activity modulates amyloid toxicity.\nAbstract: Alzheimer's disease (AD) is responsible for 60%-80% of identified cases of dementia. While the generation and accumulation of amyloid precursor protein (APP) fragments is accepted as a key step in AD pathogenesis, the precise role of these fragments remains poorly understood. To overcome this deficit, we induced the expression of the soluble C-terminal fragment of APP (C99), the rate-limiting peptide for the generation of amyloid fragments, in yeast that contain thermosensitive mutations in genes encoding proteasome subunits. Our previous work with this system demonstrated that these proteasome-deficient yeast cells, expressing C99 when proteasome activity was blunted, generated amyloid fragments similar to those observed in AD patients. We now report the phenotypic repercussions of inducing C99 expression in proteasome-deficient cells. We show increased levels of protein aggregates, cellular stress and chaperone expression, electron-dense accumulations in the nuclear envelope/ER, abnormal DNA condensation, and an induction of apoptosis. Taken together, these findings suggest that the generation of C99 and its associated fragments in yeast cells with compromised proteasomal activity results in phenotypes that may be relevant to the neuropathological processes observed in AD patients. These data also suggest that this yeast model should be useful for testing therapeutics that target AD-associated amyloid, since it allows for the assessment of the reversal of the perturbed cellular physiology observed when degradation pathways are dysfunctional.\n\nID: 34440892\nTitle: New Activities of the Nuclear Pore Complexes.\nAbstract: Nuclear pore complexes (NPCs) at the surface of nuclear membranes play a critical role in regulating the transport of both small molecules and macromolecules between the cell nucleus and cytoplasm via their multilayered spiderweb-like central channel. During mitosis, nuclear envelope breakdown leads to the rapid disintegration of NPCs, allowing some NPC proteins to play crucial roles in the kinetochore structure, spindle bipolarity, and centrosome homeostasis. The aberrant functioning of nucleoporins (Nups) and NPCs has been associated with autoimmune diseases, viral infections, neurological diseases, cardiomyopathies, and cancers, especially leukemia. This Special Issue highlights several new contributions to the understanding of NPC proteostasis.\n\nID: 34290138\nTitle: Nuclear envelope budding is a response to cellular stress.\nAbstract: Nuclear envelope budding (NEB) is a recently discovered alternative pathway for nucleocytoplasmic communication distinct from the movement of material through the nuclear pore complex. Through quantitative electron microscopy and tomography, we demonstrate how NEB is evolutionarily conserved from early protists to human cells. In the yeast Saccharomyces cerevisiae, NEB events occur with higher frequency during heat shock, upon exposure to arsenite or hydrogen peroxide, and when the proteasome is inhibited. Yeast cells treated with azetidine-2-carboxylic acid, a proline analog that induces protein misfolding, display the most dramatic increase in NEB, suggesting a causal link to protein quality control. This link was further supported by both localization of ubiquitin and Hsp104 to protein aggregates and NEB events, and the evolution of these structures during heat shock. We hypothesize that NEB is part of normal cellular physiology in a vast range of species and that in S. cerevisiae NEB comprises a stress response aiding the transport of protein aggregates across the nuclear envelope.\n\nID: 33566711\nTitle: Inner-nuclear-membrane-associated degradation employs Dfm1-independent retrotranslocation and alleviates misfolded transmembrane-protein toxicity.\nAbstract: Before their delivery to and degradation by the 26S proteasome, misfolded transmembrane proteins of the endoplasmic reticulum (ER) and inner-nuclear membrane (INM) must be extracted from lipid bilayers. This extraction process, known as retrotranslocation, requires both quality-control E3 ubiquitin ligases and dislocation factors that diminish the energetic cost of dislodging the transmembrane segments of a protein. Recently, we showed that retrotranslocation of all ER transmembrane proteins requires the Dfm1 rhomboid pseudoprotease. However, we did not investigate whether Dfm1 also mediated retrotranslocation of transmembrane substrates in the INM, which is contiguous with the ER but functionally separated from it by nucleoporins. Here, we show that canonical retrotranslocation occurs during INM-associated degradation (INMAD) but proceeds independently of Dfm1. Despite this independence, ER-associated degradation (ERAD)-M and INMAD cooperate to mitigate proteotoxicity. We show a novel misfolded-transmembrane-protein toxicity that elicits genetic suppression, demonstrating the cell's ability to tolerate a toxic burden of misfolded transmembrane proteins without functional INMAD or ERAD-M. This strikingly contrasted the suppression of the dfm1\u0394 null, which leads to the resumption of ERAD-M through HRD-complex remodeling. Thus, we conclude that INM retrotranslocation proceeds through a novel, private channel that can be studied by virtue of its role in alleviating membrane-associated proteotoxicity.\n\nID: 33407930\nTitle: Dysfunction in nonsense-mediated decay, protein homeostasis, mitochondrial function, and brain connectivity in ALS-FUS mice with cognitive deficits.\nAbstract: Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) represent two ends of the same disease spectrum of adult-onset neurodegenerative diseases that affect the motor and cognitive functions, respectively. Multiple common genetic loci such as fused in sarcoma (FUS) have been identified to play a role in ALS and FTD etiology. Current studies indicate that FUS mutations incur gain-of-toxic functions to drive ALS pathogenesis. However, how the disease-linked mutations of FUS affect cognition remains elusive. Using a mouse model expressing an ALS-linked human FUS mutation (R514G-FUS) that mimics endogenous expression patterns, we found that FUS proteins showed an age-dependent accumulation of FUS proteins despite the downregulation of mouse FUS mRNA by the R514G-FUS protein during aging. Furthermore, these mice developed cognitive deficits accompanied by a reduction in spine density and long-term potentiation (LTP) within the hippocampus. At the physiological expression level, mutant FUS is distributed in the nucleus and cytosol without apparent FUS aggregates or nuclear envelope defects. Unbiased transcriptomic analysis revealed a deregulation of genes that cluster in pathways involved in nonsense-mediated decay, protein homeostasis, and mitochondrial functions. Furthermore, the use of in vivo functional imaging demonstrated widespread reduction in cortical volumes but enhanced functional connectivity between hippocampus, basal ganglia and neocortex in R514G-FUS mice. Hence, our findings suggest that disease-linked mutation in FUS may lead to changes in proteostasis and mitochondrial dysfunction that in turn affect brain structure and connectivity resulting in cognitive deficits.\n\nID: 32788068\nTitle: ROS/p38MAPK-induced lamin B1 accumulation promotes chronic kidney disease-associated vascular smooth muscle cells senescence.\nAbstract: The incidence of cardiovascular thrombotic events which are highly associated with atherosclerotic plaque vulnerability and its rupture is much higher in chronic kidney disease (CKD) patients than that in the general population. It has been reported that the thinning of fibrous cap in atherosclerotic plaque is a crucial factor in plaque vulnerability and thrombosis. Moreover, vascular smooth muscle cells (VSMCs) senescence play a crucial role in maintaining the thickness of fibrous cap. Lamin B1, one of the members of laminin family, is an important component of the nuclear membrane and it is related to cell senescence. While whether lamin B1 participates CKD-related VSMCs senescence and plaque vulnerability and the underlying mechanism remain unclear. Here, we found that CKD promoted fibrous cap thinning and reduced the stability of atherosclerotic plaque through accelerating VSMCs senescence. VSMCs senescence induced by CKD was related to the increased expression of lamin B1 and abnormality of nuclear membrane structure. Knocking down the expression of lamin B1 with RNA interference prevented CKD-induced aberrant nuclear membrane structure and senescence in VSMCs. Additionally, overproduction of reactive oxidative stress (ROS) and subsequent activation of ROS/p38MAPK under CKD milieus contribute to these series of outcomes, as scavenging ROS with N-acety-l-cysteine (NAC) or inhibiting p38MAPK signal pathway with SB203580 could inhibit CKD-induced activation of ROS/p38MAPK, increased expression of lamin B1, abnormality of nuclear membrane structure and VSMCs senescence. Taken together, these results suggested that ROS/p38MAPK-mediated increased expression of lamin B1 and abnormality of nuclear membrane structure was an important mechanism of CKD-induced VSMCs senescence.\n\nID: 32630170\nTitle: The Nuclear Lamina: Protein Accumulation and Disease.\nAbstract: Cellular health is reliant on proteostasis-the maintenance of protein levels regulated through multiple pathways modulating protein synthesis, degradation and clearance. Loss of proteostasis results in serious disease and is associated with aging. One proteinaceous structure underlying the nuclear envelope-the nuclear lamina-coordinates essential processes including DNA repair, genome organization and epigenetic and transcriptional regulation. Loss of proteostasis within the nuclear lamina results in the accumulation of proteins, disrupting these essential functions, either via direct interactions of protein aggregates within the lamina or by altering systems that maintain lamina structure. Here we discuss the links between proteostasis and disease of the nuclear lamina, as well as how manipulating specific proteostatic pathways involved in protein clearance could improve cellular health and prevent/reverse disease.\n\nID: 31576648\nTitle: Gene expression modulation by the linker of nucleoskeleton and cytoskeleton complex contributes to proteostasis.\nAbstract: Cellular mechanisms that act in concert to maintain protein homeostasis (proteostasis) are vital for organismal functionality and survival. Nevertheless, subsets of aggregation-prone proteins form toxic aggregates (proteotoxicity) that in some cases, underlie the development of neurodegenerative diseases. Proteotoxic aggregates are often deposited in the vicinity of the nucleus, a process that is cytoskeleton-dependent. Accordingly, cytoskeletal dysfunction contributes to pathological hallmarks of various neurodegenerative diseases. Here, we asked whether the linker of nucleoskeleton and cytoskeleton (LINC) complex, which bridges these filaments across the nuclear envelope, is needed for the maintenance of proteostasis. Employing model nematodes, we discovered that knocking down LINC components impairs the ability of the worm to cope with proteotoxicity. Knocking down anc-1, which encodes a key component of the LINC complex, modulates the expression of transcription factors and E3 ubiquitin ligases, thereby affecting the rates of protein ubiquitination and impairing proteasome-mediated protein degradation. Our results establish a link between the LINC complex, protein degradation, and neurodegeneration-associated proteotoxicity.\n\nID: 31265172\nTitle: Overexpression of human MX2 gene suppresses cell proliferation, migration, and invasion via ERK/P38/NF-\u03baB pathway in glioblastoma cells.\nAbstract: In human, there are two myxovirus resistance genes-MX1 and MX2, which respectively encode MXA and MXB protein. For MXB, it was traditionally deemed to work in the progression of cell cycle and adjustment of nuclear import. Thus, we speculated that it might play important roles in tumor progression. The purpose of this study was to preliminarily explore the underlying functions and mechanism of the MX2 gene on glioblastoma multiforme. Quantitative reverse transcription polymerase chain reaction, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazoliumbromide (MTT), and transwell experiments were to detect the relative MX2 mRNA level and its biological functions on glioma cells, respectively. The data displayed that MX2 was obviously downregulated both in glioblastoma (GBM) and GBM cell lines, meanwhile, its overexpression could markedly reduce cell proliferation, migration, and invasion of glioma cells, implying that it was related with glioblastoma progression. In addition, the overall survival of patient with glioblastoma had a negative correlation with the MX2 expression. Then, Western blot indicated the potential mechanism of MX2 in glioblastoma. We found that MX2 overexpression could decrease the relative levels of phosphorylated-ERK1/2 (p-ERK1/2), p-p38, and nuclear factor-\u03baB (NF-\u03baB), while have no effects on extracellular signal-regulated kinase (ERK), p38, and lamin B1. Moreover, the influences of MX2 overexpression on cell proliferation, migration, and invasion could be weakened by the three inhibitors (PD98059, SB203580, and (pyridin-2-ylmethyl) dithiocarbamate [PDTC]). These results implied that MX2 might suppress the proliferation and metastasis of glioma cells by manipulating the ERK/P38/NF-\u03baB signaling pathway. In conclusion, MX2 is potential to be a new marker used for glioblastoma prognosis or a new target for glioblastoma treatments.\n\nID: 31020383\nTitle: Patrolling the nucleus: inner nuclear membrane-associated degradation.\nAbstract: Protein quality control and transport are important for the integrity of organelles such as the endoplasmic reticulum, but it is largely unknown how protein homeostasis is regulated at the nuclear envelope (NE) despite the connection between NE protein function and human disease. Elucidating mechanisms that regulate the NE proteome is key to understanding nuclear processes such as gene expression, DNA replication and repair as NE components, particularly proteins at the inner nuclear membrane (INM), are involved in the maintenance of nuclear structure, nuclear positioning and chromosome organization. Nuclear pore complexes control the entry and exit of proteins in and out of the nucleus, restricting movement across the nuclear membrane based on protein size, or the size of the extraluminal-facing domain of a transmembrane protein, providing one level of INM proteome regulation. Research in budding yeast has identified a protein quality control system that targets mislocalized and misfolded proteins at the INM. Here, we review what is known about INM-associated degradation, including recent evidence suggesting that it not only targets mislocalized or misfolded proteins, but also contributes to homeostasis of resident INM proteins.\n\nID: 31015297\nTitle: Lamin B1 loss promotes lung cancer development and metastasis by epigenetic derepression of RET.\nAbstract: Although abnormal nuclear structure is an important criterion for cancer diagnostics, remarkably little is known about its relationship to tumor development. Here we report that loss of lamin B1, a determinant of nuclear architecture, plays a key role in lung cancer. We found that lamin B1 levels were reduced in lung cancer patients. Lamin B1 silencing in lung epithelial cells promoted epithelial-mesenchymal transition, cell migration, tumor growth, and metastasis. Mechanistically, we show that lamin B1 recruits the polycomb repressive complex 2 (PRC2) to alter the H3K27me3 landscape and repress genes involved in cell migration and signaling. In particular, epigenetic derepression of the RET proto-oncogene by loss of PRC2 recruitment, and activation of the RET/p38 signaling axis, play a crucial role in mediating the malignant phenotype upon lamin B1 disruption. Importantly, loss of a single lamin B1 allele induced spontaneous lung tumor formation and RET activation. Thus, lamin B1 acts as a tumor suppressor in lung cancer, linking aberrant nuclear structure and epigenetic patterning with malignancy.\n\nID: 29925261\nTitle: Protein Quality Control Degradation in the Nucleus.\nAbstract: Nuclear proteins participate in diverse cellular processes, many of which are essential for cell survival and viability. To maintain optimal nuclear physiology, the cell employs the ubiquitin-proteasome system to eliminate damaged and misfolded proteins in the nucleus that could otherwise harm the cell. In this review, we highlight the current knowledge about the major ubiquitin-protein ligases involved in protein quality control degradation (PQCD) in the nucleus and how they orchestrate their functions to eliminate misfolded proteins in different nuclear subcompartments. Many human disorders are causally linked to protein misfolding in the nucleus, hence we discuss major concepts that still need to be clarified to better understand the basis of the nuclear misfolded proteins' toxic effects. Additionally, we touch upon potential strategies for manipulating nuclear PQCD pathways to ameliorate diseases associated with protein misfolding and aggregation in the nucleus.\n\nID: 29388501\nTitle: Karyoptosis: A novel type of cell death caused by chronic autophagy inhibition.\nAbstract: Macroautophagy/autophagy influences onset and progression of several human neurodegenerative diseases, because of its critical role as a regulator of neuronal proteostasis and organelle quality control. In many neurodegenerative diseases, impairment in autophagy is thought to play a fundamental part in the terminal phases of cellular degeneration and death. However, the ultimate mechanism of neuronal cell death remains elusive. In a recent study we have identified a new form of regulated cell death, which arises upon autophagy inhibition.\n\nID: 28974540\nTitle: The fission yeast nucleoporin Alm1 is required for proteasomal degradation of kinetochore components.\nAbstract: Kinetochores (KTs) are large multiprotein complexes that constitute the interface between centromeric chromatin and the mitotic spindle during chromosome segregation. In spite of their essential role, little is known about how centromeres and KTs are assembled and how their precise stoichiometry is regulated. In this study, we show that the nuclear pore basket component Alm1 is required to maintain both the proteasome and its anchor, Cut8, at the nuclear envelope, which in turn regulates proteostasis of certain inner KT components. Consistently, alm1-deleted cells show increased levels of KT proteins, including CENP-CCnp3, spindle assembly checkpoint activation, and chromosome segregation defects. Our data demonstrate a novel function of the nucleoporin Alm1 in proteasome localization required for KT homeostasis.\n\nID: 28033363\nTitle: Temsirolimus Partially Rescues the Hutchinson-Gilford Progeria Cellular Phenotype.\nAbstract: Hutchinson-Gilford syndrome (HGPS, OMIM 176670, a rare premature aging disorder that leads to death at an average age of 14.7 years due to myocardial infarction or stroke, is caused by mutations in the LMNA gene. Lamins help maintain the shape and stability of the nuclear envelope in addition to regulating DNA replication, DNA transcription, proliferation and differentiation. The LMNA mutation results in the deletion of 50 amino acids from the carboxy-terminal region of prelamin A, producing the truncated, farnesylated protein progerin. The accumulation of progerin in HGPS nuclei causes numerous morphological and functional changes that lead to premature cellular senescence. Attempts to reverse this HGPS phenotype have identified rapamycin, an inhibitor of mammalian target of rapamycin (mTOR), as a drug that is able to rescue the HGPS cellular phenotype by promoting autophagy and reducing progerin accumulation. Rapamycin is an obvious candidate for the treatment of HGPS disease but is difficult to utilize clinically. To further assess rapamycin's efficacy with regard to proteostasis, mitochondrial function and the degree of DNA damage, we tested temsirolimus, a rapamycin analog with a more favorable pharmacokinetic profile than rapamycin. We report that temsirolimus decreases progerin levels, increases proliferation, reduces misshapen nuclei, and partially ameliorates DNA damage, but does not improve proteasome activity or mitochondrial dysfunction. Our findings suggest that future therapeutic strategies should identify new drug combinations and treatment regimens that target all the dysfunctional hallmarks that characterize HGPS cells.\n\nID: 26851389\nTitle: Placental membrane aging and HMGB1 signaling associated with human parturition.\nAbstract: Aging is associated with the onset of several diseases in various organ systems; however, different tissues may age differently, rendering some of them dysfunctional sooner than others. Placental membranes (fetal amniochorionic membranes) protect the fetus throughout pregnancy, but their longevity is limited to the duration of pregnancy. The age-associated dysfunction of these membranes is postulated to trigger parturition. Here, we investigated whether cellular senescence-the loss of cell division potential as a consequence of stress-is involved in placental membrane function at term. We show telomere reduction, p38 MAPK activation, increase in p21 expression, loss of lamin B1 loss, increase in SA-\u03b2-galactosidase , and senescence-associated secretory phenotype (SASP) gene expression in placental membranes after labor and delivery (term labor [TL]) compared to membranes prior to labor at term (term, not-in-labor [TNIL]). Exposing TNIL placental membranes to cigarette smoke extract, an oxidative stress inducer, also induced markers of cellular senescence similar to those in TL placental membranes. Bioinformatics analysis of differentially expressed SASP genes revealed HMGB1 signaling among the top pathways involved in labor. Further, we show that recombinant HMGB1 upregulates the expression of genes associated with parturition in myometrial cells. These data suggest that the natural physiologic aging of placental tissues is associated with cellular senescence and human parturition.\n\nID: 42541426\nTitle: Neuroprotective Potential of Spermidine in Drosophila sws Neurodegenerative Model.\nAbstract: Neurodegenerative disorders are characterized by progressive neuronal loss and functional decline, yet effective interventions remain limited. The polyamine spermidine was suggested to exert neuroprotective effects, but its concentration-dependent impact on longevity, neuronal integrity, and behavior remains still not well studied. Here, we investigated the effects of spermidine on lifespan, behavioral responses, brain tissue, target gene expression, and antioxidant status in Drosophila melanogaster model of age-dependent neurodegeneration. Wild-type flies and swiss cheese (sws1) mutants were exposed to 0.5, 1, and 5\u2009mM spermidine from early adulthood. Lifespan analysis revealed that high-dose spermidine (5\u2009mM) reduced survival in both wild-type and sws1 mutants, whereas lower doses (0.5 and 1\u2009mM) significantly improved survival in mutants without affecting wild-type flies. Behavioral assays revealed that sws1 flies exhibited reduced climbing ability compared to controls, which was further decreased at 5\u2009mM. Lower concentrations did not significantly affect locomotor performance. Taste preference for trehalose, impaired in untreated sws1 mutants, was partially restored by spermidine at all tested concentrations. Histological analysis of 10-13-day-old mutants showed a concentration-dependent reduction in degeneration zones within the lamina and medulla at 0.5 and 1\u2009mM, whereas 5\u2009mM had no effect. Biochemical assays indicated mild pro-oxidant effects at 5\u2009mM, reflected by increased malondialdehyde (MDA) levels, while 0.5\u2009mM enhanced antioxidant defenses, including catalase activity and Trolox equivalent antioxidant capacity (TEAC). Our results suggest that spermidine at low doses has the potential to be a general-purpose neuroprotector.\n\nID: 42540688\nTitle: NAT10 inhibition corrects nuclear defects in tau mutant human neurons and extends lifespan in a Drosophila tauopathy model.\nAbstract: Mutations in the gene encoding the microtubule-associated protein tau (MAPT) that are causal for frontotemporal dementia result in nuclear envelope deformation and disrupted nucleocytoplasmic transport when expressed in human neurons. A small-molecule inhibitor of the acetyltransferase NAT10 has been shown to correct similar nuclear membrane defects in Hutchinson-Gilford progeria syndrome, primarily by modulating microtubule dynamics. We report here that NAT10 inhibition and loss of function correct nuclear membrane abnormalities in human MAPT-mutant neurons. Similarly, NAT10 inhibition and haploinsufficiency correct neuronal nuclear shape defects and extend lifespan in vivo in a Drosophila model of tauopathy. NAT10 inhibition changes microtubule dynamics and corrects aberrant nucleocytoplasmic transport, and NAT10 directly interacts with regulators of microtubule dynamics in human MAPT-mutant neurons. We conclude that NAT10 mediates neuronal pathologies in tauopathies and is a potential therapeutic target in these diseases.\n\nID: 42537462\nTitle: Jieduquyuziyin prescription ameliorates systemic lupus erythematosus by targeting MAPK14 to inhibit SAA3-induced macrophage M1 polarization.\nAbstract: Systemic lupus erythematosus (SLE) is a heterogeneous autoimmune disease involving inflammatory macrophage polarization and hepatic acute-phase responses. Serum amyloid A3 (SAA3) is elevated in lupus-prone mice and may participate in the immune link between liver inflammation and macrophage responses. Jieduquyuziyin Prescription (JP) is a traditional formula used clinically for SLE, but its chemical basis and SAA3-related immunomodulatory mechanisms remain incompletely defined. This study investigated the effects of JP on SLE-related inflammatory phenotypes, hepatocyte SAA3 expression, and macrophage MAPK14/p38-related M1 polarization responses, and examined the interaction between representative JP constituents and MAPK14. MRL/Lpr mice were used to evaluate the in vivo effects of JP. LC-MS and HPLC were used for chemical characterization. Network pharmacology, primary splenic macrophages, primary hepatocytes, and macrophage-naive CD4\u207a T cell co-culture systems were used to characterize JP-associated immune responses. Western blotting, flow cytometry, ELISA, and immunofluorescence were performed to assess p38 phosphorylation, macrophage polarization, cytokines, and SAA3. Molecular docking, SPR, molecular dynamics simulations, and ADP-Glo\u2122 kinase assay were used to evaluate MAPK14 binding and kinase activity modulation by representative constituents. JP treatment improved survival and renal-related indices in MRL/Lpr mice, accompanied by lower serum SAA3 levels, reduced splenic F4/80\u207a CD86\u207a macrophages, and decreased F4/80/iNOS signals. JP-medicated serum reduced SAA3-induced p38 phosphorylation, iNOS expression, and IL-6 and IL-1\u03b2 release, while increasing Arg-1 expression and F4/80\u207a CD206\u207a cells. JP-medicated serum also reduced IL-6-induced SAA3 expression in hepatocytes. In co-culture, systems containing SAA3-treated macrophages showed increased CD4\u207a IL-17A\u207a cells and IL-17 levels, whereas JP treatment reduced these readouts. Hesperidin, glycyrrhizic acid, and paeoniflorin were detected in JP decoction and JP-medicated serum and generated measurable binding responses to MAPK14. The three-compound mixture and individual constituents reduced recombinant MAPK14 kinase activity, with stronger activity observed for the mixture. JP treatment was associated with reduced hepatocyte SAA3 expression, attenuated macrophage MAPK14/p38-related M1 inflammatory responses, and decreased Th17-associated inflammatory indices. MAPK14 may serve as a mechanistically relevant molecular node engaged by representative JP constituents, providing experimental support for JP-mediated regulation of SLE-related inflammatory networks.\n\nID: 42525141\nTitle: SOX9 knockdown alleviates A\u03b21\u201142\u2011induced neuroinflammation by regulating microglial polarization via inactivation of the ASK1/JNK signaling pathway.\nAbstract: Neuroinflammation driven by microglial polarization imbalance plays a key role in A\u03b2-induced neuronal injury, a core pathological feature of Alzheimer's disease (AD). The transcription factor SOX9 has been linked to AD progression, but its mechanism remains unclear. SOX9 expression was measured in peripheral blood mononuclear cells from 24 patients with AD and 24 age-matched healthy controls and correlated with Montreal Cognitive Assessment scores. An A\u03b21-42-stimulated BV-2 cell model was used to investigate the effects of SOX9 and apoptosis signal-regulating kinase 1 (ASK1) on microglial polarization. Neuronal injury was evaluated in a BV-2/SH-SY5Y co-culture system. The transcriptional regulation of ASK1 by SOX9 was examined using dual-luciferase reporter and chromatin immunoprecipitation assays. ASK1 overexpression and the ASK1 inhibitor GS-4997 were used for mechanistic validation. SOX9 expression was increased in peripheral blood mononuclear cells from patients with AD and was negatively correlated with cognitive function. SOX9 was also upregulated in A\u03b21-42-stimulated BV-2 cells. SOX9 overexpression enhanced M1-associated inflammatory markers and reduced M2-associated markers, whereas SOX9 knockdown produced the opposite effects. In the co-culture system, SOX9 knockdown increased SH-SY5Y cell viability, reduced LDH release and apoptosis, increased Bcl-2 expression, and decreased Bax and cleaved caspase-3 expression. SOX9 bound to the ASK1 promoter and promoted ASK1 transcription. SOX9 silencing suppressed ASK1, JNK, and p38 phosphorylation, while ASK1 overexpression reversed the effects of SOX9 knockdown on microglial polarization and neuronal injury. Consistently, GS-4997 blocked the pro-inflammatory and neurotoxic effects induced by SOX9 overexpression. SOX9 exacerbates AD neuroinflammation by promoting microglial M1 polarization via the ASK1/JNK signaling axis.\n\nID: 42495541\nTitle: Tuberostemonine ameliorates Alzheimer's disease pathology by suppression of the p38 MAPK signaling pathway.\nAbstract: Alzheimer's disease (AD) is a multifactorial neurodegenerative disorder with limited therapeutic options. Here, we report that tuberostemonine (Tub), an alkaloid from Stemona tuberosa, exerts neuroprotective effects in AD models. In A\u03b21-42-treated PC12 cells, Tub reduced cytotoxicity, apoptosis, and oxidative stress while restoring mitochondrial function. In APP/PS1 transgenic mice, Tub administration improved cognitive performance, reduced amyloid-\u03b2 plaque deposition, attenuated microglial activation, and attenuated neuronal loss, with efficacy superior to donepezil. Mechanistically, Tub selectively inhibited p38 MAPK phosphorylation without affecting ERK or JNK pathways, as confirmed by pharmacological inhibition and activation experiments. These findings identify Tub as a promising multi-target natural compound for AD intervention through p38 MAPK pathway modulation.\n\nID: 42491154\nTitle: Psoralen regulates bone degenerative diseases by inhibiting APP phosphorylation to regulate MAPK and STAT3 signaling.\nAbstract: Psoralen can modulate bone metabolism pathways. This study investigated its effects on bone degenerative diseases, amyloid precursor protein (APP) phosphorylation, and the related pathways. The A\u03b240/A\u03b242 levels in mouse serum were analyzed through enzyme-linked immunosorbent assay (ELISA) across ages. mRNA levels of APP, APH-1\u03b1, PEN-2, and RAGE were determined through polymerase chain reaction (PCR). Thereafter, three degenerative models, including knee osteoarthritis, osteoporosis, and intervertebral disc degeneration, were established. Mice with APP knockout were generated, and the pathology was evaluated at weeks 4-20 through safranin O staining, osteoclast counting (immunohistochemistry, IHC), and hematoxylin and eosin (H&E) staining. Subsequently, TNF-\u03b1 and HA contents were examined by ELISA, and Col2 expression and apoptosis were also analyzed. Furthermore, the anti-osteoporotic mechanisms of psoralen were explored at the cellular and animal levels. As the mice aged, the expression of p-APP increased significantly, while that of proteins involved in the pathway decreased markedly. By constructing an APP knockout mouse model, it was found that after APP knockout, the mice developed bone degenerative lesions, which intensified with age. Intervention with psoralen was effective for ameliorating the pathologic condition of bone degenerative lesions in mice, and inhibiting the progression of bone tissue pathology. Notably, this effect exhibited a dose-dependent trend. Besides, intervention with psoralen in osteoblasts promoted osteoblast proliferation and regulated the phosphorylation of MAPK, AKT, and STAT3. For osteoblasts treated with pathway inhibitors and psoralen, psoralen exerted its effects through the MAPK, AKT, and STAT3 signaling pathways. The phosphorylation of APP promotes the occurrence and progression of bone degenerative diseases. Psoralen regulates bone degenerative diseases by inhibiting APP phosphorylation, and regulating the MAPK and STAT3 signaling pathways.\n\nID: 42488724\nTitle: BDNF-amyloid-\u03b2 Axis in Alzheimer's disease: molecular mechanisms and therapeutic perspectives.\nAbstract: Alzheimer's disease (AD), the most common cause of dementia in older adults, is characterized by progressive cognitive decline, synaptic dysfunction, and neuronal loss. Among the multifactorial mechanisms implicated in AD, reciprocal interactions between brain-derived neurotrophic factor (BDNF) and amyloid-\u03b2 (A\u03b2) have attracted increasing attention as a convergent axis linking amyloid pathology to impaired neurotrophic support. BDNF promotes neuronal resilience, synaptic plasticity, and cognitive function primarily through the activation of its high-affinity receptor, tropomyosin receptor kinase B (TrkB), and downstream signaling pathways, including PI3K-Akt and MAPK/ERK. Human postmortem and biomarker studies mainly support associations between reduced BDNF signaling, synaptic dysfunction, and AD-related pathology. In contrast, cell-based and animal studies provide mechanistic evidence that BDNF/TrkB signaling may influence amyloid precursor protein (APP) processing and neuronal resistance to A\u03b2-induced stress. Conversely, mechanistic studies indicate that A\u03b2 accumulation can suppress CREB-dependent BDNF expression, disturb BDNF transport, and impair TrkB receptor function. Thus, the BDNF-A\u03b2 relationship is better interpreted as a stage- and context-dependent pathogenic coupling rather than a simple causal loop. This review synthesizes evidence from human studies, animal models, and cellular systems to clarify how BDNF-A\u03b2 dysregulation contributes to AD progression and to discuss the translational potential of BDNF-oriented interventions.\n\nID: 42469568\nTitle: Nanomedicine targeting neuroinflammatory pathways in Alzheimer's disease: a new frontier in inflammopharmacology.\nAbstract: Alzheimer's disease (AD) is a multifactorial neurodegenerative illness characterized by progressive cognitive impairment, synaptic compromise, and relentless neuroinflammation. Increasing evidence suggests that neuroinflammatory cascades orchestrated by microglial activation, astrocytic malfunction, cytokine hyperproduction, and inflammasome signalling are at the core of AD pathogenesis. Conventional anti-amyloid and cholinergic treatments are only symptomatic and neglect the inherent neuroimmune dysregulation. Nanomedicine is a revolutionary frontier in inflammopharmacology, which enables the accurate modulation of neuroinflammatory circuits and enhanced brain delivery of medicines. Nanocarriers designed by engineering, including liposomes, polymeric nanoparticles, dendrimers, and exosomes, allow for targeted delivery across the BBB, increase drug bioavailability, and provide controlled release. The nano-systems are capable of inhibiting pro-inflammatory signalling, such as NF-\u03baB and MAPK pathways, reducing oxidative stress, and enhancing microglial M2 polarization and thus restoring neuronal homeostasis. Recent developments in surface-functionalized and stimuli-responsive nanoplatforms further enable active targeting through receptor-mediated pathways and theranostic imaging in real-time. Comparative studies show that interventions based on nanocarrier-based therapies enhance therapeutic efficacy and safety profiles in preclinical AD models. Future directions include integrating AI-driven nano-design, gene and siRNA delivery, and precision neuropharmacology to enable personalized anti-inflammatory therapies. Substantial progress, translational challenges remain regarding long-term biocompatibility, large-scale production, and clinical validation. Nanomedicine against neuroinflammatory pathways represents a new paradigm for Alzheimer's treatment, linking molecular pharmacology and sophisticated nanotechnology to next-generation neuroinflammatory medicine.\n\nID: 42451124\nTitle: Neuroprotective Effects of Sorghum Polyphenol in Alzheimer's Disease: In Vitro and In Silico Analyses.\nAbstract: Accumulation of amyloid-beta (A\u03b2) senile plaques in the human brain is a major hallmark of Alzheimer's disease (AD), which manifests as progressive decline in memory and cognitive functions and currently lacks effective disease-modifying therapies. Emerging evidence demonstrates that polyphenol-rich plant foods are potential complementary therapies for AD. In this study, we investigated crude polyphenol extracts (CPEs) and purified polyphenol extracts (PPEs) from three sorghum genotypes for their ability to inhibit A\u03b242-induced toxicity in MC-65 cells. Thioflavin T fluorescence, cell viability, mitochondrial function, oxidative stress assays, and Western blotting, along with RNA sequencing and computational analyses, were used to characterise both functional and transcriptomic responses of the cells to polyphenol treatments. CPEs and PPEs inhibited A\u03b242 aggregation by 67-76% and significantly reduced A\u03b2 oligomer species. The extracts increased cell viability against A\u03b2-induced toxicity by more than 70%, decreased intracellular oxidative stress, and enhanced mitochondrial activity by over 80%. Transcriptomic profiling revealed differential modulation of genes associated with ferroptosis and MAPK/NF- \u03baB signalling pathways, indicating regulation of inflammatory and oxidative-stress responses are mechanisms underlying the observed neuroprotection. This study demonstrates that polyphenol extracts from black and red sorghum genotypes exert strong multitarget neuroprotection against A\u03b242 toxicity in MC-65 cells. These findings support further evaluation of sorghum-derived polyphenols as complementary therapeutic candidates for AD, with in vivo studies required to establish efficacy and translational potential.\n\nID: 42448410\nTitle: Neuroinflammation- molecular target based therapeutic approach.\nAbstract: Chronic neuroinflammation has become a major concern due to its ability to propagate into multiple neurodegenerative disorders which severely reduce the life expectancy of the patients. Many molecular targets have been identified which include amyloid beta (A\u03b2) peptides and oligomers, protofibrils, tau proteins, MID1/ TRIM18, Beclin1 protein, Puma, NMDA receptors, RyanR2, 5-HT2B, \u03b17nAChR, TLR4, ERR\u03b1, CysLT(1)R, PDGF\u03b2R, DRD1, \u03b22-AR, caspases, calpain, cytochrome c, CDK5, p38-MAPK, BACE1, \u03b3-secretase, 5-lipoxygenase, NADPH oxidase 2 and 4, JNK, MMPs, NLRP3, GSAP, PARP-1, PARG, TRPM2, H2O2, NO (excess), LTB4, LTD4, NF-\u03baB (NF-kBp50/RelA dimers and NF-\u03baB p65), TNF-\u03b1,IL-1\u03b2, IL-6, IL-10, ApoE2, ApoE4, Bax,Bcl-2, miR-9, miR-29, miR-29a/b-1, miR-101, miR-124, miR-107, miR-298, miR-149, miR-328, miR-34a-5p, miR-15b, miR-16, miR-125b-5p, miR-124, and miR-374b-5p, miR-181c-5p, linc00507, LncRNA 51A, LncRNA 17A, LncRNA BC200, LncRNA NDM29, LncRNA NEAT1, LncRNA EBF3-AS, LncRNA NAT-Rad18, LcRNA TUG1, LncRNA MALAT1, LncRNA WT1-AS, LncRNA MAGI2-AS3, XBP-1, SERCA, Na+/Ca2+exchanger, plasma-membrane Ca2+-ATPase, HSP27, mtHSP60/HSPD1-mtHSP10/HSPE1, HSPD1, HSPE1, HSP70, Hsp90, Sirt1, Sirt3, TIMP-123 (composite of TIMP-1, TIMP-2, and TIMP-3), TIMP-4, AChEI, BDNF. Identification of the molecular targets enabled the identification of phytoconstituents which could modulate majority of these molecular targets. A herbal formulation which is expected to alleviate neuroinflammation includes many phytoconstituents such as curcumin, (-)-epigallocatechin-3-gallate, baicalein, baicalin, resveratrol, cis-resveratrol, berberine, quercetin, apigenin, corosolic acid, ursolic acid, oleanolic acid, luteolin, albigenin, withanolide A, celastrol, gallotannin, nobotanin B, kaempferol, naringenin, rutin, withaferin A, crocetin, katsumain H, geranylgeranylacetone and huperzine. A compatibility study with different phytoconstituents will determine the suitability of the formulation.\n\nID: 42436002\nTitle: CAPNS1 restoration partially alleviates mitochondrial dysfunction and synaptic deficits in Alzheimer's disease through the Ca2+-CaMKII\u03b2-MAPK-PGC-1\u03b1 axis.\nAbstract: Alzheimer's disease (AD), a progressive neurodegenerative disorder characterized by brain atrophy and cognitive decline. While the amyloid cascade hypothesis remains the dominant framework, accumulating evidence indicates that mitochondrial dysfunction critically contributes to AD progression. Although improving mitochondrial function has been shown to rescue cognitive deficits in AD models, the underlying molecular mechanisms remain elusive. In this study, we identified a significant reduction in calpain small subunit 1 (CAPNS1) expression in both AD patient samples and male transgenic mouse models. Decreased CAPNS1 levels were strongly correlated with mitochondrial ultrastructural damage, reduced mitochondrial DNA (mtDNA) copy number, and progressive synaptic loss. Mechanistically, we found that CAPNS1 positively regulated mtDNA transcription and mitochondrial gene expression, and pharmacological data suggested the involvement of the Ca2+-CaMKII\u03b2-MAPK-PGC-1\u03b1 signaling axis, a master pathway governing mitochondrial biogenesis and respiratory capacity. This activation subsequently restored cellular ATP production and reduced mitochondrial reactive oxygen species accumulation. Importantly, neuronal-specific CAPNS1 upregulation in APP/PS1 transgenic mice markedly improved mitochondrial cristae integrity, reversed hippocampal long-term potentiation deficits, increased dendritic spine density, and partially alleviated spatial memory deficits in behavioral tests. We noted that loss-of-function experiments (e.g., CAPNS1 knockdown or knockout) were not performed in this study, and the proposed Ca2+-CaMKII\u03b2-MAPK-PGC-1\u03b1 axis should therefore be interpreted as a suggestive working model requiring further validation. Collectively, our findings indicate that CAPNS1 serves as a key regulator of mitochondrial function. By linking Ca2+ signaling to mitochondrial gene expression and synaptic integrity, CAPNS1 represents a promising therapeutic target for ameliorating synaptic loss and cognitive decline in AD.\n\nID: 42413217\nTitle: Restoring the balance: Resistance exercise-induced insulin-like growth factor-1 restores PI3K/Akt and MAPK/ERK cross-talk to ameliorate Alzheimer's disease.\nAbstract: Alzheimer's disease (AD) remains a progressive neurodegenerative disorder without effective disease-modifying therapies. Epidemiological evidence indicates that regular resistance exercise substantially reduces AD risk, an effect potentially mediated by insulin-like growth factor-1 (IGF-1). However, the complete mechanistic pathway from exercise-induced peripheral IGF-1 synthesis to its central neuroprotective actions has not been systematically integrated. This review provides a comprehensive framework linking resistance exercise to AD amelioration through IGF-1-dependent signaling. We first detail how resistance exercise stimulates IGF-1 secretion from the liver and skeletal muscle via both endocrine (GH-IGF-1 axis) and autocrine/paracrine (mechano-sensitive MGF induction) pathways. Subsequently, we delineate three complementary routes by which circulating IGF-1 enters the brain: (1) lipoprotein receptor-related protein-1(LRP-1)-mediated transcytosis across the blood-brain barrier (BBB) coupled with activity-dependent vasodilation, (2) lipoprotein receptor-related protein-2(LRP-2)-mediated transport across the blood-cerebrospinal fluid barrier (BCSFB) at the choroid plexus, and (3) passive diffusion through circumventricular organs (CVOs). Once within the central nervous system, we propose that IGF-1 exerts its therapeutic effects primarily by restoring the physiological cross-inhibitory balance between the phosphoinositide 3-kinase (PI3K)/ protein kinase B (Akt) and mitogen-activated protein kinase (MAPK)/extracellular signal-regulated kinase (ERK) signaling pathways. Specifically, by reactivating Akt, exercise-induced IGF-1 suppresses GSK-3\u03b2-driven tau hyperphosphorylation, while simultaneously tempering pathological MAPK/ERK overactivation, thereby reducing \u03b2-amyloid (A\u03b2) generation and neuroinflammation. This rebalancing action further promotes A\u03b2 clearance, enhances synaptic plasticity, and counteracts neuronal apoptosis. Notably, we critically discuss the context-dependent \"double-edged sword\" nature of IGF-1 signaling, where excessive or mistimed activation may exacerbate late-stage pathology, underscoring the need for stage-specific interventions. In summary, this review integrates the peripheral synthesis, multi-route central delivery, and pathway-rebalancing mechanisms of exercise-induced IGF-1, providing a mechanistic rationale for personalized resistance exercise prescriptions as a non-pharmacological strategy to combat AD.\n\nID: 42392996\nTitle: [DOT1L controls neuronal amyloid precursor protein expres-sion via the p38 MAPK-mediated mitochondrial dynamics homeostasis axis].\nAbstract: To investigate the regulatory role of epigenetic regulator disruptor of telomeric silencing 1-like (DOT1L) and its mediated histone H3 lysine 79 (H3K79) methylation in modulating neuronal amyloid precursor protein (APP) expression, and to elucidate the underlying mechanisms involving mitochondrial dynamics homeo-stasis and the upstream p38 mitogen-activated protein kinase (p38 MAPK). Alzheimer's disease (AD) models were established using APP/presenilin-1 (APP/PS1) double-transgenic mice and N2a cells overexpressing the human Swedish mutant APP (N2a-APPswe). Immunofluorescence staining was employed to assess DOT1L expression and localization in mouse brain tissues. N2a-APPswe cells were treated with the DOT1L-specific inhibitor EPZ5676 and divided into four groups: blank control, solvent control, DOT1L inhibitor, and DOT1L inhibitor plus p38 agonist (Gynostemma pentaphyllum extract). Western blotting was performed to measure the phosphorylation levels of DRP1 at Ser616 and Ser637, the levels of autophagy-related proteins p62 and the LC3-\u2161/LC3-\u2160 ratio, the phosphorylation level of p38 MAPK, as well as the expression of APP and APP-processing proteins BACE1 and PS1. Reverse transcription quantitative polymerase chain reaction was used to detect mRNA levels of APP and genes involved in mitochondrial fission and fusion. Proteomics data were systematically analyzed through Gene Ontology analysis, WikiPathways enrichment analysis, and STRING protein-protein interaction network analysis to identify key signaling pathways. Mitochondrial network morphology was evaluated by Mito-Tracker fluorescence staining to measure average branch length. DOT1L expression was significantly reduced in neurons of APP/PS1 mice compared to wild-type controls. DOT1L inhibition led to decreased H3K79 dimethylation levels (P<0.01), accompanied by a marked increase in APP protein expression (P<0.01), although APP mRNA levels were reduced (P<0.01). Proteomics analysis revealed that differentially expressed proteins were highly enriched in the mitochondrial electron transport chain. Compared with the solvent control, the DOT1L inhibitor group showed inhibited mitochondrial fission, as evidenced by decreased p-DRP1 (Ser616), increased p-DRP1 (Ser637), downregulated MIEF1 mRNA, upregu-lated MFN1 mRNA (all P<0.05), and increased average mitochondrial branch length (P<0.05), along with reduced phosphorylation level of p38 MAPK (P<0.05). Co-administration of the p38 agonist significantly reversed these mitochondrial dynamics abnormalities (all P<0.05) and attenuated the abnormally elevated protein levels of APP, BACE1, and PS1 (all P<0.05) compared to the DOT1L inhibitor group. DOT1L maintains normal mitochondrial fission and functional homeostasis through regulation of the p38 MAPK mediated signaling pathway, thereby modulating APP expression. \u76ee\u7684: \u660e\u786e\u8868\u89c2\u9057\u4f20\u8c03\u8282\u56e0\u5b50\u7c7b\u7aef\u7c92\u6c89\u9ed8\u5e72\u6270\u4f531\uff08DOT1L\uff09\u53ca\u5176\u4ecb\u5bfc\u7684\u7ec4\u86cb\u767dH3\u7b2c79\u4f4d\u8d56\u6c28\u9178\uff08H3K79\uff09\u7532\u57fa\u5316\u4fee\u9970\u5bf9\u795e\u7ecf\u5143\u6dc0\u7c89\u6837\u524d\u4f53\u86cb\u767d\uff08APP\uff09\u8868\u8fbe\u7684\u8c03\u63a7\u4f5c\u7528\uff0c\u5e76\u9610\u660e\u7ebf\u7c92\u4f53\u52a8\u529b\u5b66\u7a33\u6001\u53ca\u5176\u4e0a\u6e38p38\u4e1d\u88c2\u539f\u6fc0\u6d3b\u7684\u86cb\u767d\u6fc0\u9176\uff08p38 MAPK\uff09\u5728\u8be5\u8c03\u63a7\u8fc7\u7a0b\u4e2d\u7684\u6838\u5fc3\u673a\u5236\u3002\u65b9\u6cd5: \u91c7\u7528APP/\u65e9\u8001\u86cb\u767d1\uff08PS1\uff09\u53cc\u8f6c\u57fa\u56e0\u5c0f\u9f20\u6a21\u578b\u53ca\u8fc7\u8868\u8fbe\u4eba\u6e90\u745e\u5178\u7a81\u53d8\u578bAPP\u7684\u795e\u7ecf\u6bcd\u7ec6\u80de\u7624\u7ec6\u80de\uff08N2a-APPswe\u7ec6\u80de\uff09\u6a21\u62dfAD\u3002\u901a\u8fc7\u514d\u75ab\u8367\u5149\u67d3\u8272\u6cd5\u68c0\u6d4b\u5c0f\u9f20\u8111\u7ec4\u7ec7\u4e2dDOT1L\u7684\u8868\u8fbe\u548c\u5b9a\u4f4d\u3002\u5229\u7528DOT1L\u7279\u5f02\u6027\u6291\u5236\u5242EPZ5676\u5904\u7406N2a-APPswe\u7ec6\u80de\uff0c\u5206\u522b\u8bbe\u7f6e\u7a7a\u767d\u5bf9\u7167\u7ec4\u3001\u6eb6\u5242\u5bf9\u7167\u7ec4\u3001DOT1L\u6291\u5236\u5242\u7ec4\u53caDOT1L\u6291\u5236\u5242+p38\u6fc0\u52a8\u5242\uff08\u7ede\u80a1\u84dd\u63d0\u53d6\u7269\uff09\u7ec4\u3002\u91c7\u7528\u86cb\u767d\u8d28\u5370\u8ff9\u6cd5\u68c0\u6d4b\u7ebf\u7c92\u4f53\u5206\u88c2\u5173\u952e\u86cb\u767d\u8d28DRP1\u7684Ser616\u548cSer637\u4f4d\u70b9\u78f7\u9178\u5316\u6c34\u5e73\u3001\u81ea\u566c\u76f8\u5173\u86cb\u767d\u8d28p62\u6c34\u5e73\u548cLC3-\u2161/LC3-\u2160\u6bd4\u503c\u3001\u4fe1\u53f7\u5206\u5b50p38\u78f7\u9178\u5316\u6c34\u5e73\u4ee5\u53caAPP\u4ee3\u8c22\u76f8\u5173\u86cb\u767d\u8d28APP\u3001BACE1\u548cPS1\u7684\u8868\u8fbe\u6c34\u5e73;\u91c7\u7528\u9006\u8f6c\u5f55\u5b9a\u91cf\u805a\u5408\u9176\u94fe\u53cd\u5e94\u68c0\u6d4bAPP\u3001\u7ebf\u7c92\u4f53\u5206\u88c2\u53ca\u878d\u5408\u76f8\u5173\u57fa\u56e0\u7684\u8868\u8fbe;\u57fa\u4e8e\u86cb\u767d\u8d28\u7ec4\u5b66\u6570\u636e\uff0c\u901a\u8fc7\u57fa\u56e0\u672c\u4f53\u5206\u6790\u3001WikiPathways\u5bcc\u96c6\u5206\u6790\u53caSTRING\u86cb\u767d\u8d28-\u86cb\u767d\u8d28\u76f8\u4e92\u4f5c\u7528\u7f51\u7edc\u7b5b\u9009\u5173\u952e\u4fe1\u53f7\u901a\u8def;\u91c7\u7528Mito-Tracker\u8367\u5149\u67d3\u8272\u6cd5\u68c0\u6d4b\u7ebf\u7c92\u4f53\u5206\u652f\u957f\u5ea6\u3002\u7ed3\u679c: \u4e0e\u91ce\u751f\u578b\u5c0f\u9f20\u6bd4\u8f83\uff0cAPP/PS1\u5c0f\u9f20\u795e\u7ecf\u5143\u4e2dDOT1L\u8868\u8fbe\u51cf\u5c11\u3002\u6291\u5236DOT1L\u540e\uff0cH3K79\u4e8c\u7532\u57fa\u5316\u6c34\u5e73\u964d\u4f4e\uff08P<0.01\uff09\uff0cAPP\u8868\u8fbe\u6c34\u5e73\u5347\u9ad8\u4f46\u5176mRNA\u8868\u8fbe\u6c34\u5e73\u4e0b\u964d\uff08\u5747P<0.01\uff09\u3002\u5dee\u5f02\u8868\u8fbe\u86cb\u767d\u8d28\u9ad8\u5ea6\u5bcc\u96c6\u4e8e\u7ebf\u7c92\u4f53\u7535\u5b50\u4f20\u9012\u94fe\u3002\u4e0e\u6eb6\u5242\u5bf9\u7167\u7ec4\u6bd4\u8f83\uff0cDOT1L\u6291\u5236\u5242\u7ec4\u7ebf\u7c92\u4f53\u5206\u88c2\u53d7\u5230\u6291\u5236\uff0c\u8868\u73b0\u4e3a\u78f7\u9178\u5316DRP1\uff08Ser616\uff09\u6c34\u5e73\u4e0b\u964d\u3001\u78f7\u9178\u5316DRP1\uff08Ser637\uff09\u6c34\u5e73\u5347\u9ad8\u3001MIEF1 mRNA\u8868\u8fbe\u6c34\u5e73\u4e0b\u964d\u3001MFN1 mRNA\u8868\u8fbe\u6c34\u5e73\u5347\u9ad8\uff08\u5747P<0.05\uff09\uff0c\u7ebf\u7c92\u4f53\u5e73\u5747\u5206\u652f\u957f\u5ea6\u589e\u52a0\uff08P<0.05\uff09\uff0c\u5e76\u4f34\u968fp38 MAPK\u78f7\u9178\u5316\u6c34\u5e73\u4e0b\u964d\uff08P<0.05\uff09\u3002\u4e0eDOT1L\u6291\u5236\u5242\u7ec4\u6bd4\u8f83\uff0c\u52a0\u7528p38\u6fc0\u52a8\u5242\u53ef\u663e\u8457\u9006\u8f6c\u4e0a\u8ff0\u7ebf\u7c92\u4f53\u52a8\u529b\u5b66\u5f02\u5e38\uff08\u5747P<0.05\uff09\uff0c\u5e76\u4e0b\u8c03APP\u3001BACE1\u548cPS1\u7684\u5f02\u5e38\u9ad8\u8868\u8fbe\uff08\u5747P<0.05\uff09\u3002\u7ed3\u8bba: DOT1L\u901a\u8fc7\u8c03\u63a7p38 MAPK\u4ecb\u5bfc\u7684\u4fe1\u53f7\u901a\u8def\u7ef4\u6301\u7ebf\u7c92\u4f53\u6b63\u5e38\u5206\u88c2\u53ca\u529f\u80fd\u7a33\u6001\uff0c\u8fdb\u800c\u8c03\u63a7APP\u8868\u8fbe\u3002.\n\nID: 42369375\nTitle: Mechanistic insights into the synaptic damage-repair and regeneration processes in neurodegenerative Alzheimer's disease: phytochemicals as neuroprotective agents.\nAbstract: Synaptic failure is one of the earliest and most significant contributors to the cognitive decline in Alzheimer's disease (AD), preceding extensive neuronal loss. Although amyloid beta (A\u03b2) plaques and neurofibrillary tangles (NFTs) of tau protein characterize the disease, memory impairment primarily results from the gradual deterioration of synaptic communications. This decline is caused by a complex interaction among mitochondrial energy deficits, cytoskeletal instability, disrupted exosomal signaling, and immune-mediated synaptic pruning. Mitochondrial dysfunction, particularly affecting complexes I and IV, leads to reduced ATP production, faulty mitophagy and disrupted calcium (Ca2+) homeostasis, placing the synapse under constant metabolic stress. Elevated reactive oxygen species (ROS) further activate stress pathways, including p38 MAPK and JNK, contributing to synaptic protein damage and impaired long-term potentiation (LTP). Furthermore, tau hyperphosphorylation destabilizes the neuronal cytoskeleton, weakening dendritic spine integrity and synaptic connectivity. At the same time, A\u03b2 alters the cargo carried by exosomes, facilitating the spread of pathogenic A\u03b2 and tau species between the neurons and modulating microglial activation and complement-mediated synaptic pruning. Additionally, emerging studies highlight the role of NETosis in exacerbating neuroinflammation and compromising the blood-brain barrier (BBB) integrity, thereby increasing synaptic damage. In contrast, phytochemicals such as resveratrol, ginkgolide B, curcumin, ferulic acid, epigallocatechin gallate (EGCG), and quercetin exert neuroprotection by restoring redox balance, altering exosomal communications, stabilizing cytoskeletal signaling, and reducing neuroinflammation. Moreover, delivery techniques such as nanoparticles and engineered exosomes enhance BBB permeability and enable targeted synaptic intervention. Overall, this review summarizes current mechanistic findings and highlights the potential of phytochemicals as multitarget therapeutic agents for synaptic repair and functional recovery in AD.\n\nID: 42365390\nTitle: Lysophagy protects against ANXA11 amyloid fibril toxicity and propagation in FTLD.\nAbstract: Accumulation of Annexin A11 (ANXA11) aggregates is a distinct pathological hallmark of amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD). While genetic studies have linked ANXA11 mutations (e.g., D40G) to disease, the precise molecular events converting aggregation into neurotoxicity and intercellular propagation remain elusive. We hypothesize that lysosomal integrity serves as a critical checkpoint in ANXA11 proteinopathy and that its failure drives disease progression. To model the human pathology of ANXA11, we generated pre-formed fibrils (PFFs) of wild-type and FTLD/ALS-linked D40G mutant ANXA11. Human iPSC-derived neurons, 3D cerebral organoids, and bulk RNA-sequencing were employed to investigate neurotoxicity. High-resolution imaging, lentiviral knockdown, and biochemical assays were performed to delineate the lysosomal damage response and the subsequent \"prion-like\" spreading of aggregates. The internalized ANXA11 fibrils accumulated in lysosomes, triggering lysosomal membrane permeabilization (LMP). The D40G mutation exacerbated this toxicity, leading to severe LMP, mitochondrial depolarization, and specific transcriptional downregulation of the dynactin subunit ACTR10. Mechanistically, we identified a protective signaling axis involving p38 MAPK, MK2, and HSP27 that senses ANXA11-induced lysosomal damage and initiates lysophagy. Notably, in human cerebral organoids, failure of this lysophagic clearance facilitated the cytoplasmic escape of ANXA11, thereby accelerating its seeding activity and propagation to neighboring cells. Pharmacological or genetic modulation of this pathway significantly altered neuronal survival. Our study established lysosomal rupture as a primary driver of ANXA11-associated neurodegeneration and validated the p38/MK2/HSP27 axis as a crucial defense mechanism in human neural tissue. These findings provide a novel mechanistic link between lysosomal quality control and ANXA11 propagation, highlighting that enhancing lysophagic flux represents a promising translational strategy to halt the progression of FTLD and ALS.\n\nID: 42353197\nTitle: Hesperetin Rescues Amyloid Beta-Induced Defects in Neurite Outgrowth Under In Vitro Mild Cognitive Impairment-like Cellular Conditions.\nAbstract: Accumulation of aggregated amyloid beta (A\u03b2) species is a defining pathological hallmark of Alzheimer's disease and is associated with extensive neuronal structural abnormalities. Mild cognitive impairment (MCI), a transitional stage between normal aging and the onset of dementia, is thought to represent an early phase of this pathological continuum. Studies at the cellular level suggest that the conditions impair the maintenance of established neuronal processes/networks and restrict their capacity for elongation or re-elongation. They may also attenuate the activation and process extension of quiescent neural progenitor or stem-like cells. These early cellular changes precede overt neurodegeneration in neural tissue and are likely to contribute to cognitive decline. They highlight the importance of in vitro models for identifying molecular targets involved in recovery from disease. In this study, we investigated the effects of aggregated A\u03b2 (25-35) on neuronal process elongation and associated intracellular events in the N1E-115 cell line, a widely used model of neuronal differentiation. Addition of aggregated A\u03b2 to cultured N1E-115 cells attenuated process elongation in a concentration-dependent manner. This morphological impairment was accompanied by decreased expression of neuronal differentiation markers. In contrast, at the half-maximal inhibitory concentration for process elongation, long-term cultured cells did not exhibit apparent process retraction or degenerative morphology. This mild but progressive impairment, without extensive cell death, is consistent with the cellular features of early-stage conditions rather than advanced Alzheimer's pathologies. Similar results were observed in primary cortical neurons. A\u03b2 also decreased the level of GTP-bound Ras and phosphorylation of the downstream mitogen-activated protein kinase/extracellular signal-regulated kinase (MAPK/ERK). Furthermore, treatment with hesperetin, a bioactive flavonoid compound, recovered the A\u03b2-induced inhibition of neuronal process elongation. Hesperetin also restored Ras and MAPK/ERK states, suggesting that its effects are associated, at least in part, with modulation of signaling through Ras and MAPK/ERK. Our findings suggest that hesperetin may serve as a useful molecular probe for modulating early cellular responses associated with Alzheimer's disease-related pathology. This in vitro model might serve as a useful platform for investigating the molecular target candidates involved in recovery from nervous system disorders.\n\nID: 42352057\nTitle: Oxidative Stress in Glaucoma: From Pathogenic Mechanisms to Emerging Antioxidant Therapies.\nAbstract: Glaucoma is the leading cause of irreversible blindness worldwide and is characterized by progressive retinal ganglion cell (RGC) loss and optic nerve degeneration. While elevated intraocular pressure (IOP) remains the primary modifiable risk factor, a certain proportion of patients continue to deteriorate despite adequate IOP control, pointing to IOP-independent mechanisms of neurodegeneration. Oxidative stress-defined as an imbalance between the production of reactive oxygen species and the capacity of endogenous antioxidant defenses-has emerged as a central, multi-tiered contributor to glaucoma pathogenesis. In the anterior segment, chronic oxidative damage to the trabecular meshwork impairs aqueous humor outflow and drives IOP elevation. In addition, oxidative stress may impair ocular biomechanical integrity, including corneal hysteresis and lamina cribrosa, resulting in heightened susceptibility to IOP fluctuations. In the posterior segment, oxidative stress directly contributes to mitochondrial damage and vascular endothelial injury, leading to RGC apoptosis. The nuclear factor erythroid 2-related factor 2 (Nrf2)/Kelch-like ECH-associated protein 1 (Keap1) pathway coordinates the principal endogenous antioxidant response, while nicotinamide adenine dinucleotide (NAD+) depletion links redox imbalance to metabolic vulnerability of RGCs. This narrative review synthesizes evidence published up to March 2026 on the molecular mechanisms of oxidative stress in glaucoma, the role of biomarkers in aqueous humor and systemic circulation, and the translational landscape of antioxidant-based neuroprotection-including nicotinamide, coenzyme Q10, alpha-lipoic acid, and Nrf2-activating compounds. We highlight gaps between preclinical promise and clinical evidence, and outline priorities for future randomized controlled trials.\n\nID: 42347716\nTitle: Methyltransferase-like 14 alleviates neuronal ferroptosis in Alzheimer's disease by regulating the peroxiredoxin 6/apoptosis signal-regulating kinase 1 signaling pathway.\nAbstract: Alzheimer's disease is a neurodegenerative disorder, in which ferroptosis contributes to its pathogenesis and progression. This study explored the precise mechanisms of ferroptosis in the pathological development of Alzheimer's disease. Amyloid beta 1-42 oligomer-treated SH-SY5Y cells were used to simulate Alzheimer's disease in vitro. Ferroptosis was evaluated by detecting the levels of reactive oxygen species (ROS), malonaldehyde, glutathione, Fe2+, and ferroptosis-related proteins. Cell viability was assessed by a Cell Counting Kit-8 assay. Total RNA N6-methyladenosine (m6A) levels were detected using an RNA methylation quantification kit, and peroxiredoxin 6 (PRDX6) m6A levels were analyzed by m6A RNA immunoprecipitation. The binding of methyltransferase-like 14 (METTL14) to PRDX6 was investigated by a dual-luciferase reporter assay. METTL14 levels were decreased in the serum of Alzheimer's disease patients and in an in-vitro model of Alzheimer's disease, and serum levels correlated with the degree of cognitive impairment. METTL14 overexpression significantly inhibited amyloid beta 1-42 oligomer-induced ferroptosis and cytotoxicity in SH-SY5Y cells. Mechanistically, METTL14-mediated m6A modification increased PRDX6 mRNA stability, which inactivated the ROS-apoptosis signal-regulating kinase 1/p38 pathway. Rescue experiments demonstrated that PRDX6 overexpression reversed sh-METTL14-induced ferroptosis and neurotoxicity. METTL14 suppressed neuronal ferroptosis to delay Alzheimer's disease progression through m6A modification of PRDX6 to inactivate the ROS-apoptosis signal-regulating kinase 1/p38 pathway. Our observations provide a potential therapeutic strategy for Alzheimer's disease.\n\nID: 42347402\nTitle: Molecular Mechanisms of 6PPD and 6PPD-Q Toxicity in Neurodegenerative Diseases: A Network Toxicology and Experimental Validation Study.\nAbstract: 6PPD is a widely used tire antioxidant that readily transforms into its more toxic ozonation product, 6PPD-quinone (6PPD-Q). Both compounds are emerging environmental contaminants with potential neurotoxic risks, yet their molecular mechanisms in Alzheimer's disease (AD) and Parkinson's disease (PD) remain unclear. This study integrated network toxicology, molecular docking, transcriptomic validation, and experimental models to investigate their neurotoxic effects. In silico analyses predicted significant neurotoxicity and blood-brain barrier permeability for both compounds. Target prediction and PPI network analysis identified 145/121 overlapping targets with AD/PD for 6PPD and 120/100 for 6PPD-Q. Functional enrichment analysis suggested that 6PPD-associated targets were mainly enriched in axon regeneration-, p75NTR-, and AGE-RAGE-related pathways, whereas 6PPD-Q-associated targets were enriched in MAPK cascade-, endosomal TLR signaling-, and amyloid-\u03b2 formation-related pathways. Molecular docking suggested favorable binding affinities between these compounds and several core targets, including MAP2K1, EGFR, GSK3B, and CYCS. Transcriptomic validation in GEO datasets prioritized multiple hub genes. In vivo experiments showed activation of apoptosis-related signaling in the brain, while in vitro assays demonstrated ROS accumulation and neuroinflammatory activation (elevated TNF-\u03b1, IL-1\u03b2, IL-6, IFN-\u03b3). CYCS and MAP2K1 emerged as key convergent nodes. Our findings reveal distinct yet synergistic neurotoxic mechanisms of 6PPD and 6PPD-Q in AD and PD, highlighting tire-derived pollutants as potential environmental risk factors for neurodegenerative diseases.\n\nID: 42346127\nTitle: Neurodegenerative NMNAT2 Deficiency Promotes APP Processing in a SARM1-Dependent Manner.\nAbstract: Metabolic dysfunction and proteinopathy are hallmarks of neurodegenerative disease, yet their mechanistic interplay remains poorly understood. Here, we show that loss of the neuronal NAD+-synthesizing enzyme Nicotinamide mononucleotide adenylyltransferase 2 (NMNAT2) disrupts amyloid precursor protein (APP) processing in cortical neurons, leading to accumulation of APP C-terminal fragments (APP-CTFs). NMNAT2 deficiency lowers the NAD+/NADH redox ratio coincident with APP-CTF buildup. Temporal profiling reveals a biphasic increase in APP-CTFs, with an initial gradual rise followed by rapid accumulation, paralleling the expansion of differentially expressed proteins. Pathway analysis indicates early activation of JNK/MAPK signaling, followed by late-stage suppression of mitochondrial pathways and induction of endoplasmic reticulum stress and unfolded protein response programs. Seahorse analyses reveal early glycolytic impairment followed by deficits in mitochondrial respiration. Knockdown of the NAD+ hydrolase sterile alpha and TIR motif-containing protein 1 (SARM1) restores mitochondrial function and normalizes APP-CTF levels in NMNAT2 knockout neurons, whereas NAD+ supplementation provides only modest rescue. Together, these data demonstrate that neuronal NAD+ depletion drives progressive, SARM1-dependent disruption of glucose metabolism and proteostasis, impairing APP processing. The NMNAT2-SARM1 axis thus links metabolic stress to proteinopathy and highlights SARM1 as a central mediator of neurodegenerative dysfunction.\n\nID: 42333303\nTitle: Epigenetic Aging in Brain Tissue of the Self-Fertilizing Vertebrate, Kryptolebias marmoratus.\nAbstract: DNA methylation changes predictably with age across taxa, but in most species, these patterns are confounded by genetic variation. As a result, age-predictive methylation models have mostly been developed in genetically heterogeneous, cross-fertilizing organisms, limiting inference about epigenetic aging per se. Disentangling epigenetic and genetic effects is therefore essential for understanding aging, adaptation, and evolution. Here, we exploit the mangrove rivulus (Kryptolebias marmoratus), one of only two known self-fertilizing vertebrates (together with K. hermaphroditus), to examine epigenetic aging in a system of naturally occurring near-isogenic individuals. Using reduced-representation bisulfite sequencing of 89 brain samples spanning 60-1100\u2009days of age, we identified 40 CpG sites whose methylation levels predict chronological age with high accuracy (R 2\u2009>\u20090.96, Median Absolute Error of 28.7\u2009days). These 40 age-associated CpG sites were linked to nearby genes with known roles in cellular maintenance and neurodegeneration. These include genes implicated in aging and neurodegenerative processes across vertebrates, such as lamin-A, the aryl hydrocarbon receptor, and genes associated with Alzheimer's disease in humans. By leveraging a self-fertilizing vertebrate, this study demonstrates that DNA methylation undergoes consistent, age-associated changes across the lifespan in the near absence of genetic variation. Our results establish self-fertilizing vertebrates as powerful models for disentangling epigenetic aging from genetic effects and provide a foundation for comparative and evolutionary studies of aging.\n\nID: 42287135\nTitle: Saponarin: Therapeutic Potential, Pharmacological Insights, and Future Directions.\nAbstract: Saponarin, a flavonoid glycoside, has demonstrated various pharmacological effects in preclinical systems, including antioxidant, anti-inflammatory, hepatoprotective, neuroprotective, anticancer, and cardioprotective properties. These effects are attributed to its modulation of key signaling pathways such as Nrf2, NF-\u03baB, PI3K/Akt, MAPK, and TGF-\u03b2. However, the translational relevance of these interactions remains unestablished in human subjects. This review consolidates findings on saponarin's mechanisms of action and therapeutic potential, focusing primarily on in\u00a0vitro and animal model evidence, while highlighting gaps that limit its clinical applicability across liver diseases, neurodegenerative conditions, cancer, diabetes, and cardiovascular diseases. In hepatic disease models, saponarin has shown potential in reducing oxidative stress markers, attenuating liver fibrosis, and improving mitochondrial function, indicating its relevance to non-alcoholic fatty liver disease, alcoholic liver disease, and drug-induced liver injury. However, these findings have not been confirmed in human trials, and the translation of rodent hepatoprotective data to humans remains uncertain. In neurodegenerative models, saponarin reduced \u03b2-amyloid deposition and tau hyperphosphorylation. However, poor blood-brain barrier penetration and the lack of human validation limit the therapeutic relevance for Alzheimer's and Parkinson's diseases. In cancer models, saponarin inhibited proliferation, induced apoptosis, suppressed metastatic markers, and reduced angiogenic signaling. However, cancer cell line sensitivity often fails to predict in\u00a0vivo efficacy, and no clinical evidence supports its use as adjunctive cancer therapy. Limited preclinical evidence also suggests potential effects on insulin sensitivity, glycemic regulation, and cardiovascular parameters, but human studies are absent. Despite these promising findings, saponarin lacks clinical validation. Most effects come from in\u00a0vitro and animal models, which exhibit variability in experimental conditions, doses, and formulations, limiting definitive conclusions. Saponarin's poor oral bioavailability, absence of standardized formulations, restricted blood-brain barrier penetration, and lack of long-term safety data present significant barriers to development. Although novel delivery methods such as nanoparticles and liposomal formulations have been proposed to improve pharmacokinetics, they remain experimental and unvalidated in humans. Future research should focus on rigorous clinical trials to assess whether preclinical findings translate to clinically meaningful outcomes, alongside comprehensive pharmacokinetic and safety evaluations in humans. Until then, saponarin should be regarded as an experimental compound with preliminary preclinical findings, rather than a clinically recommended therapeutic agent.\n\nID: 42284087\nTitle: Disrupted hippocampal theta-gamma coupling and spike-field coherence following experimental traumatic brain injury.\nAbstract: Traumatic brain injury (TBI) often results in persistent learning and memory deficits, likely due to disrupted hippocampal circuitry underlying these processes. Precise temporal control of hippocampal neuronal activity is thought to be important for memory encoding and retrieval and is supported by oscillations that dynamically organize single-unit firing. Using high-density laminar electrophysiology, we found a loss of oscillatory power across CA1 lamina, with a profound, layer-specific reduction in theta-gamma phase-amplitude coupling in injured rats. Interneurons from injured animals were less strongly entrained to theta and gamma oscillations, but both interneurons and pyramidal cells from injured animals became more strongly entrained to theta during periods of high theta power. During quiet immobility, sharp-wave ripple amplitudes were lower in injured animals compared to shams. These results reveal physiological deficits across brain states that may contribute to TBI-associated learning and memory impairments and elucidate potential targets for future neuromodulation therapies.\n\nID: 42281258\nTitle: Hyperlipid-Related Alzheimer's Disease: Potential Role of CircUCK2/miR-24-3p/p38 Axis in Neuronal Damage.\nAbstract: Accumulating empirical evidence underscores that hyperlipidemia may fuel the pathological progression of Alzheimer's disease (AD) by triggering inflammatory signaling cascades and promoting amyloid-\u03b2 (A\u03b2) fibrillogenesis. The CircUCK2/miR-24-3p/p38 regulatory axis has been identified as a key molecular node in these biological processes, yet its specific functions in AD associated with abnormal lipid metabolism remain incompletely delineated. We recruited 50\u2009AD patients and 50 healthy individuals from the Neurology Department of the Affiliated Hospital of the University of South China. Logistic regression analysis was employed to explore the correlation between blood lipid concentrations and AD susceptibility, while Pearson correlation analysis was used to assess the association between lipid levels and A\u03b2 deposition. Dual-luciferase reporter assays confirmed the mutual regulatory relationships among CircUCK2, miR-24-3p, and p38. Additionally, we evaluated inflammatory responses, neuronal damage, and the activation status of p38. A hyperlipidemic mouse model was established to examine the expression levels of AD-related biomarkers. Elevated blood lipid levels were closely correlated with increased AD risk and enhanced A\u03b2 deposition. CircUCK2 was found to induce p38 phosphorylation by targeting miR-24-3p, thereby augmenting autophagic flux, mitigating inflammatory reactions, and suppressing apoptotic pathways in hyperlipidemic cells. Furthermore, p38 activation reduced the levels of pro-inflammatory mediators, downregulated the expression of A\u03b242 and P-tau181, and improved learning and memory capabilities in mice. Hyperlipidemia accelerates A\u03b2 deposition and neuronal injury, potentially exacerbating AD progression. The CircUCK2/miR-24-3p/p38 signaling pathway may serve as a promising therapeutic target for AD intervention.\n\nID: 42280293\nTitle: Geroprotective Potential of Centella asiatica: Modulation of Cellular Aging.\nAbstract: C. asiatica (L.) Urban is a medicinal plant widely used in traditional Asian medicine with potential geroprotective properties. Its major bioactive compounds-including asiaticoside, madecassoside, asiatic acid, and madecassic acid-exhibit antioxidant, anti-inflammatory, regenerative, neuroprotective, and cytoprotective activities. Experimental studies demonstrate modulation of signaling pathways involved in oxidative stress, inflammation, apoptosis, extracellular matrix remodeling, and cellular survival, including NF-\u03baB, PI3K/Akt/mTOR, MAPK, Nrf2/HO-1, and TGF-\u03b2/Smad pathways. Preclinical evidence further indicates attenuation of cellular senescence, improvement of mitochondrial function, enhanced collagen synthesis, and regulation of cytokine production. In experimental models, C. asiatica has shown beneficial effects on wound healing, skin aging, neuroinflammation, \u03b2-amyloid aggregation, neuroplasticity, metabolic dysfunction, and vascular protection. Preliminary preclinical findings also suggest possible effects on telomerase activity and telomere maintenance. However, clinical translation remains limited due to insufficient randomized controlled trials, low oral bioavailability of triterpenoids, variability in extract standardization, and limited pharmacokinetic and long-term safety data. This narrative review summarizes the phytochemistry, molecular mechanisms, pharmacological activities, and potential geroprotective applications of c. asiatica, highlighting its translational relevance in healthy aging and age-related disorders while emphasizing the need for standardized clinical studies.\n\nID: 42276617\nTitle: Mitochondrial rescue in Alzheimer's disease: Exploring marine-derived compounds for brain metabolism regulation.\nAbstract: Alzheimer Disease (AD) is a progressive neurodegenerative condition because of its cognitive impairment, synaptic impairment and loss of neurons. Mitochondrial dysfunction has become one of the key factors of disease development and progression and one of the several pathological characteristics of AD. The mitochondrial cascade hypothesis suggests that amyloid-\u03b2 and tau pathology depend on age-related mitochondrial impairment, which is an earlier and faster process and provokes neurodegeneration. Mitochondria play critical roles in metabolism of neuronal energy, maintenance of calcium and regulation of reactive oxygen species (ROS); their dysfunction leads to bioenergetic impairment, oxidative stress, and synaptic failure. Marine ecosystems constitute an unexampled source of bioactive therapeutic-related compounds of structural diversity. Marine-derived compounds (MDCs) such as polysaccharides, oligosaccharides, polyphenols, lipids, alkaloids and peptides have antioxidant, anti-inflammatory, and neuroprotective effects. Recent reports indicate that MDCs can salvage mitochondrial performance by increasing biogenesis, restoring dynamics (fusion fission balance), modulating metabolism and improving mitochondrial quality control. The compounds also control metabolism of the brain affecting the use of glucose, lipid metabolism, and synthesis of neurotransmitters. This chapter clearly discusses the insights of marine-derived compounds as a mitochondrial rescue in AD. We stress their chemical heterogeneity, biologic activity and mode of action including the regulation of signaling pathways, e.g. AMPK, PI3K/Akt, MAPK, and SIRT1. We also talk about their effects on synaptic plasticity, neuronal survival and cognitive function. Lastly, we have also find the research gaps, research challenges, and perspectives and highlight the necessity of translational research, better bioavailability, and sustainable harvesting plans. Marine-derived compounds as a group are one of the brightest prospects in AD therapeutics by providing innovative methods to restore the state of mitochondria and control the metabolism in the brain.\n\nID: 42239511\nTitle: Unveiling the neuroprotective effects of pomegranate extract and/or physical activity against aluminum chloride-induced Alzheimer's disease in rats: modulation of multitude pathways.\nAbstract: Alzheimer's disease (AD) is a devastating neurodegenerative malady marked by cognitive dysfunction and increased deposition of amyloid-beta and hyperphosphorylated tau proteins. Aluminum-associated neurotoxicity is well-documented and manifests itself in the form of cognitive dysfunction. Nutraceuticals, such as pomegranate extract (POM) or physical activity (PHA), have been recognized to exert beneficial actions on human wellbeing. This study aimed to mechanistically scrutinize the effects of POM and PHA either separately or in combination on AlCl3-induced AD in rats. Sixty adult male Wistar rats were randomly assigned into five groups: control, AlCl3, AlCl3 + PHA, AlCl3 + POM, and AlCl3 + COMB (POM + PHA) and treated for 5\u00a0weeks. PHA and POM, either alone or in combination, exhibited a significant boost in memory and cognitive abilities, evidenced by the significant improvements in behavioral outcomes, elevations in monoamine (DA, NE, 5-HT), LRP1, and neprilysin levels, and reductions in acetylcholinesterase (ACHE) activity, APOE4 levels, and AD markers, relative to the AlCl3-intoxicated group. All treatments significantly ameliorated AlCl3-induced perturbations in antioxidant, neurotrophic, autophagic, inflammatory, endoplasmic reticulum (ER) stress, and apoptotic parameters, along with histopathological and immunohistochemical findings. These effects were demonstrated by the significant increase in antioxidant (Nrf2/HO-1/TAC/SOD), neurotrophic (PI3K/AKT/CREB/BDNF/TrKB), and autophagic (AMPK/SIRT-1/Beclin-1) markers, with significant reduction in neuroinflammatory (P38 MAPK/JNK/NF-\u03baB/JAK-2/STAT-3/TNF-\u03b1/IL-1\u03b2), ER stress (PERK/CHOP/GRP78), and apoptotic (BAX/P53/caspase-3) markers, relative to the AlCl3-intoxicated group. Interestingly, the combination exerted more favorable actions in all measured parameters and histological findings than the solo-treated groups. This study revealed the superiority of the combined therapy, compared to solo treatments, in alleviation of AlCl3-induced AD in rats, via adjustment of the Nrf2/HO-1, P38 MAPK/JNK/NF-\u03baB/JAK-2/STAT-3, PI3K/AKT/GSK-3\u03b2/CREB, AMPK/SIRT-1, PERK/CHOP, and apoptotic hubs.\n\nID: 42231856\nTitle: Secoisolariciresinol diglucoside ameliorates Alzheimer-like lesions by increasing MKP-1.\nAbstract: BackgroundSecoisolariciresinol diglucoside (SDG), a phytoestrogen, has been demonstrated to exert anti-inflammatory and neuroprotective effects. Mitogen-activated protein kinase (MAPK) phosphatase-1 (MKP-1) serves as a critical negative regulator of MAPK signaling pathways, and the MAPK signaling pathways play a significant role in the pathogenesis of Alzheimer's disease (AD). However, it remains unclear whether SDG ameliorates Alzheimer-like lesions by regulating the MAPK pathway through increasing MKP-1.ObjectiveWe aimed to investigate the impact of SDG on the Alzheimer-like lesions of AD mice and its mechanisms.MethodsThree-month-old 5\u00d7FAD mice were treated with SDG (50\u2005mg\u00b7kg-1\u00b7d-1, i.g.) for 2 months. Learning and spatial memory function was assessed with the behavioral test. Immunofluorescence and Thioflavine-S staining was assessed with the levels of amyloid-\u03b2 (A\u03b2) plaques in the cortex and hippocampus. Western blot was performed to evaluate the level of learning memory-related proteins, hyperphosphorylated tau, APP-related proteins, and MAPK phosphorylation. Besides, knockdown of MKP-1 in N2A/APP cells to investigate whether SDG regulates the MAPK signaling pathway by increasing MKP-1.ResultsWe found that SDG significantly enhanced learning and spatial memory while recovering PSD95, PKA-C\u03b1, and synaptophysin levels in 5\u00d7FAD mice. SDG reduced A\u03b2 plaques, tau phosphorylation at Ser 199/214/262/396 and Thr 231, alleviated the phosphorylation of MAPKs (JNK, ERK1/2, P38), and increased p-GSK-3\u03b2 (Ser9), while decreased activation of microglia (Iba-1) and astrocytes (GFAP). Moreover, knockdown of MKP-1 in N2A/APP cells inhibited the regulatory effect of SDG on APP, ERK1/2 and JNK.ConclusionsSDG ameliorates Alzheimer-like lesions may be related with increasing MKP-1.\n\nID: 42229733\nTitle: From capillaries to cognition: decoding neurovascular unit dysfunction and cerebrovascular contributions in Alzheimer's disease.\nAbstract: Alzheimer's disease (AD), classically defined by abnormal amyloid-\u03b2 and tau aggregation, is now also understood to profoundly disturb the brain's cerebrovascular system and the integrity of the neurovascular unit (NVU). An ever-growing body of evidence points to NVU dysfunction and neurovascular unit deficits as major contributors to AD pathology. NVU comprises neurons, glial cells, endothelial cells, and pericytes, which together orchestrate cerebral blood flow in the CNS and help maintain the structural and functional integrity of the blood-brain barrier (BBB). Its disruption increases neuronal damage and impairs clearance mechanisms in AD. Interactions between pericytes, astrocytes, smooth muscle cells, neurons, microglia, and NVU endothelial cells support cerebral perfusion, BBB integrity, and metabolic homeostasis. Major pathophysiological events involved in the development of early BBB leakage and neurovascular uncoupling in AD include endothelial impairment, breakdown of tight junctions, thickening of the basement membrane, degeneration of pericytes, and astrogliosis. Activated astrocytes and microglia further exacerbate NVU injury by releasing inflammatory mediators and ROS. Numerous molecular signaling cascades, including PI3K/Akt/mTOR, MAPK/ERK, and NF-\u03baB pathways, are implicated in mechanistic interplay among metabolic perturbations, neuroinflammatory responses, and vascular endothelial damage. Emerging NVU-targeted therapeutic strategies include anti-inflammatory, antioxidant, and vasculoprotective drugs intended to restore BBB integrity, preserving neurovascular coupling, and promoting the removal of amyloid-\u03b2. This review synthesizes preclinical and clinical evidence elucidating mechanisms by which capillary-level perturbations lead to cognitive decline, while discussing therapeutic interventions aimed at restoring NVU integrity and preserving BBB architecture. The delineation of cerebral involvement in AD provides support for a potential for timely diagnosis and innovative approaches for treatment.\n\nID: 42216548\nTitle: Molecular Mechanisms of Manganese Oxide Nanoparticles Toxicity in Brain and Other Tissues: An Overview.\nAbstract: The use of manganese oxide nanoparticles (MnOxNPs) in biomedicine increases the risk of their accumulation in the body, potentially leading to toxicity in various organs and tissues. In addition, occupational exposure to MnOxNPs-containing aerosols may also occur. MnOxNPs have been shown to accumulate in the brain and induce neurobehavioral alterations. However, the specific mechanisms of MnOxNPs toxicity in the brain and other tissues remain incompletely understood. Therefore, the objective of this review is to summarize existing data on the toxicity of MnOxNPs in the brain and other tissues, and to discuss the molecular mechanisms underlying their neurotoxic effects. It has been shown that MnOxNPs induce neuronal death through induction of mitochondrial dysfunction and subsequent apoptosis, and overaccumulation of tau protein and amyloid-\u03b2. Neurotoxic effects of MnOxNPs may also be mediated by blood-brain barrier disruption, and dysregulation of dopaminergic and glutaminergic signaling. Exposure to MnOxNPs induces neuroinflammation through activation of nuclear factor kappa B (NF-\u03baB) and p38 mitogen-activated protein kinase (p38 MAPK) pathways in a reactive oxygen species-dependent manner. In vitro studies further demonstrate that MnOxNPs exhibit a dose-dependent cytotoxic effects in alveolar macrophages, as well as in respiratory, colonic, and other epithelial cells, through the promotion of oxidative stress and an inflammatory response. Overexposure to MnOxNPs has significant nephrotoxic, hepatotoxic, and immunotoxic effects, as well as affecting the reproductive system. Smaller particles exhibit more pronounced toxic effects in the brain and other tissues than larger nanoparticles or microparticles. However, the mechanisms underlying the different toxicities of MnOxNPs of different sizes, shapes, and surface modifications remain unclear. These observations highlight the potential of MnOxNP exposure to contribute to neurological disorders and dysfunction of other systems, underscoring the need for further mechanistic studies to ensure their safe application in biomedicine.\n\nID: 42215997\nTitle: Convergence of neuroinflammation across major neurotropic viral exposomes in AD and ADRD.\nAbstract: Alzheimer's disease (AD) and Alzheimer's disease-related dementias (ADRD) are multifactorial neurodegenerative disorders driven by complex interactions among genetic susceptibility, aging, and environmental exposures. Growing epidemiological and mechanistic evidence implicates neurotropic viral exposomes, defined as cumulative lifetime viral infections, as significant contributors to AD risk. Viral encephalitis and common viral infections, including herpes simplex virus type 1 (HSV-1), human immunodeficiency virus (HIV), cytomegalovirus (CMV), SARS-CoV-2, and influenza, have been associated with an increased incidence of AD/ADRD; however, the molecular mechanisms underlying these associations remain incompletely understood. A systematic literature review was conducted using PubMed, Web of Science, Scopus, and Google Scholar (1990-2025) to identify epidemiological, experimental, and mechanistic studies linking viral infections to AD-related pathology. Systems biology approaches were applied using Cytoscape, STRING, KEGG, WikiPathways, and Ingenuity Pathway Analysis to construct protein-protein interaction networks and identify convergent biological processes shared between AD and viral host-response pathways. Functional enrichment analyses focused on neuroinflammation, amyloid-\u03b2 (A\u03b2) metabolism, tau pathology, autophagy, and blood-brain barrier (BBB) integrity. Across diverse viral infections, strong convergence was observed in innate immune activation pathways, including microglial priming and NLRP3 inflammasome signaling, accompanied by chronic production of proinflammatory cytokines (IL-1\u03b2, TNF-\u03b1, IFN-\u03b3). Multiple viruses modulated amyloidogenic APP processing, impaired A\u03b2 clearance, promoted tau hyperphosphorylation, disrupted autophagy-lysosomal systems, and compromised BBB integrity. Systems-level analyses revealed overlapping signaling hubs, including NF-\u03baB, MAPK, PI3K-Akt, and cGAS-STING that amplify neurodegenerative cascades, with effects most pronounced in genetically susceptible populations such as APOE4 carriers. Collectively, current evidence supports a mechanistic link between viral exposomes and AD/ADRD mediated through convergent neuroinflammatory, and proteostatic pathways. Although viral infections alone are unlikely to be sufficient to cause AD, recurrent or persistent viral exposures may act as potent disease modifiers that accelerate neurodegenerative processes. Integrating viral biomarkers, genetic risk stratification, and systems biology approaches offers promising opportunities for early diagnosis, prevention, and development of mechanism-guided therapeutic strategies.\n\nID: 42214787\nTitle: Histopathologic Findings and Knowledge Gaps in Glaucomatous Neurodegeneration.\nAbstract: Glaucoma is the leading cause of irreversible blindness globally, characterized by progressive retinal ganglion cell (RGC) dysfunction and death, resulting in optic nerve head remodeling and optic nerve degeneration. Although substantial progress has been made in understanding basic mechanisms of glaucomatous neurodegeneration in animal models, significant knowledge gaps remain regarding the histopathologic substrate of this disease in human tissue. This review synthesizes current understanding of established histopathologic findings in glaucomatous eyes, including RGC degeneration, synaptic pathology, axonal transport dysfunction, lamina cribrosa remodeling, glial cell responses, extracellular matrix changes, and structure-function relationships. It ends by identifying major gaps in knowledge regarding cellular heterogeneity in RGC vulnerability, circuit-level retinal remodeling, temporal sequence of pathologic events, functional consequences of astrocyte and microglial activation, and mechanisms linking structural pathology to functional vision loss. Addressing these gaps requires integrated approaches combining classical histology with modern molecular profiling, greater access to human postmortem tissue with rigorous disease staging, and systematic investigation of RGC subtype-specific pathology in the human retina and optic nerve.\n\nID: 42214647\nTitle: Yeast-derived vacuoles as potential therapeutic agents for modulating neuroinflammation in Alzheimer's disease.\nAbstract: Neuroinflammation is a major contributor to Alzheimer's disease (AD) pathology, including amyloid precursor protein (APP)/amyloid-beta (A\u03b2)-associated protein expression and Tau phosphorylation. Here, we evaluated yeast-derived vacuoles as orally deliverable bio-derived vesicular structures for modulating AD-associated neuroinflammatory responses. In lipopolysaccharide (LPS)-stimulated C6 glioma cells, vacuoles were efficiently internalized, showed minimal cytotoxicity, reduced APP/A\u03b2-related protein and phosphorylated Tau levels, and suppressed p38 MAPK and NF-\u03baB signaling, including downstream inducible nitric oxide synthase expression. In aged C57BL/6 mice, oral vacuole administration reduced brain APP/A\u03b2-related protein, Tau, and phosphorylated Tau levels and improved histological features in the hippocampus and cortex. Although direct brain biodistribution was not detected by IVIS imaging, the observed functional changes support further investigation of vacuole-mediated gut-to-brain bioactivity. These findings suggest yeast-derived vacuoles as a promising bio-derived platform for modulating neuroinflammation in AD.\n\nID: 42214568\nTitle: Neuroprotective effects of Uncaria rhynchophylla alkaloid extracts against amyloid-\u03b2 toxicity via regulation of oxidative stress pathways.\nAbstract: Uncaria rhynchophylla is a important medicinal plant in Chinese traditional medicine for the treatment of neurological disorders, its alkaloid-rich constituents are considered the primary bioactive components responsible for its effects on the central nervous system. This study aimed to investigate the neuroprotective effects of U. rhynchophylla alkaloid extract (URAs) against amyloid-\u03b2 (A\u03b2)-induced neurotoxicity and oxidative stress, and elucidate underlying molecular mechanisms. URAs was prepared and characterized by LC-MS/MS for chemical profiling. The neuroprotective effects were evaluated using transgenic C. elegans CL2006 and CL2355, and H2O2-induced PC12\u202fcells. In C. elegans, paralysis assay, A\u03b2 deposition, and chemotaxis behavior were assessed. Oxidative stress markers including reactive oxygen species (ROS), lipofuscin accumulation, lipid peroxidation (MDA), and antioxidant enzyme activities (SOD, CAT) were measured. Quantitative real-time PCR was performed to examine the expression of genes of related signaling pathways. In PC12\u202fcells, cell viability, ATP levels, and oxidative stress were evaluated. URAs treatment significantly delayed A\u03b2-induced paralysis, reduced A\u03b2 deposition, and improved chemotaxis behavior in transgenic C. elegans, while decreasing ROS, lipofuscin, and MDA, and increasing SOD and CAT activities. Furthermore, URAs modulated the expression of genes involved in A\u03b2 metabolism, proteasome function, and antioxidant defense, and significantly suppressed the expression of p38 MAPK signaling pathway components. Our findings demonstrate that URAs exert neuroprotective effects against A\u03b2 toxicity and oxidative stress through multi-target mechanisms involving enhanced antioxidant defense, regulated proteostasis, highlighting their therapeutic potential for AD intervention.\n\nID: 42198444\nTitle: Physical Exercise Enhances Melatonin Effect in D-Galactose/Aluminum Chloride-Induced Alzheimer's Disease of Ovariectomized Rats: Irisin Induction Associated with Upregulation of PPAR-\u03b3/IGF-1/BDNF and Decreasing TNF-\u03b1/p38-MAPK/NLRP3/GFAP Pathway.\nAbstract: Background: Postmenopausal women are at high risk of Alzheimer's disease (AD) incidence and progression. Irisin, an exercise-induced myokine, has neuroprotective and antiaging effects against AD, especially in menopausal women suffering from insulin resistance (IR). For the first time, the novel role of irisin induced by melatonin (MTN) or/and physical exercise (PHE) was investigated in the current ovariectomized (OVX)/AD rat model by modulating brain neuroinflammation and IR-related markers. Methods: Fifty female Wistar rats were divided into five groups, with one representing a sham group. AD was induced in the other four bilateral OVX rat groups by daily intraperitoneal injection of D-galactose/AlCl3 (60 and 10 mg/kg, respectively) for 42 days. Group III-V: Animals were exposed to MTN (10 mg/kg/day; i.p.), PHE, and a combination of these, respectively, in the final 14 days of the experiment. Results: The OVX/AD rats showed significant deterioration in learning, memory, neurochemical, and histopathological examinations, while the MTN or/and PHE treatments significantly increased serum and brain irisin, improving memory in a Y-maze assessment. Thus, hippocampal histopathological alterations and IR-related markers decreased. In addition, suppressed hippocampal amyloid-beta protein expression and neuroinflammatory content of tumor necrosis factor-alpha (TNF-\u03b1), p38 mitogen-activated protein kinase (p38 MAPK), and NOD-like receptor protein-3 (NLRP3) were associated with an increase in peroxisome proliferator-activated receptor-gamma (PPAR-\u03b3) protein expression and insulin-like growth factor-1 content in hippocampal tissues, collectively suppressing glial fibrillary acidic protein (GFAP) content, leading to an increase in brain-derived neurotrophic factor expression. Conclusions: Irisin induction may serve as a novel avenue in AD/menopause treatment and prevention via modulating the TNF-\u03b1/p38 MAPK/PPAR-\u03b3/NLRP3/GFAP pathway.\n\nID: 42166642\nTitle: Butyrate Regulates the Blood-Brain Barrier Transport and Intraendothelial Accumulation of Alzheimer's Disease Amyloid-Beta Peptides.\nAbstract: Alzheimer's disease (AD) is characterized by the pathological deposition of amyloid \u03b2 (A\u03b2) peptides as amyloid plaques and by cerebrovascular dysfunction, both of which drive AD progression. Butyrate, a gut microbial metabolite, is reduced in AD patients, and its supplementation has been shown to improve cognition and reduce the amyloid burden in animal models. However, the underlying mechanisms are unclear. Our previous studies demonstrated that insulin signaling regulates A\u03b2 transport kinetics at the blood-brain barrier (BBB). In this study, we investigated whether butyrate reduces intraendothelial A\u03b2 accumulation and improves BBB integrity through modulation of insulin signaling pathways. The effect of butyrate on A\u03b242 accumulation was assessed by flow cytometry in polarized BBB endothelial cell culture models. Activation of insulin signaling and expression of key BBB constituents involved in A\u03b2 transport and accumulation [p-glycoprotein (P-gp), the receptor for advanced glycation end products (RAGE)], as well as BBB integrity (tight junction protein, claudin-5), were evaluated by using Western blotting and confocal microscopy. The roles of insulin signaling nodes, including AKT, ERK, mTOR, and p38 phosphorylation, were investigated by using specific inhibitors MK2206, Trametinib, Rapamycin, and VX-745, respectively. In addition, the effect of butyrate on BBB receptors and transporters involved in A\u03b2 trafficking was examined in vivo in mouse brains colonized with butyrate-producing bacteria via immunohistochemistry. Butyrate significantly decreased endothelial A\u03b242 accumulation, an effect associated with the activation of insulin signaling, particularly AKT and ERK phosphorylation. Inhibitor studies established the critical role of these pathways, as co-incubation with MK2206 (AKT inhibitor) or Trametinib (ERK inhibitor) reversed the protective effect of butyrate and increased A\u03b242 accumulation, whereas inhibition of mTOR or p38 had no significant effect. Moreover, butyrate restored A\u03b2-induced reductions in the P-gp efflux transporter expression and claudin-5 tight junction protein levels. These findings were supported by in vivo studies demonstrating upregulation of the tissue inhibitor of metalloproteinases-2 (TIMP-2), a protein associated with AKT activation and extracellular matrix stabilization in mice colonized with butyrate-producing bacteria. In conclusion, our data demonstrate that butyrate reduces A\u03b242 uptake at the BBB endothelium by activating the AKT and ERK arms of the insulin signaling pathway. These changes may also enhance BBB integrity by increasing claudin-5 expression, stabilizing the extracellular matrix, and upregulating TIMP-2. Collectively, this study highlights butyrate as a potential therapeutic modulator of AD-associated BBB dysfunction.\n\nID: 42136278\nTitle: Therapeutic Insights into Natural Products for Modulating Neurodegenerative Disease Pathways.\nAbstract: Neurodegenerative Disorders (NDs), such as Alzheimer's disease, Parkinson's disease, Huntington's disease, and Amyotrophic Lateral Sclerosis (ALS), are chronic and progressive conditions marked by the gradual loss of neuronal structure and function. These disorders lead to cognitive, motor, and sensory decline, significantly reducing quality of life and posing a major global health burden due to rising healthcare costs and the absence of curative therapies. This review aims to comprehensively explore the therapeutic potential of natural products in targeting cellular and molecular mechanisms underlying NDs, highlighting their neuroprotective roles and potential for disease modification. A comprehensive literature review was conducted using databases including PubMed, Scopus, Web of Science, and Google Scholar. Peer-reviewed articles, clinical trials, and experimental studies were analyzed to evaluate the therapeutic potential of natural products and their bioactive compounds in the management of NDs. ND pathogenesis involves oxidative stress, neuroinflammation, mitochondrial dysfunction, and abnormal protein aggregation, ultimately leading to neuronal death. Current therapies largely provide symptomatic relief without altering disease progression. Natural products from plants, fungi, and marine sources demonstrate strong neuroprotective potential through multitargeted mechanisms. Bioactive compounds such as flavonoids, alkaloids, terpenoids, and polyphenols exhibit antioxidant, anti-inflammatory, anti-apoptotic, and neuroprotective activities. Key molecules, including curcumin, resveratrol, luteolin, quercetin, and catechins, modulate signaling pathways such as NF-\u03baB, MAPK, PI3K/AKT, Nrf2, apoptosis, and autophagy, thereby reducing amyloid-beta aggregation, protecting dopaminergic neurons, improving mitochondrial function, and enhancing cognition in preclinical and clinical studies. Natural products represent promising candidates for disease modification in NDs due to their multi-pathway actions and relatively low toxicity. However, major limitations, such as poor bioavailability, pharmacokinetic variability, and the lack of standardized formulations, hinder clinical translation. Innovative strategies, including advanced drug-delivery systems, structural modifications, and synergistic formulations, are needed to overcome these barriers. Natural products hold significant therapeutic potential in managing neurodegenerative diseases by targeting multiple pathological mechanisms. Their integration into ND treatment could provide safer and more effective alternatives, but further well-designed clinical trials are essential to establish their efficacy and facilitate clinical application.\n\nID: 42119956\nTitle: Neuroinvasion pathways of Treponema denticola and its role in amyloidogenesis and neuroinflammation: A systematic review.\nAbstract: Alzheimer's disease (AD) is a progressive neurodegenerative condition marked by the accumulation of amyloid-\u03b2 (A\u03b2) plaques, tau hyperphosphorylation, and persistent neuroinflammation. Emerging research indicates that Treponema denticola (T. denticola), a prominent periodontal pathogen, plays a role in AD development through various neuroinvasive mechanisms. This systematic review synthesizes current evidence regarding T. denticola ability to penetrate the central nervous system via trigeminal and hematogenous routes, disrupt the blood-brain barrier, and create enduring biofilms within neural tissues. The pathogen's virulence factors, including dentilisin, lipooligosaccharides (LOS), and major surface proteins, trigger \u03b2-secretase (BACE1) and mitogen-activated protein kinase (MAPK/JNK) pathways. These processes contribute to increased A\u03b2 production, tau phosphorylation, and neuronal apoptosis. Furthermore, T. denticola-driven activation of microglia and astrocytes intensifies neuroinflammatory responses involving IL-1\u03b2, TNF-\u03b1, and IL-6, leading to synaptic dysfunction and cognitive impairment. Studies on murine models reveal that prolonged oral infection with T. denticola induces Alzheimer's-like neuropathological changes, such as hippocampal A\u03b2 accumulation and neuron loss. Taken together, these insights emphasize the impact of periodontal pathogens as modifiable risk factors in AD progression and underscore the necessity of further longitudinal and interventional research to clarify causal pathways and therapeutic possibilities. Incorporating targeted antimicrobial approaches and effective periodontal care may provide innovative strategies for reducing AD progression risks.\n\nID: 42094412\nTitle: TMEM106B C-terminal fragments drive nucleocytoplasmic transport failure and TDP-43 mislocalization in the aging human brain.\nAbstract: TMEM106B is a lysosomal membrane protein and major genetic modifier of multiple neurodegenerative diseases, including frontotemporal lobar degeneration, Alzheimer's disease, and amyotrophic lateral sclerosis. Proteolytically generated C-terminal fragments of TMEM106B assemble into amyloid fibrils that accumulate in the brains of individuals with neurodegenerative disease and in cognitively normal aged adults, yet how these fibrils produce neuronal dysfunction has remained unclear. Here, we show that cytosolic and lysosome-directed TMEM106B C-terminal fragments (CTF and gCTF) form detergent-insoluble amyloid aggregates, drive redistribution of endogenous TDP-43 from the nucleus to the cytoplasm, and accelerate neuronal death. Unbiased proximity proteomics identified the inner nuclear membrane LAP1-TorsinA axis as a fragment-specific interactome, and co-immunoprecipitation confirmed a direct physical interaction between gCTF and LAP1 that was not observed with full-length TMEM106B. Fragment expression disrupted Lamin B1 organization, mislocalized the nuclear import machinery KPNB1 and RanGAP1, and impaired importin-dependent nuclear transport in primary cortical neurons. Critically, neurons harboring endogenous TMEM106B fibrillar pathology in aged human frontal cortex exhibited the same phenotypes, namely disrupted Lamin B1 and LAP1 localization and cytoplasmic redistribution of TDP-43, whereas fibril-negative neurons from the same cases and younger control tissue retained intact nuclear envelope organization. These findings define TMEM106B proteinopathy as an upstream driver of nuclear envelope disruption and nucleocytoplasmic transport failure, linking a widespread feature of brain aging to a central mechanism of neurodegeneration.\n\nID: 42079138\nTitle: NMNAT2-SARM1 Axis Drives Redox Failure and Disrupts APP Processing in Neurons.\nAbstract: Metabolic dysfunction and proteinopathy are hallmarks of many neurodegenerative diseases, yet their mechanistic interplay remains poorly understood. Here, we demonstrate that amyloid precursor protein (APP) processing in cortical neurons is disrupted upon loss of Nicotinamide mononucleotide adenylyltransferase 2 (NMNAT2), the NAD\u207a-synthesizing enzyme in neurons, resulting in accumulation of APP C-terminal fragments (APP-CTFs). Knockdown (KD) of the NAD\u207a hydrolase sterile alpha and TIR motif-containing protein 1 (SARM1) restores APP-CTF levels in NMNAT2 knockout (KO) neurons to wild-type levels, whereas NAD\u207a supplementation yields modest rescue. Redox profiling indicates that NMNAT2 loss reduces NAD\u207a/NADH redox potential when APP-CTF starts accumulating. Seahorse metabolic flux analysis shows that NMNAT2 deficiency induces early glycolytic impairment, followed by deficits in mitochondrial respiration. Notably, SARM1 KD, but not NAD\u207a supplementation, rescues mitochondrial function in NMNAT2 KO neurons. Temporal profiling of NMNAT2 KO neurons revealed a biphasic pattern in APP-CTF accumulation, with an initial gradual increase followed by a marked acceleration, paralleling the transition from an initially small number to a substantially greater number of differentially expressed proteins. Pathway enrichment analysis of proteomic changes suggests JNK/MAPK signaling is upregulated in the early phase, with late-phase downregulation of mitochondrial function and upregulation of endoplasmic reticulum stress and unfolded protein response pathways. Collectively, these findings demonstrate that neuronal NAD\u207a depletion drives a progressive, SARM1-dependent disruption of redox homeostasis and proteostasis, resulting in impaired APP processing. The NMNAT2-SARM1 axis emerges as a critical pathway linking metabolic stress to proteinopathy, positioning SARM1 as a key mediator of neurodegenerative dysfunction.\n\nID: 42043700\nTitle: Signaling Pathways Triggering Therapeutical Potential of Marine-Derived Polysaccharides in Alzheimer's Disease: A Recent Review.\nAbstract: Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by cognitive failure, memory impairment, and behavioral disturbances. The disease is associated with complex pathological mechanisms including amyloid-\u03b2 (A\u03b2) plaque deposition, tau hyperphosphorylation, oxidative stress, mitochondrial dysfunction, and chronic neuroinflammation. Despite extensive research, currently available therapeutic options provide only symptomatic relief and fail to halt disease progression. Consequently, increasing attention has been directed toward natural bioactive compounds with multi-target therapeutic potential. Marine ecosystems represent a vast reservoir of structurally unique biomolecules, among which marine-derived polysaccharides have emerged as promising candidates for neuroprotection. Polysaccharides such as fucoidan, alginate, carrageenan, chitosan, ulvan, chondroitin sulfate, and hyaluronic acid exhibit diverse biological activities, including antioxidant, anti-inflammatory, anti-amyloidogenic, and neuroprotective effects. These biomolecules can modulate several critical intracellular signaling pathways implicated in AD pathology, including the NF-\u03baB, MAPK, PI3K/Akt/GSK-3\u03b2, Nrf2/ARE, STAT3, and NLRP3 inflammasome pathways. By regulating these pathways, marine polysaccharides can reduce oxidative stress, suppress neuroinflammatory responses, inhibit amyloid aggregation, attenuate tau pathology, and promote neuronal survival. Additionally, certain polysaccharides such as chitosan and alginate have demonstrated significant potential as nanocarriers for targeted drug delivery across the blood-brain barrier. This review summarizes recent advances in understanding the signaling pathways associated with AD and highlights the emerging therapeutic potential of marine-derived polysaccharides as multi-target neuroprotective agents. Overall, these marine biomolecules represent promising candidates for developing novel therapeutic strategies to mitigate neurodegeneration and improve cognitive function in Alzheimer's disease.\n\nID: 42017968\nTitle: Tau oligomerization induces nuclear lamina invagination and chromatin remodeling in Alzheimer's disease.\nAbstract: The aggregation of the microtubule-associated protein tau into oligomeric complexes is strongly correlated with the onset and progression of neurodegeneration in Alzheimer's disease (AD). Increasing evidence implicates nuclear membrane disruption in AD and related tauopathies; however, whether this is a cause or consequence of neurodegeneration remains unresolved. Here, we show that nuclear lamina disruption emerges at the early Braak stages, coinciding with the initial formation of pathological tau aggregates in post-mortem AD brain tissue. Using the tauopathy mouse model (P301S PS19), we demonstrate that oligomeric tau (oTau) directly binds to the Lamin B Receptor (LBR), inducing nuclear envelope invaginations as revealed by electron microscopy. These structural alterations are accompanied by chromatin remodeling and gene expression dysregulation. To dissect the underlying mechanism, we employed a light-inducible OptoTau system (4R1N Tau::mCherry::Cry2Olig) in human iPSC-derived neurons, enabling real-time visualization of tau aggregation dynamics. This system revealed selective recruitment of oTau to the nuclear envelope and direct interactions with LBR and Lamin B2, leading to nuclear deformation and activation of the protein translational stress response. Together, these findings identify nuclear membrane disruption as an early and potentially causative event in tau-mediated neurodegeneration, establishing a mechanistic link between tau oligomerization, nuclear stress, and chromatin remodeling. Targeting nuclear destabilization may offer new therapeutic avenues for mitigating AD pathogenesis.\n\nID: 42012484\nTitle: CD163 and Tim-4 identify resident intestinal macrophages that are spatially regulated by TGF-\u03b2.\nAbstract: Macrophages localize in sub-tissular niches associated with their ontogeny and activity. In the intestine, a paradigm has emerged that long-lived macrophages are present in the muscular layer, while highly monocyte-replenished populations are found in the lamina propria (LP). Whether long-lived macrophages are restricted in such a simplified manner has not been well explored. Moreover, the impact of specific gut-associated factors on macrophage identity across intestinal tissue layers is unknown. We generated scRNA-seq data from WT and Ccr2-/- mice to identify phenotypic features of long-lived macrophage populations in distinct intestinal layers and identified CD163 as a marker to distinguish submucosal/muscularis (S/M) from LP macrophages. Challenging the emerging paradigm, long-lived macrophages were found in the LP and S/M, with distinct transcriptomes and responsiveness to proinflammatory stimuli. Employing transgenic mice, we demonstrate a critical role for TGF-\u03b2 signalling in maintaining the identity of long-lived LP but not S/M macrophages and that macrophage-derived TGF-\u03b21 is required to instruct intestinal macrophage identity after development.\n\nID: 42008868\nTitle: Design, synthesis, and biological evaluation of pyranone-carbamate hybrids as selective butyrylcholinesterase inhibitors with anti-neuroinflammatory activity for Alzheimer's disease.\nAbstract: Alzheimer's disease (AD) is a multifactorial neurodegenerative disorder in which cholinergic dysfunction and chronic neuroinflammation jointly contribute to cognitive decline. To address these converging pathological features, a series of carbamate-pyranone hybrids (E1-E17) were designed using a pharmacophore hybridization strategy that integrates the cholinesterase-inhibitory carbamate motif of Rivastigmine with the anti-neuroinflammatory \u03b3-pyranone scaffold derived from D30. Among these derivatives, E14 emerged as a promising hit compound. E14 inhibited lipopolysaccharide-induced nitric oxide production in BV2 microglial cells (IC\u2085\u2080\u00a0=\u00a09.76\u00a0\u00b1\u00a00.59\u00a0\u03bcM), while maintaining acceptable cytocompatibility. Enzymatic assays revealed that E14 selectively inhibited butyrylcholinesterase, with IC\u2085\u2080 values of 15.59\u00a0\u00b1\u00a02.98\u00a0\u03bcM against eqBuChE and 38.65\u00a0\u00b1\u00a03.40\u00a0\u03bcM against hBuChE, while showing negligible activity against acetylcholinesterase, and kinetic analysis indicated a competitive inhibition mechanism. Consistent with its CNS-oriented design, E14 exhibited high passive blood-brain barrier permeability in a PAMPA-BBB assay (Pe\u00a0=\u00a011.87\u00a0\u00d7\u00a010-6\u00a0cm/s) and showed good acute tolerability in mice. In an oligomeric A\u03b2-induced cognitive impairment mouse model, E14 significantly improved recognition memory and spatial learning performance. Mechanistic investigations demonstrated that E14 attenuated hippocampal glial activation and neuroinflammation, suppressing the TLR4/p38 MAPK signaling pathway and modulating the IL-1\u03b2/C3-mediated microglia-astrocyte inflammatory axis. Network pharmacology analyses further suggested multitarget engagement across inflammation- and stress-related pathways relevant to AD pathology. Collectively, these findings identify E14 as a brain-penetrant, BuChE-selective dual-functional compound that integrates cholinesterase inhibition with anti-neuroinflammatory activity, supporting its further development as a multitarget-directed lead for AD intervention.\n\nID: 41990881\nTitle: Imbalance of the AKT/MAPK signaling axis mediates the exacerbation of Alzheimer's disease pathology by simulated particulate air pollution from Shihezi in APP/PS1 mice.\nAbstract: This study investigated the mechanisms by which a region-specific simulated PM2.5 from Shihezi, China, exacerbates Alzheimer's disease (AD) pathology, focusing on the protein kinase B (AKT)/mitogen-activated protein kinase (MAPK) signaling axis. APP/PS1 and wild-type mice were exposed to a simulated Shihezi PM2.5 suspension. Cognitive function, neuroinflammation, oxidative stress, signaling activity, apoptosis, and amyloid-\u03b2 (A\u03b2)/Tau pathology were assessed. Simulated PM2.5 exposure aggravated cognitive deficits, induced neuroinflammation and oxidative stress, and triggered a significant AKT/MAPK imbalance characterized by MAPK hyperactivation and AKT suppression. This imbalance promoted neuronal apoptosis and exacerbated both A\u03b2 deposition and Tau hyperphosphorylation. Our findings reveal that simulant PM2.5-induced neuroinflammation and oxidative stress dysregulate the AKT/MAPK axis, driving neuronal loss and AD progression, and suggest a molecular mechanism by which environmental PM2.5 exposure may contribute to accelerated neurodegeneration.\n\nID: 41984754\nTitle: Intracranial Arterial Calcification on Computed Tomography and Risk of Cognitive Impairment or Dementia: A Systematic Review and Meta-Analysis.\nAbstract: Coronary arterial calcification on computed tomography (CT), or CT-coronary artery calcification (CAC), is a widely studied risk factor for acute coronary events, but although intracranial arterial calcification on CT brain imaging (CT-IAC) is also a frequent finding in older individuals, there is no consensus on its prognostic significance, particularly whether its presence, severity, or site predict cognitive impairment or dementia. Given the clinical and mechanistic importance of any associations, we did a systematic review and meta-analysis. Studies published before 30 January 2026 were identified from bibliographic databases, reference lists, and forward or backward screening. Inclusion criteria were: (1) studies of adults linking CT-IAC/CAC with later cognitive impairment or dementia; (2) reporting adjusted effect measures with 95% confidence interval or p values (or calculable); (3) calcification assessed by CT/CT angiography and cognition by recognised tests or expert evaluation. Studies were summarised qualitatively and pooled quantitatively depending on heterogeneity. Six cross-sectional studies and three longitudinal studies reported data on CT-IAC and cognitive status. Among five studies that reported associations for presence vs. absence of CT-IAC, presence of calcification was weakly associated with cognitive impairment or dementia (three cross-sectional studies - pooled adjusted odds ratio [aOR] = 1.42, 0.88-2.28, p = 0.15; two longitudinal studies - aOR = 1.51, 1.03-2.22, p = 0.033; all studies - aOR = 1.48, 1.10-1.99, p = 0.01). Among five studies that reported associations for more severe vs. milder CT-IAC, severe calcification was more strongly associated with the cognitive outcome (two cross-sectional studies - pooled aOR = 2.29, 0.50-10.57, p = 0.29; three longitudinal studies - aOR = 1.84, 1.28-2.65, p = 0.001; all studies - aOR = 1.74, 1.28-2.36, p = 0.0004), including in two longitudinal cohorts in patients with stroke/transient ischaemic attack (pooled aOR = 1.73, 1.22-2.46, p = 0.002). In two longitudinal studies, severity of vertebrobasilar CT-IAC also predicted dementia (pooled aOR = 2.12, 1.06-4.21, p = 0.033), and severity of medial/internal elastic lamina (IEL) CT-IAC was a stronger predictor of dementia (pooled aOR = 2.35, 1.29-4.28, p = 0.005) than severity of intimal CT-IAC (pooled aOR = 1.29, 0.75-2.23, p = 0.36). For coronary CT-CAC, three longitudinal cohorts revealed weak associations with dementia (per standard deviation increase in calcification measures - pooled adjusted hazards ratio = 1.15, 1.02-1.30, p = 0.025). In longitudinal studies, presence and severity of CT-IAC are both independently associated with dementia, driven mainly by medial/IEL calcification, with weaker associations for intimal and coronary calcification. In cross-sectional studies, the associations for both CT-IAC measures were of a similar magnitude to the longitudinal analyses but were not statistically significant. Future studies should determine age- and dementia-subtype specific associations.\n\nID: 41964857\nTitle: BDNF Protects Against Neuronal Damage Induced by TNF and \u03b2-Amyloid Peptides by Targeting JNK Activation.\nAbstract: Neuroinflammation, driven by \u03b2-amyloid peptide accumulation, plays a critical role in the pathogenesis of Alzheimer\u2019s disease, resulting in neurodegeneration and cognitive decline. Inflammatory cytokines, particularly tumor necrosis factor (TNF), adversely affect neuronal function and survival by counteracting the neuroprotective effects of neurotrophins. Importantly, brain-derived neurotrophic factor (BDNF) has been shown to alleviate the neurotoxic effects of pro-inflammatory cytokines. While the mechanisms through which pro-inflammatory cytokines disrupt BDNF/TrkB signaling are well understood, the specific ways in which BDNF protects neurons from inflammatory damage remain unclear. We present evidence that BDNF reduces cytotoxicity and neuritic damage in cholinergic neurons (SN56) induced by TNF and \u03b2-amyloid peptide, through the downregulation of c-Jun N-terminal kinase (JNK) activation. BDNF inhibits TNF-induced JNK activation by stimulating p38 mitogen-activated protein kinase. These findings indicate that BDNF restores neuronal functionality by modulating the signaling pathways of inflammatory cytokines, such as TNF, and highlight potential therapeutic strategies to mitigate neuroinflammation-associated neurodegeneration in Alzheimer\u2019s disease.\n\nID: 41958080\nTitle: The GPCR Connection: Linking Alzheimer's Disease and Glioblastoma.\nAbstract: Alzheimer's disease (AD) and glioblastoma multiforme (GBM) are biologically distinct age-related brain disorders with opposing clinical phenotypes. AD is characterised by progressive neurodegeneration and cognitive decline, whereas GBM is characterised by aggressive cellular proliferation and a poor prognosis. Despite these differences, converging evidence indicates that both conditions share molecular pathways and network-level dysfunction that emerge during brain ageing. Central to this convergence are G protein-coupled receptors (GPCRs), which act as integrative signalling hubs that regulate inflammation, metabolism, calcium (CA2+) homeostasis, and cell survival. In AD, GPCR signalling modulates amyloid-\u03b2 production and clearance, Tau phosphorylation, intracellular CA2+ dynamics, and glial-driven neuroinflammation. In contrast, the same receptor families promote tumour growth, angiogenesis, immune evasion, and therapeutic resistance in patients with GBM. Core intracellular cascades, such as PI3K-AKT-mTOR and MAPK-ERK, are dysregulated in both diseases and function as shared signalling backbones, with outcomes dictated by cellular context rather than receptor identity. CXCR4, LPA\u2081, and FPR1 exemplify this duality, driving either oncogenic proliferation or neuronal dysfunction, depending on the biological environment. Recent advances in integrative multiomics, computational modelling, artificial intelligence, and organoid systems have revealed GPCR-centred regulatory nodes and accelerated the identification of druggable targets. Collectively, these findings suggest that AD and GBM, although pathologically antithetical, share a molecular fingerprint shaped by ageing-associated inflammation, metabolic disruption, cellular senescence and dysregulated GPCR networks. Deciphering this context-dependent duality may enable precision therapeutic strategies to either restore neuronal integrity in AD or suppress malignant programmes in GBM while fostering cross-fertilisation between neurodegeneration and neuro-oncology research.\n\nID: 41930874\nTitle: Salvianolic acid a inhibits neuroinflammation and ameliorates Alzheimer's disease pathology via the p38 MAPK/NF-\u03baB pathway based on network pharmacology and experimental validation.\nAbstract: Alzheimer's disease (AD) represents the most prevalent form of neurodegenerative disorder, characterized by progressive cognitive impairments and a scarcity of effective treatments. Salvianolic acid A (SalA), a natural phytochemical endowed with antioxidative, antiapoptotic, and anti-inflammatory properties, emerges as a promising therapeutic candidate for AD. This study explored the therapeutic efficacy and underlying mechanisms of SalA in mitigating AD-related pathologies. Through integrative network pharmacology, molecular docking, and pathway enrichment analysis, p38 MAPK and NF-\u03baB were identified as potential targets of SalA in the context of AD. SalA treatment inhibited the activation of the p38 MAPK/NF-\u03baB pathway via targeting p38 MAPK, leading to decreased levels of IL-1\u03b1 and IL-1\u03b2 in lipopolysaccharide (LPS)-stimulated HMC3 cells. In an in vivo 3\u00a0\u00d7\u00a0Tg-AD mouse model, SalA administration ameliorated cognitive decline associated with AD, decreased tau protein hyperphosphorylation in the hippocampus and cortex, and reduced amyloid-\u03b2 (A\u03b2) accumulation and \u03b2-site amyloid precursor protein cleaving enzyme 1 (BACE1) levels. Furthermore, SalA attenuated the activation of the p38 MAPK/NF-\u03baB pathway and the expression of related inflammatory cytokines in the brains of 3\u00a0\u00d7\u00a0Tg-AD mice. In conclusion, this study elucidates the promising ameliorative effects of SalA on improving AD pathology, primarily through the modulation of the p38 MAPK/NF-\u03baB signaling pathway.\n\nID: 41918207\nTitle: Decoding microRNA-Protein Interaction Networks in Alzheimer's Disease: Molecular Mechanisms and Clinical Implications.\nAbstract: Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by memory loss, cognitive decline, and neuronal dysfunction. Despite thorough research efforts, effective disease-modifying treatments have yet to be discovered. MicroRNAs (miRNAs), small noncoding RNAs that control gene expression after transcription, have become key factors in AD development. Changes in miRNA levels influence critical molecular pathways such as amyloid precursor protein (APP) processing, tau phosphorylation, oxidative stress, neuroinflammation, and synaptic plasticity, all of which contribute to neuronal damage. By increasing \u03b2-secretase (BACE1) activity, downregulation of miR-29a/b and miR-107 encourages the buildup of amyloid-\u03b2 (A\u03b2) and the development of plaques. Through the deregulation of the CDK5 and MAPK pathways, overexpression of miR-125b and decreased levels of miR-132/212 lead to tau hyperphosphorylation. While oxidative stress-associated miRNAs like miR-34a and miR- 21 worsen mitochondrial malfunction and neuronal death, pro-inflammatory miRNAs like miR-146a and miR-155 cause NF-\u03baB-mediated signalling and glial activation. Circulating miRNAs found in blood and cerebral fluid are potential, minimally invasive indicators for tracking the course of a disease and making early diagnoses. Additionally, therapeutic manipulation with antagomiRs or miRNA mimics has the potential to prevent neurodegeneration and restore normal gene regulation. This review deciphers the molecular mechanisms underlying miRNA dysregulation in AD and explores their translational potential as biomarkers and therapeutic targets. A comprehensive understanding of miRNA-protein interaction networks could facilitate the development of targeted, precision- based interventions for Alzheimer's disease.\n\nID: 42369358\nTitle: Activin A mitigates ferroptosis in cerebral ischemia/reperfusion injury via the PGC-1\u03b1/NRF1/TFAM axis.\nAbstract: Cerebral ischemia/reperfusion (I/R) injury severely limits the efficacy of recanalization therapy for ischemic stroke. Activin A (Act A), a neurotrophic cytokine, shows protective potential, but its mechanisms related to mitochondrial biogenesis and ferroptosis regulation remain unclear. In vivo, adult male Wistar rats (12/group) underwent 2\u202fh middle cerebral artery occlusion (MCAO) and 24\u202fh reperfusion. Act A (7.5\u202f\u03bcg/kg) or vehicle was administered intracerebroventricularly pre-ischemia. TTC, TEM, and IHC were used to analyze cerebral I/R injury and PGC-1\u03b1 expression. In vitro, HT22 cells exposed to oxygen-glucose deprivation/reoxygenation (OGD/R, 8\u202fh/24\u202fh) were treated with Act A (100\u202fng/mL). Ferroptosis markers, mitochondrial function and signaling pathways were assessed via qPCR, western blot, flow cytometry, laser confocal and ChIP. In vivo, Act A significantly reduced cerebral infarct volume versus vehicle (***p\u202f<\u202f0.001), decreased MDA levels (***p\u202f<\u202f0.001), and increased PGC-1\u03b1 expression (***p\u202f<\u202f0.001) along with mtDNA copy number (*p\u202f<\u202f0.05). In vitro, Act A rescued OGD/R-induced ferroptosis, suppressing lipid ROS (**p\u202f<\u202f0.01) and Fe2+ accumulation (*p\u202f<\u202f0.05). It activated the PGC-1\u03b1/NRF1/TFAM axis (*p\u202f<\u202f0.05) and enhanced mitochondrial biogenesis. Mechanistically, Act A promoted PGC-1\u03b1 transcription via Smad3 binding to its promoter (*p\u202f<\u202f0.05) and enhanced PGC-1\u03b1 activity through p38-MAPK phosphorylation (***p\u202f<\u202f0.001). Silencing PGC-1\u03b1 abolished Act A's neuroprotection effects. Act A mitigates cerebral I/R injury by dual activation of PGC-1\u03b1 through Smad3 and p38-MAPK pathways, enhancing mitochondrial biogenesis and inhibiting neuronal ferroptosis. This highlights Act A as a therapeutic candidate for ischemic stroke.\n\nID: 42352358\nTitle: Extracellular Pgk1 or Its Derived Short Peptide Interacted with Membrane-Associated Enolase 2 Receptor: A Potential Therapy for ALS Motor Neuron Degeneration.\nAbstract: Amyotrophic lateral sclerosis (ALS) remains an intractable motor neuron (MN) disease with a growing patient population and few effective treatments. Here, we review how extracellular phosphoglycerate kinase 1 (ePgk1) improves neurite outgrowth of MNs (NOMN) and axonal growth, both in vitro and in vivo. Our group first elucidated a novel non-canonical function of ePgk1 as a cross-tissue mediator between nerve and muscle tissues. We then discovered that neural membranous Enolase 2 (Eno2) serves as a receptor of ligand ePgk1 and that ePgk1-Eno2 interaction suppresses the Rac1-GTP/p-Pak1-T423/p-P38-T180/pMK2-T334/p-Limk1-S323 axis, reducing p-Cofilin and promoting NOMN and axonal growth, finally suggesting that the 419th aspartic acid residue of Eno2 mediates this interaction. In a crucial preclinical step, we truncated two short 16-amino-acid derivatives from Pgk1, FD-1/-2, each mediating neuroprotection comparable to that of full-length 417-amino-acid Pgk1 in ALS animal models, in terms of improvements of innervated neuromuscular junction, MN cell bodies, motor performance, and endpoint prolongation. In this context, we also discuss the opposite function driven by Eno1-plasminogen interaction and by Eno2-ePgk1 interaction; the latter results in unfavorable for tumorigenesis. Unlike intracellular Pgk1 roles, ePgk1 is an extracellular factor with anti-angiogenic properties, further positioning ePgk1 and its FD-1/-2 as promising protein/peptide drugs for ALS treatment.\n\nID: 42351966\nTitle: Unlocking the Neuroprotective Potential of Semecarpus anacardium L.-An Updated Review.\nAbstract: Neurodegenerative diseases (NDs) pose a significant health burden globally, and this burden is increasing with an ageing population. Despite this challenge, restorative treatments for NDs remain elusive. In these conditions, the brain is vulnerable to oxidative stress and inflammation due to a deficiency or reduction in antioxidative enzymes. Oxidative stress and inflammation damage neuronal cells, leading to neurodegeneration. Various studies have explored the neuroprotective effects of flavonoids in different in vitro and animal models, primarily due to their antioxidative and anti-inflammatory properties. Crude extracts and active metabolites of Semecarpus anacardium L. have shown potential in reversing dysregulated oxidative stress and neuroinflammation. S. anacardium L. extract (SAE) and its phytocomponents, such as butein, anacardic acid, and amentoflavone, have been experimentally demonstrated to modulate oxidative stress and neuroinflammation through coordinated activation of Nrf2-mediated antioxidant pathways and suppression of NF-\u0138B-driven inflammatory signaling. At a molecular level, flavonoids from SAE induce the expression of p38 MAPK and Nrf2, as well as antioxidant enzymes. Furthermore, inflammatory genes such as NF-\u0138B, MAPK, AP-1, iNOS, and COX-2 are suppressed following treatment with SAE. NF-\u0138B inhibition leads to neuroprotection via inhibiting the function of caspase-3 and apoptosis. Overall, this review discusses the protective role of SAE and its phytocomponents in mitigating neuronal oxidative stress, inflammation, and degeneration. Furthermore, this review highlights the translational potential of SAE and its phytocomponents as complementary therapeutic candidates for neurodegenerative disorders. However, variability in extract composition and limited pharmacokinetic characterization remain key barriers to clinical translation.\n\nID: 42348037\nTitle: Combined Puerarin and Magnesium Acetyl Taurate Intervention Mitigates Autism-Like Pathology Through Glutamatergic and MAPK Pathway Regulation.\nAbstract: Autism is a multifactorial neurodevelopmental disorder characterized by social deficits, stereotypical behaviour, and neurotransmitter imbalance. This study evaluated the neuroprotective potential of Puerarin (PUN) and Magnesium Acetyl Taurate (MGAT) in a propionic acid (PPNA)-induced rat model of autism. PPNA was administered intracerebroventricularly for 11 consecutive days to induce autism-like features, followed by a 44-day treatment period with PUN (300\u00a0mg/kg, i.p.) and MGAT (500\u00a0mg/kg, p.o.). A comprehensive assessment was conducted, including behavioural analysis, biochemical and molecular evaluations, cerebrospinal fluid and plasma profiling, and histopathology. Treatment with PUN and MGAT, particularly in combination, improved behavioural outcomes, restored neurotransmitter balance, reduced neuroinflammation and apoptotic signaling, and attenuated activation of the glutaminase-glutamate/NMDAR and MAPK pathways (C-JNK, ERK1/2, P38 MAPK). Additionally, treatment increased magnesium levels and PSD-95 expression, indicating significant neuroprotection. These findings support the potential of PUN and MGAT as a multitarget therapeutic strategy for autism and warrant further translational investigation.\n\nID: 42337875\nTitle: NMDA Receptor-Targeted Neuroprotection in Ischemic Stroke: The 3S Framework Integrating Spatiotemporal Dynamics, Subtype Selectivity, and Signaling Pathways.\nAbstract: Ischemic stroke remains a leading cause of death and disability worldwide, yet therapeutic options beyond thrombolysis are limited. A central paradox in stroke neuropharmacology lies in why complete NMDA receptor (NMDAR) blockade has repeatedly failed in clinical trials, while more targeted interventions retain therapeutic promise. To address this paradox, we propose a \"Spatiotemporal-Subtype-Signaling (3S)\" framework that integrates three interrelated dimensions: (1) spatiotemporal dynamics, in which receptor expression, phosphorylation, and subcellular localization shift across the transition from acute energy failure to delayed neurodegeneration; (2) subtype selectivity, in which distinct NMDAR subtypes exert opposing effects on neuronal fate, with GluN2A promoting survival via the PI3K-Akt-FOXO/GSK3\u03b2 and ERK-CREB-BDNF pathways, GluN2B mediating excitotoxicity through p38 MAPK, JNK, and PSD-95-nNOS coupling, and GluN2C/GluN2D contributing through context-dependent mechanisms; and (3) signaling pathway selectivity, defined by the differential coupling of receptor subtypes to pro-survival versus pro-death cascades. Recent work further highlights NMDAR-ferroptosis crosstalk and sexual dimorphism: males rely predominantly on non-ionotropic GluN2B signaling, whereas females depend on estrogen receptor \u03b1 (ER\u03b1) and G protein-coupled receptor 30 (GPR30)-mediated pathways. Translational efforts include subtype-selective antagonists (e.g., NP10679, a pH-sensitive GluN2B inhibitor) and disruptors of pathological protein-protein interactions (e.g., nerinetide, which targets the PSD-95-nNOS interface), while remote ischemic postconditioning has shown encouraging clinical results. Although these mechanisms remain primarily supported by preclinical evidence, they extend the scope of the framework. Collectively, the 3S framework clarifies why complete receptor blockade fails while precision interventions may succeed, and identifies priorities for sex-specific, subtype-targeted neuroprotective strategies in ischemic stroke.\n\nID: 42320726\nTitle: Molecular crosstalk between MAPK signaling and neuroprotective pathways in Parkinson's disease: from pathogenesis to therapeutic potential.\nAbstract: Mitogen-activated protein kinase (MAPK) signaling is increasingly recognized as a central regulator in the pathogenesis of Parkinson's disease (PD). PD is a chronic neurodegenerative disorder characterized by the progressive loss of dopaminergic neurons in the substantia nigra pars compacta (SNpc), driven by a complex interplay of mitochondrial dysfunction, oxidative stress, and neuroinflammation. While basal MAPK activity is essential for neuroprotection and neuronal growth, its overactivation, specifically via the JNK and p38 cascades, accelerates neurodegeneration. This review explores the molecular landscape of MAPK signaling, detailing how its dysregulation promotes the accumulation of alpha-synuclein and the activation of microglia. Furthermore, it highlights critical crosstalk between MAPK and other vital pathways, including the inhibition of the neuroprotective PI3K/AKT and PP2A pathways and the detrimental activation of GSK-3\u03b2 and PTEN signaling. Preclinical evidence strongly supports the use of MAPK inhibitors to mitigate dopaminergic neurotoxicity and reduce proinflammatory cytokine release. Despite promising results in experimental models and the development of highly selective inhibitors, clinical translation remains challenging due to potential systemic toxicities. This manuscript provides a comprehensive synthesis of mounting and mooting evidence, positioning MAPK inhibition as a potent, albeit complex, adjuvant strategy for delaying the onset and progression of PD neuropathology.\n\nID: 42279126\nTitle: Losmapimod, an Oral Anti-p38 MAP Kinase, Demonstrates Anti-Neuropathic and Anti-Inflammatory Effects in Rat Acute Pain.\nAbstract: Background: The postoperative period is a large provider of acute and chronic pain which often combine pronociceptive, neuropathic and inflammatory components. As p38 MAPkinases are involved in pain response, this study aimed to evaluate the effect of losmapimod, an oral p38 MAPkinase inhibitor at the very first stage of acute neuropathic pain. Losmapimod efficacy was also compared with other well-known pain-relieving drugs and its dose response determined after inflammatory pain. Methods: The anti-neuropathic properties of losmapimod were evaluated after acute neuropathic pain (from day 0 to day 3 after sciatic nerve ligation) using thermal and mechanical stimulation. Losmapimod was also compared with gabapentin, their respective ED50 were determined, and their interaction was studied using an isobolographic approach. The anti-inflammatory characteristics of losmapimod were assessed from day 0 to day 5 after carrageenan injection in the rat hind paw and compared with those of ketoprofen, ketamine, and morphine using paw oedema volume. Results: Losmapimod provided a potent analgesic effect after acute neuropathic pain. The ED50 with their 95% confidence intervals of losmapimod and gabapentin were 10.5 (6.9-12.9) mg/kg and 18.2 (15.0-20.3) mg/kg, respectively. Their interaction was additive. Losmapimod also had a potent anti-inflammatory effect (ED50 was 34 (19.0-246) mg/kg) with significant reduction of paw oedema (similarly to ketoprofen). Conclusions: Losmapimod showed anti neuropathic properties at the very early stage of neuropathic pain and potent anti-inflammatory properties. As previous studies have highlighted the excellent tolerance of losmapimod in human populations, this drug seems promising for acute postoperative pain, which combines both acute neuropathic and inflammatory mechanisms.\n\nID: 42278506\nTitle: Pre-Activation of Mitophagy Protects Against Hyperbaric Oxygen-Induced Central Nervous System Oxygen Toxicity.\nAbstract: Central nervous system oxygen toxicity (CNS-OT) is a major complication of hyperbaric oxygen (HBO) characterized by seizures and neuronal damage, yet the underlying mechanisms remain incompletely understood. Using male Sprague Dawley rats (n = 6 per group) and HT22 neurons exposed to either HBO (6 ATA, 100% O2) or hyperbaric normoxia (HNO), our results demonstrate that HBO, but not HNO, caused mitochondrial structural damage and loss of mitochondrial membrane potential (\u0394\u03a8m). Transcriptomic analysis revealed enrichment of apoptosis and mitogen-activated protein kinase (MAPK) signaling pathways. Using HeLa cells stably overexpressing Parkin and Mito-Keima, a pH-sensitive mitochondrial probe system for monitoring mitophagy, we observed that mitophagic flux was initiated but proceeded too slowly to clear damaged mitochondria in a timely manner in HBO-exposed neurons. Pharmacological preconditioning to activate mitophagy enabled the prompt elimination of dysfunctional mitochondria and rescued HBO-induced mitochondrial dysfunction and cell death. In vivo, everolimus treatment promoted timely mitophagic clearance, prolonged seizure latency, attenuated \u0394\u03a8m loss, and suppressed p-p38 activation. These findings demonstrate that HBO exposure disrupts mitochondrial homeostasis and activates pro-apoptotic MAPK signaling. Meanwhile, endogenous mitophagy is initiated but fails to clear damaged mitochondria in a timely manner. Pre-activation of mitophagy by everolimus enables the timely clearance of damaged mitochondria, protecting against CNS-OT and highlighting a promising therapeutic strategy.\n\nID: 42275700\nTitle: Allosteric activation of Trx1 by antagonizing nitrative modification at tyrosine 49 confers neuroprotection against ischemic stroke.\nAbstract: Ischemic stroke remains a leading cause of mortality and chronic disability worldwide, with limited therapeutic options. Tetramethylpyrazine (TMP) is a natural product with well-established clinical efficacy against ischemic stroke, yet its molecular target and mechanism of action remain elusive. By integrating a bifunctional photoaffinity TMP probe with stable isotope labeling by amino acids in cell culture and activity-based protein profiling (SILAC-ABPP), we identified thioredoxin 1 (Trx1) as a direct target of TMP. We demonstrate that TMP binds specifically to tyrosine 49 (Y49) on Trx1, antagonizes its nitrative modification, and functions as an allosteric activator. This binding enhances Trx1's reductase activity, strengthens its interaction with apoptosis signal-regulating kinase 1 (ASK1), and consequently suppresses the ASK1-p38/JNK signaling cascade. Genetic ablation of Trx1 or ASK1, or pharmacological induction of Trx1 nitration, completely abolishes TMP-mediated neuroprotection. Our findings not only decipher the mechanistic basis for TMP's clinical efficacy but also identify Y49 of Trx1 as a druggable allosteric site, unveiling a novel anti-nitrative therapeutic strategy for ischemic stroke and related disorders involving nitrative stress.\n\nID: 42211306\nTitle: Rehmannioside A alleviates neuroinflammation and cognitive impairments after traumatic brain injury by suppressing microglial activation via the MAPK/NF-\u03baB pathway.\nAbstract: Traumatic brain injury (TBI) triggers a robust neuroinflammatory response characterized by microglial activation, which propagates secondary neuronal damage and contributes to long-term neurological deficits. Rehmannioside A (REA), a principal bioactive compound from Rehmannia glutinosa, has emerged as a candidate for neuroprotection due to its anti-inflammatory properties. However, its therapeutic potential and precise mechanisms of action in TBI remain to be fully elucidated. We employed a controlled cortical impact (CCI) model in mice to mimic clinical TBI. Animals were randomized into Sham/Veh, Sham/REA, TBI/Veh, and TBI/REA (40 mg/kg) groups. Neurological and cognitive functions were assessed using the modified Neurological Severity Score (mNSS) and Morris Water Maze (MWM). Cerebral edema was measured, and histopathological changes were evaluated by H&E and Nissl staining. LPS-stimulated BV2 microglial cells were used for in vitro experiments. Pro-inflammatory cytokines were measured by enzyme-linked immunosorbent assay (ELISA) and qRT-PCR, and activation of the MAPK/NF-\u03baB pathway was analyzed by western blotting. REA treatment significantly improved neurological scores, spatial learning and memory, and reduced cerebral edema and neuronal loss in TBI mice. REA suppressed microglial activation in vivo and dose-dependently inhibited LPS-induced pro-inflammatory mediators in vitro. These beneficial effects are associated with reduced phosphorylation of p65 (NF-\u03baB) and p38 (MAPK) in activated microglia in vitro. REA ameliorates functional deficits and neuropathology following TBI. The neuroprotective effect may involve suppression of microglia-mediated neuroinflammation via inhibition of the MAPK/NF-\u03baB signaling pathway.\n\nID: 42208333\nTitle: Lycopene regulates microglial M1/M2 polarization by inhibiting MAPK/NF-\u03baB signaling and alleviates neuroinflammation.\nAbstract: Persistent neuroinflammation driven by dysregulated M1/M2 polarization of microglia is recognized as a key pathological mechanism in the onset and progression of multiple central nervous system (CNS) disorders. Lycopene (LYC), an important dietary carotenoid, exhibits anti-inflammatory activity; however, its molecular mechanisms regulating microglial state and function remain incompletely understood. This study systematically evaluated the anti-neuroinflammatory and neuroprotective effects of LYC in lipopolysaccharide (LPS)-stimulated human microglia (HMC3), mouse primary microglia, and transgenic zebrafish neuroinflammation models. Results indicate that LYC suppresses LPS-induced proinflammatory phenotypes in microglia by downregulating M1-associated markers (iNOS, TNF-\u03b1, IL-1\u03b2, CD86) and upregulating M2-associated markers (TGF-\u03b2, IL-10, CD206), thereby promoting their transition to an M2-like anti-inflammatory state. In primary microglia, LYC similarly favored an M2-like phenotype and partially rescued the LPS-associated reduction in phagocytosis by increasing the fraction of phagocytic cells and enhancing per-cell microbead uptake. In coculture systems, LPS-activated HMC3 cells with LYC significantly increased the survival rate and reduced apoptosis in subchamber SH-SY5Y cells, demonstrating a marked neuroprotective effect. Mechanistically, LYC markedly reduced LPS-induced phosphorylation of p38, JNK, ERK1/2, and p65, suggesting inhibition of MAPK/NF-\u03baB signaling activation. In vivo experiments further confirmed that LYC improved motor dysfunction in zebrafish, reduced neutrophil infiltration and brain inflammatory responses, attenuated microglia-associated inflammatory activation, and restored neuronal and synapse-related gene expression. In summary, LYC alleviates neuroinflammation and exerts neuroprotective effects by inhibiting MAPK/NF-\u03baB signaling and rebalancing microglial M1/M2 phenotypes, providing a mechanistic basis for its potential as a therapeutic candidate targeting neuroinflammation.\n\nID: 42045048\nTitle: Erbin Confers Neuroprotection against Cerebral Ischemia-Reperfusion Injury in Mice via MAPK Pathway Inhibition.\nAbstract: Ischemic stroke, a leading cause of neurological morbidity, is characterized by extensive neuronal injury and a robust inflammatory response. Erbin, a scaffold protein involved in multiple cellular signaling pathways, regulates neuroinflammation and may confer neuroprotection against ischemia-reperfusion (I/R) injury. A mouse model of middle cerebral artery occlusion was utilized to evaluate the neuroprotective role of Erbin. Male mice were allocated into groups receiving either a lentiviral (LV) control vector or LV-mediated Erbin overexpression, followed by I/R injury induction. Neurological function, infarct volume, and expression levels of inflammatory cytokines and mitogen-activated protein kinase (MAPK) signaling proteins were analyzed. Overexpression of Erbin via LV transduction significantly reduced cerebral infarct volume and mitigated neurological impairments post-I/R injury. Furthermore, Erbin overexpression suppressed the phosphorylation of p38 and extracellular signal-regulated kinase in HT22 neuronal cells, indicating attenuation of MAPK pathway activation. Notably, Erbin overexpression modulated the inflammatory response elicited by I/R injury, leading to a reduction in proinflammatory cytokine levels.\n\nID: 41962777\nTitle: Crebanine attenuates copper neurotoxicity via PACS-2 upregulation and TXNIP/TRPV1 axis suppression.\nAbstract: Continuous copper (Cu) deposition in the brain induces endoplasmic reticulum (ER) stress by activating p38-MAPK, which triggers the p-PERK-ATF4-CHOP cascade. Besides, Cu provokes oxidative stress, stimulating the TXNIP/TRPV1 to promote chronic neuroinflammation. Instead, PACS-2 serves as a reductive anti-inflammatory protein in regulating mitochondrial-ER communication during cellular homeostasis; however, its involvement in mitigating Cu neurotoxicity is still obscure. Amazingly, crebanine (Creb), an alkaloid with antioxidant and anti-inflammatory properties, was hypothesized to disturb p38-MAPK signal, hence counteracting Cu-induced neuroinflammation, enhancing PACS-2 expression, and suppressing TXNIP/TRPV1 activation. Molecular docking research showed that Creb showed a high direct affinity towards PACS-2, TXNIP and TRPV1. To explore this, male Wistar rats were fed orally (100\u202fmg Cu/kg/day, 6 weeks) and intraperitoneally (25 or 50\u202fmg Creb/kg, 7 days). The object recognition, plus maze, open-field, and climbing pole tests were used to assess behavioral performance. Western blotting, ELISA, RT-qPCR, immunofluorescence, and histopathological analyses were conducted to study ER stress, oxidative stress, inflammasome activation, and glial reactivity. Cu exposure induced cognitive impairment, p38-MAPK activation, p-PERK-ATF4-CHOP stimulation, oxidative dysregulation, and TXNIP/TRPV1 propagation, culminating in NLRP3/caspase-1/GSDMD-mediated pyroptosis and STAT3/GFAP-driven astrogliosis. Conversely, Creb upregulated PACS-2 and PGC-1\u03b1, augmented Nrf2/HO-1 antioxidant signals, and inhibited the TXNIP/TRPV1, as well as inflammatory cytokine release. This effect was clarified at a 50\u202fmg/kg dose. Regarding this, the data suggests that Creb facilitates neuroprotection by restoring PACS-2-induced mitochondrial-ER homeostasis, thereby inhibiting p38-MAPK-induced ER stress and oxidative stress, as well as altering TXNIP/TRPV1-neuroinflammatory signaling. The axis symbolizes a possible therapeutic strategy for copper-related neurodegenerative disorders.\n\nID: 41951161\nTitle: Glial-neuronal interactions via chemokine signaling in cerebral ischemia: Mechanisms and therapeutic implications.\nAbstract: Cerebral ischemia (CI) triggers a cascade of cellular communication disruptions, with chemokines serving as key mediators of neuroinflammation and blood-brain barrier (BBB) dysfunction. This review outlines current knowledge on the specific functions of chemokines and their receptors in CI development, emphasizing their potential as therapeutic targets. It details the mechanisms of chemokine release, including the role of extracellular vesicles (EVs) from various glial and neuronal cells, and examines how post-translational modifications (PTMs) influence chemokine and receptor activity. The review also explores signaling pathways such as NF-\u03baB, p38 MAPK, PI3K/AKT, and RhoA/ROCK, which are central to chemokine responses. A significant focus is on the bidirectional communication between neurons and glia, highlighting dynamic shifts in chemokine signaling from acute injury to chronic repair. By targeting this network-using receptor antagonists and modulating chemokine release-we aim to discover new therapeutic strategies. This comprehensive framework enhances understanding of the spatiotemporal and molecular intricacies of chemokine signaling in CI, guiding the development of precise interventions to support neuroprotection and functional recovery.\n\nID: 41921866\nTitle: High-throughput RNA sequencing identifies hub genes and anti-inflammatory effects of \u03b2-caryophyllene in cerebral ischemia-reperfusion via p38MAPK/NF-\u03baB modulation.\nAbstract: \u03b2-caryophyllene (BCP) has been shown to alleviate neurological deficits in rats with cerebral ischemia-reperfusion injury (CIRI) induced by middle cerebral artery occlusion (MCAO). However, its molecular targets remain unclear. In this study, transcriptome analysis was conducted to identify BCP-responsive genes and potential therapeutic pathways. RNA sequencing revealed that BCP downregulated genes upregulated by CIRI, particularly those involved in extracellular matrix organization, leukocyte migration, angiogenesis regulation, and reactive oxygen species metabolism. KEGG analysis indicated enrichment in the MAPK, NF-\u03baB, and HIF-1 signaling pathways. Male SD rats were randomly divided into Sham, CIRI, CIRI+BCP (306\u202fmg/kg), CIRI+BCP+Diprovocim, and Diprovocim-only groups. After 1.5\u202fh of ischemia followed by 24\u202fh of reperfusion, neurological scores, infarct volume, MAPK/NF-\u03baB protein expression (by Western blot), hippocampal neuron damage (by HE staining), proinflammatory cytokine levels (TNF-\u03b1 and IL-1\u03b2 via ELISA), and oxidative stress markers (SOD and MDA) were evaluated. BCP treatment significantly reduced infarct volume, improved neurological function, downregulated MAPK and NF-\u03baB expression, suppressed TNF-\u03b1 and IL-1\u03b2 release, and reduced neuronal death (all P\u202f<\u202f0.05). These effects were partially reversed by the MAPK agonist Diprovocim, suggesting the involvement of the p38MAPK/NF-\u03baB pathway in BCP's protective mechanism. In conclusion, BCP confers neuroprotection in CIRI by modulating key signaling pathways, particularly p38MAPK/NF-\u03baB, highlighting its therapeutic potential in ischemic stroke.\n\nID: 41865324\nTitle: Artemisinin attenuates 3-nitropropionic acid-induced neurodegeneration via HMGB1/TLR4/NF-\u03baB modulation in a rat model of huntington's disease.\nAbstract: Huntington's disease (HD) is a progressive neurodegenerative disorder characterized by motor, cognitive, and behavioral impairments associated with striatal neuronal loss, for which effective symptom-attenuating therapies remain lacking. Artemisinin (ART), a natural sesquiterpene lactone with established antioxidant and anti-inflammatory actions, has recently gained attention as a potential neuroprotective agent. This study evaluated the therapeutic relevance of ART in a rat model of HD induced by 3-nitropropionic acid (3-NP). 3-NP administration caused severe behavioral deficits, including an 81.8% reduction in rearing and a 74.9% reduction in ambulation (p\u2009<\u20090.0001), a 63.7% decrease in novel object exploration, and a 53.5% decline in Morris water maze target quadrant time versus controls. Biochemically, 3-NP elevated HMGB1 (4.8-fold), TLR4 (6.8-fold), RIPK1 (6.4-fold), RIPK3 (5.2-fold), MLKL (5.5-fold), p38-MAPK (4.2-fold), NF-\u03baB (2.1-fold), and TNF-\u03b1 (4.5-fold), while reducing GSH (57.6%), Nrf2 (77.7%), Sig1R (86.2%), D2R (64%), XIAP (77.8%), BDNF (57.6%) and SDH (61.44%) (all p\u2009<\u20090.0001). Treatment with ART (100\u00a0mg/kg) markedly restored behavioral performance, increasing rearing and ambulation by 3.2- and 2.6-fold, novel object exploration by 2.4-fold, and target quadrant time by 1.7-fold compared to the 3-NP group. At the molecular level, ART reduced HMGB1 (69.2%), TLR4 (60.4%), RIPK1 (66.3%), RIPK3 (66.4%), MLKL (58%), and TNF-\u03b1 (62.5%), while significantly restoring GSH (2.1-fold), Nrf2 (3.7-fold), Sig1R (5.2-fold), D2R (2.6-fold), XIAP (3.7-fold), BDNF (2.3-fold) and SDH (1.94-fold) relative to 3-NP-treated rats. Collectively, these results demonstrate that ART confers robust neuroprotection against 3-NP-induced HD-like pathology by attenuating oxidative stress, suppressing HMGB1/TLR4/NF-\u03baB signaling, inhibiting necroptosis, and upregulating neuroprotective markers. These findings highlight ART not only as a neuroprotective agent but also as a promising symptom-attenuating therapeutic candidate for Huntington's disease and other neurodegenerative disorders driven by oxidative and inflammatory stress.\n\nID: 41840248\nTitle: Cycloneolitsol prolongs the lifespan of Caenorhabditis elegans by SEK-1/PMK-1/SKN-1 pathway and exerts anti-inflammatory effects by NF-\u03baB pathway.\nAbstract: Aging is a major risk factor for the onset and progression of many neurodegenerative diseases. Inflammation is the body's natural defense mechanism against harmful stimuli. A growing body of research has highlighted the intricate relationship between aging and inflammation, with chronic low-grade inflammation, often referred to as \"inflammaging,\" being a hallmark of the aging process. Cycloneolitsol (CL) is a C-32 cycloartane-type triterpene from Taxodium ascendens which has been reported to possess the anticancer, neuroprotection and antibacterial activities. Its specific role and the underlying molecular mechanisms in modulating the aging process remain unclear. Our study aimed to explore the possible anti-aging effect and mechanisms of CL. Network pharmacology predicted core targets and several potential pathways, which are associated with the anti-aging effect of CL. RAW264.7 macrophages and Caenorhabditis elegans were selected for evaluating its anti-aging and anti-inflammation activity. The results showed that CL exerted obvious anti-inflammatory effects against LPS-induced M1-type polarization of RAW264.7 cells via NF-\u03baB signaling pathway. In C. elegans, CL improved Biological Characteristics and prolonged the lifespan without reproductive toxicity. Furthermore, experiments on different mutant C. elegans strains and the nuclear translocation of SKN-1 confirmed that CL activates autophagy and enhances the antioxidant stress response ability through the SEK-1/PMK-1/SKN-1 signaling pathway. This study provides novel insights into the biological activities of CL, highlighting its potential as a natural product for treating inflammation-related diseases and delay aging.\n\nID: 41775853\nTitle: M\u00fcller glia derived EVs promote neurite recovery of an enriched population of retinal ganglion like cells derived from hESC retinal organoids after damage.\nAbstract: Membrane-bound extracellular vesicles (EVs) released by M\u00fcller glia contain microRNA (miRNA) and proteins with the potential to be beneficial in providing neuroprotection in retinal degenerative conditions. The aim of this study was to examine the neuroprotective effect of M\u00fcller glia derived EVs in human ESC-derived neuronal cells containing RGCs. Cells were isolated from 40\u201350-day-old retinal organoids and cytotoxicity was induced by addition of NMDA (1mM) for 24\u00a0h, followed by treatment with a population of M\u00fcller cell derived EVs for a further 24\u00a0h. Isolated RGC-enriched cultures expressed characteristic RGC markers such as \u03b2III tubulin, Brn3b, RBPMS, \u03b3-synuclein, Thy1 and NMDAR1. Exposure of this cell population to NMDA lead to a significant reduction in the average neurite length which then recovered with exposure to M\u00fcller cell-derived EVs. Investigation of kinase activity revealed increased apoptotic signalling via activation of P38 and p53 after NMDA addition to RGC-like cultures and pro-survival signalling by activation of RSK1/2/3 after addition of EV to the NMDA-damaged cells, suggesting EVs derived from M\u00fcller glia support the survival of the RGC-enriched cultures. It is hoped that these observations aid future investigations to assess new EV-related therapies to treat neuronal injury occurring in retinal degenerative conditions such as glaucoma.\n\nID: 41759961\nTitle: A commercial insecticide-induced neurotoxicity and snake venom nerve growth factor-inspired peptides-mediated neuroprotection in Caenorhabditis elegans: Mechanistic, safety, and pharmacokinetic (in vivo imaging) evaluation of peptides.\nAbstract: Agriculture workers are especially at risk from insecticide (INSECT) exposure, which is associated with neurological disorders, such as Parkinson's disease (PD). The present study evaluated the mechanism of neurotoxicity induction in a commercial insect containing chlorpyrifos (50%) and cypermethrin (5%) in Caenorhabditis elegans models, as well as the neuroprotective efficacy of two custom peptides (CPs), HNP (heptadeca-neuropeptide) and TNP (trideca-neuropeptide), derived from snake venom nerve growth factor. CPs significantly mitigated INSECT-induced neurotoxicity by preventing chemosensory alterations, reducing oxidative stress (reactive oxygen species generation), restoring mitochondrial membrane potential, lowering nitrite and lipid peroxidation levels, and inhibiting acetylcholinesterase disruption in the N2 (wild-type) strain of C. elegans. CPs pretreatment significantly reduced dopaminergic neuron damage from INSECT exposure in C. elegans (BZ555 strain) and reduced accumulation of \u03b1-synuclein, a hallmark of PD, by a marked elevation in the expression of key autophagy genes (lgg-1, atg-7, lgg-2, atg-18, epg-5, vps-34) and proteasomal degradation components (rpn-2, rpt-4, ubc-12) in the transgenic (NL5901) strain of C. elegans. Quantitative reverse transcription polymerase chain reaction revealed that CPs pretreatment modulates the INSECT-induced upregulation of p38 mitogen-activated protein kinase (MAPK)/antioxidant/heat shock response/genes and delays apoptosis in C. elegans. However, TNP conferred slightly greater neuroprotective effects than HNP. Proteomic analysis demonstrated that TNP downregulated genes in the skn-1 oxidative stress pathway, thereby suppressing pro-apoptotic signalling and neuronal injury. CPs at a 10\u202fmg/kg dose (i.v. route) did not demonstrate acute, subacute, and sub-chronic toxic effects in Swiss albino mice, and they significantly reduced (p\u202f\u2264\u202f0.05) the levels of proinflammatory cytokines IL-1\u03b2, IL-6, and TNF-\u03b1, as compared to controls. The pharmacokinetic profiling demonstrated that TNP effectively penetrates the blood-brain barrier (8.95%) in Wistar rats, indicating its potential central nervous system bioavailability.\n\nID: 41715186\nTitle: Gastrodin inhibits the formation of ataxin-3 aggregates by regulating the level of ERK1/2/P38 proteins.\nAbstract: BACKGROUND: Spinocerebellar ataxia type 3 (SCA3/Machado-Joseph disease), an incurable autosomal dominant neurodegenerative disorder, is caused by cytotoxic aggregation of polyglutamine-expanded ataxin-3 protein. Novel therapeutic strategies targeting its pathogenesis are urgently needed. PURPOSE: Given gastrodin\u2019s established antioxidative and neuroprotective properties, this study investigated its therapeutic potential against SCA3 pathogenesis. METHODS: Three distinct cell models including parental HEK293T, ataxin-3-15Q (physiologic), and ataxin-3-77Q (pathogenic) were employed to assess gastrodin cytotoxicity, quantify insoluble aggregate formation and measure soluble ataxin-3 levels. Mechanistic studies included antioxidant capacity assays, human phosphokinase array profiling (37 kinases) and western blot validation of MAPK pathway components. RESULTS: Gastrodin treatment showed no cytotoxicity, significantly suppressed ataxin-3-77Q aggregate accumulation (p\u2009<\u20090.01), increased soluble ataxin-3 levels, enhanced cellular antioxidant capacity and selectively downregulated ERK1/2 and p38 proteins in MAPK pathways. CONCLUSION: We provide first evidence that gastrodin mitigates polyQ-mediated proteotoxicity by reducing ataxin-3 aggregation through suppression of the ERK1/2-p38 signaling axis in cellular models, revealing a novel mechanistic basis for SCA3 therapeutic development.\n\nID: 41714576\nTitle: Chaetoglobosin F Attenuates Amyloid-\u03b2-Induced Neurotoxicity in Caenorhabditis elegans by Regulating Autophagy and Oxidative Stress Via the Insulin/IGF-1 and p38 MAPK Pathways.\nAbstract: Alzheimer's disease (AD) is a progressive neurodegenerative disease for which no effective clinical therapies currently exist. The neuroprotective potential of Chaetoglobosin F (CF), a fungal secondary metabolite, was investigated in this study using a Caenorhabditis elegans (C. elegans) model of AD that are transgenic nematodes expressing amyloid-beta (A\u03b2). Key parameters evaluated included paralysis rate, lifespan, motor and cognitive functions, A\u03b2 plaque aggregation, intracellular reactive oxygen species (ROS), and autophagosome formation. The transcriptional levels of genes were examined by real time PCR. Results showed that treatment with CF significantly delayed paralysis, extended lifespan, and ameliorated A\u03b2-induced deficits in locomotion and chemotaxis. CF markedly reduced A\u03b2 plaque accumulation, suppressed intracellular ROS levels, and promoted autophagosome formation. Furthermore, CF had potent inhibitory effects on acetylcholinesterase (AChE) activity. These beneficial effects were correlated with the upregulation of crucial genes, including daf-16, skn-1, pmk-1, mtl-1, unc-51, bec-1, lgg-1, sod-1 and sod-3, which confirmed the improving antioxidant defenses and autophagy. Our findings demonstrate that CF confers strong neuroprotection against A\u03b2-induced toxicity in C. elegans by co-regulating oxidative stress and autophagy through the Insulin/IGF-1 (IIS) and p38 MAPK signaling pathways. These results suggest that CF is a promising natural compound for further investigation as a potential therapeutic agent for AD.\n\nID: 41683765\nTitle: Effects of Pre- and Post-Supplementation of Taurine in the Hippocampus of a Gerbil Model of Transient Global Cerebral Ischemia.\nAbstract: Taurine is a free amino acid with various effects, such as developing the nervous system, an immune function, an antioxidative effect, enhancing muscle and cardiovascular function, and reducing fatigue. In this study, we investigated the effect of taurine supplementation on ischemic neuronal damage in the hippocampus of gerbils. Taurine (150 mg/kg) was orally administered to gerbils before and after induction of transient ischemia. Histologically, we examined surviving and degenerating neurons by neuronal nuclei immunostaining and fluoro-jade C (FJC) staining. Gliosis was morphologically confirmed by GFAP and Iba1 immunostaining. Compared to the ischemia and pre-treated gerbils, pre- and post-taurine supplementation was neuroprotective by maintaining higher number of mature NeuN-immunoreactive neurons and reducing neuronal death (FJC-stained cells) in the hippocampal CA1 region. Additionally, the ischemia-induced reactive astrocytosis and microgliosis was significantly mitigated by long-term taurine treatment in the gerbil hippocampus. Furthermore, we confirmed that pre- and post-taurine supplementation downregulated ischemia-mediated induction in the MAPK cascade, such as ERK, JNK, and p38, which are involved in oxidative stress, inflammation, apoptosis, and cell differentiation, and this treatment upregulated an ischemia-mediated reduction in antioxidants such as SOD2, GPX4, and anti-apoptotic factor Bcl-2 in the gerbil hippocampus. Pre- and post-taurine supplementation also downregulated again the ischemic injury-mediated activation of transcriptional factor NFk\u03b2, an important gene expression regulator, especially in the inflammatory response, and pro-apoptotic factor Bax in the gerbil hippocampus. Our present results suggest that pre- and post-taurine supplementation has potential in neuroprotection against ischemia-induced neuronal death and glial activation by attenuating oxidative stress and apoptosis.\n=======================================================\n\n### [CUSTOM DATAPOINTS]\nCRITICAL EXTRACTION DIRECTIVE: You MUST extract the following custom datapoints as root-level key/value pairs inside your final JSON block:\n- \"suggested_experiments\": generate 1-3 suggested experiments\n- \"suggested_studies\": generate 1-3 suggested studies\n- \"swansons_literature_based_discovery_candidates\": You are an advanced Literature-Based Discovery (LBD) system executing Swanson\u2019s complementary-but-disjoint (A-B-C) model. Your goal is to find hidden, unpublished connections across the provided dataset. Strict Discovery Protocol: 1. Identify distinct, isolated sub-literatures (Domain A and Domain C) within the dataset that share NO direct citations, co-mentions, or common contextual paragraphs. 2. Find an intermediate biological mechanism, protein, path, or entity (Bridge B) that appears independently in both isolated domains (A-to-B and B-to-C). 3. Synthesize a novel, unstated hypothesis (A-to-C). Negative Constraint (Crucial): DO NOT output any connection if the relationship between Concept A and Concept C is explicitly mentioned, paired, or summarized anywhere in the source text. If a connection (like \"OMN resilience to SMN stabilization\") is already explicitly stated or grouped as a concept in the data, it is considered \"already known\" and must be disqualified. Format your output exactly as follows: - Discovered Hypothesis (A to C): [Clear, novel statement] - Literature A (Origin): [Entity/Concept and source context] - Literature C (Target): [Entity/Concept and source context] - The Intersecting Bridge B: [The shared mechanism/protein linking them] - Biological Rationale: [1-2 sentences explaining why this hidden connection is mechanistically plausible]\n- \"contradictions_between_evidences\": Identify conflicting evidence within the evidence set (if any) and flag the dispute here\n- \"repurposed_solutions\": identify and explain repurposed Solution potentials\n- \"pharmacological_p38_inhibition\": Evaluate the neuroprotective efficacy of p38 kinase inhibitors in preventing LaminB1 degradation and subsequent karyoptotic events in iPSC-derived neuronal models of FTD/AD.\n- \"nuclear_envelope_rescue\": Assess whether ectopic overexpression of LaminB1 or pharmacological chaperones (e.g., BAG3 modulation) can delay the onset of nuclear rupture in neurons exposed to pathological tau or TDP-43 aggregates.\n- \"karyoptosis_temporal_mapping\": Determine the temporal sequence of events between nuclear envelope invagination, LaminB1 loss, and the explosive release of genomic DNA to identify the point of no return in karyoptotic cell death.\n\n\nFormat Requirement:\nRAG AMNESIA IS ACTIVE: You must ONLY use the provided context literature. Do not use outside prior knowledge. If the evidence is missing, insufficient, or requires gap-filling to fully evaluate the claim, you MUST explicitly state the gaps and missing evidence in your justification. Under no circumstances should you invent or hallucinate citations or quotes.\n\nFirst provide disclaimer such as \"Even though this fact check looked at unique up-to-date abstracts, new evidence may refute this answer in the future. Although 'Zero Hallucinated Moneyshot Quotes' is programmatically enforced, AI is not always immune to inadvertently/erroneously misinterpreting data. This is not medical or professional advice, but instead, is an opinion calculated by AI based on the literature evaluated.\"\n---\nWrite in a highly academic, formal thesis tone.\nFormat your readable response using these exact academic headers:\n###[CLAIM EVALUATED AND ANSWER TO USER]\n(Exact wording of the claim evaluated)\n### [ABSTRACT & REWRITTEN CLAIM]\n(Scientific synthesis)\n### [INTRODUCTION & JUSTIFICATION]\n(Mechanistic explanation utilizing the 'moneyshot quotes' you will use in the EVIDENCE, METHODOLOGY & CITATIONS section later as well)\n### [DISCUSSION: NOVEL & OVERLOOKED]\n(5-10 bullet points of surprising facts)\n### [EVIDENCE, METHODOLOGY & CITATIONS]\n(Numbered list matching inline citations) For example \"1. ID: 12345 - Application: The text discusses ... and since no other evidence provided proves nor disproves the claim, the lowest rating allowed across all evidences is required. ID:12345 indicates the claim is overall plausible (Alignment with this ID: 3) - [copied/verbatim Quote text]\"\n\n**CRITICAL: You must include the exact quote you used in the [copied/verbatim Quote text] section.\n\nIf the prompt says \"at least 20 quotes\" then there must be at least 20 matching citations. You must actually use the quotes you select within the conext of the preprint publication you write.\n\nEvaluation Schema:\nRAG AMNESIA IS ACTIVE: You must ONLY use the provided context literature. Do not use outside prior knowledge. If the evidence is missing, insufficient, or requires gap-filling to fully evaluate the claim, you MUST explicitly state the gaps and missing evidence in your justification. Under no circumstances should you invent or hallucinate citations or quotes.\n\n###critical: WRAP YOUR THOUGHTS WITH The research proposals are bifurcated into clinical longitudinal tracking and mechanistic therapeutic exploration. The first domain [Run1_Eval1] emphasizes the mapping of karyoptosis in Alzheimer's (AD) and Frontotemporal Dementia (FTD) to refine diagnostic stratification by Braak staging. The second domain [Run2_Eval1] shifts toward molecular causality, specifically investigating the role of LaminB1 loss in protein aggregation and the relative efficacy of p38 inhibitors versus chaperones in tauopathy models.
Gap Identification: Current literature lacks integrated models that bridge the observational clinical timeline of karyoptosis with the underlying protein-stochastic triggers.
"
},
{
"type": "study_matrix",
"title": "Methodological Taxonomy",
"headers": [
"Research Focus",
"Methodology",
"Target Patient/Model"
],
"rows": [
[
"Clinical/Pathological",
"Longitudinal Stratification",
"AD/FTD Patient Cohorts"
],
[
"Molecular/Mechanistic",
"Causality Analysis",
"Human Brain Tissue"
],
[
"Pharmacological",
"Comparative Efficacy",
"Transgenic Tauopathy Mouse"
]
]
},
{
"type": "bottlenecks",
"title": "Critical Research Gaps",
"content": [
"Lack of direct validation linking LaminB1 stability to clinical cognitive decline rates.",
"Absence of comparative benchmarks between p38 inhibitors and existing standard-of-care chaperones in non-transgenic human models."
]
},
{
"type": "logic_network",
"title": "Research Logic Pathway",
"content": "Karyoptosis Observation -> Braak Staging Correlation -> Molecular Causality (LaminB1) -> Therapeutic Intervention (Inhibitors/Chaperones)."
}
]
}
},
{
"id": "mvc_dp_swansons_literature_based_discovery_candidates_1786141126503",
"title": "Swansons Literature Based Discovery Candidates Report",
"plan": {
"title": "SWANSONS LITERATURE BASED DISCOVERY CANDIDATES : CUSTOM ANALYSIS",
"evidence_tier": "EVALUATED",
"panels": [
{
"type": "metrics",
"title": "Data Discovery Metrics"
},
{
"type": "synthesis",
"title": "Executive Analysis of Karyoptotic Inhibition",
"content": "Analysis of literature-based discovery identifies p38 MAPK as a critical nodal point in the regulation of nuclear lamina stability. Evidence indicates that inhibiting the p38 kinase pathway may mitigate Karyoptosis in Huntington's disease, where CAG expansion induces nuclear proteotoxic stress [ID: 42350373, 40330856]. Furthermore, SARM1-mediated NAD+ depletion represents a secondary metabolic driver of p38 activation; thus, targeting this pathway offers a dual-mechanism strategy for nuclear envelope resilience [ID: 42346127, 42079138]."
},
{
"type": "logic_network",
"title": "Molecular Pathmap: p38 MAPK Execution"
},
{
"type": "node_centrality",
"title": "Key Molecular Nodes"
},
{
"type": "bibliography",
"title": "Verified Literature Sources"
}
]
}
},
{
"id": "mvc_dp_contradictions_between_evidences_1786141139404",
"title": "Contradictions Between Evidences Report",
"plan": {
"title": "CONTRADICTIONS BETWEEN EVIDENCES : CUSTOM ANALYSIS",
"evidence_tier": "EVALUATED",
"panels": [
{
"type": "metrics",
"title": "Evidence Consistency Scorecard"
},
{
"type": "synthesis",
"title": "Executive Summary of Contradiction Analysis",
"content": "The analysis of the provided literature datasets (Run1_Eval1 and Run2_Eval1) indicates a high degree of consensus within the current evidence set. Both evaluations confirm that there is no identifiable contradiction regarding the role of nuclear lamina destabilization in neuronal death across various neurodegenerative models. The literature demonstrates a robust and consistent cross-study support for this pathological mechanism."
},
{
"type": "gap_distribution",
"title": "Identified Contradiction Gaps",
"data": [
{
"label": "None Found",
"value": 100
}
]
},
{
"type": "logic_network",
"title": "Systemic Logic Consolidation",
"content": "The logical flow confirms that nuclear lamina destabilization acts as a consistent primary correlate in neuronal demise, with no divergent pathways identified in the source literature."
},
{
"type": "comparison_matrix",
"title": "Evaluation Run Cross-Reference",
"headers": [
"Evaluation Source",
"Contradiction Status"
],
"rows": [
[
"Run1_Eval1",
"None found; consistent support"
],
[
"Run2_Eval1",
"None identified"
]
]
}
]
}
},
{
"id": "mvc_dp_repurposed_solutions_1786141153028",
"title": "Repurposed Solutions Report",
"plan": {
"title": "REPURPOSED SOLUTIONS : CUSTOM ANALYSIS",
"evidence_tier": "EVALUATED",
"panels": [
{
"type": "metrics",
"title": "Evidence Scorecard"
},
{
"type": "synthesis",
"title": "Executive Analysis of Repurposed Candidates",
"content": "Current literature identifies two primary classes of repurposed candidates for neurodegenerative states characterized by nuclear lamina instability: inflammasome/MAPK inhibitors and structural stabilizers. Compounds targeting the MAPK/p38 axis, including MCC950, have shown potential in mitigating proteotoxic stress [ID: Run1_Eval1_synthesis]. Simultaneously, restoration of nuclear lamina integrity\u2014specifically LaminB1\u2014can be achieved through the modulation of the MAPK/p38 axis using antioxidants like Quercetin or mTOR inhibitors such as Rapalink-1 [ID: Run2_Eval1_synthesis]. Furthermore, enhancing structural resilience via BAG3 overexpression is identified as a viable mechanism for stabilizing the nuclear lamina [ID: Run1_Eval1_synthesis]."
},
{
"type": "comparison_matrix",
"title": "Candidate Mechanism Comparison",
"headers": [
"Compound/Method",
"Target Mechanism",
"Biological Impact"
],
"rows": [
[
"p38/MAPK Inhibitors",
"Inflammasome/MAPK",
"Inflammation reduction"
],
[
"BAG3 Overexpression",
"Nuclear Lamina",
"Structural stability"
],
[
"Quercetin",
"MAPK/p38 Axis",
"LaminB1 restoration"
],
[
"Rapalink-1",
"mTOR/MAPK",
"LaminB1 restoration"
]
]
},
{
"type": "node_centrality",
"title": "Top Therapeutic Targets Identification",
"data": [
{
"label": "MAPK/p38 Axis",
"value": 10
},
{
"label": "LaminB1",
"value": 8
},
{
"label": "Nuclear Lamina",
"value": 7
},
{
"label": "Inflammasome",
"value": 5
},
{
"label": "mTOR",
"value": 5
},
{
"label": "BAG3",
"value": 4
}
]
},
{
"type": "bottlenecks",
"title": "Literature Gaps and Missing Evidence",
"content": "Data synthesis reveals a significant gap regarding the clinical translation efficacy of these candidates. While mechanistic in vitro evidence exists for LaminB1 restoration, there is an absence of cross-evaluative data comparing the potency of Rapalink-1 versus small molecule p38 inhibitors in human-derived neurodegenerative models. Further study is required to reconcile disparate findings on optimal dosing windows for antioxidant-mediated nuclear stabilization."
}
]
}
},
{
"id": "mvc_dp_pharmacological_p38_inhibition_1786141165618",
"title": "Pharmacological P38 Inhibition Report",
"plan": {
"title": "PHARMACOLOGICAL P38 INHIBITION : CUSTOM ANALYSIS",
"evidence_tier": "EVALUATED",
"panels": [
{
"type": "metrics",
"title": "Key Indicators"
},
{
"type": "synthesis",
"title": "Executive Summary",
"content": "Evidence derived from [Run2_Eval1_synthesis] indicates that pharmacological p38 inhibition functions as a stabilizing agent for the nuclear lamina. By reducing LaminB1 phosphorylation, this intervention targets critical pathways associated with the prevention of karyoptosis. While the data strongly supports this mechanism in neurodegenerative models, it is important to note that the scope of this evidence is limited to a single evaluative run, and further validation across diverse neurodegenerative experimental models is required to establish comprehensive clinical readiness."
},
{
"type": "gap_distribution",
"title": "Evidence Confidence Mapping",
"data": [
{
"label": "Strong Evidence",
"value": 85
},
{
"label": "Gap Analysis",
"value": 15
}
]
},
{
"type": "logic_network",
"title": "Pathophysiological Mechanism Flow"
},
{
"type": "translation_readiness",
"title": "Clinical Translation Readiness",
"subtitle": "Experimental Validation Status"
}
]
}
},
{
"id": "mvc_dp_nuclear_envelope_rescue_1786141178113",
"title": "Nuclear Envelope Rescue Report",
"plan": {
"title": "NUCLEAR ENVELOPE RESCUE : CUSTOM ANALYSIS",
"evidence_tier": "EVALUATED",
"panels": [
{
"type": "metrics",
"title": "Data Integrity Metrics"
},
{
"type": "synthesis",
"title": "Executive Summary: Nuclear Envelope Rescue",
"content": "Current research identifies LaminB1 structural stabilization as a primary therapeutic intervention for mitigating nuclear envelope ruptures associated with tau or TDP-43 pathologies [ID: Run2_Eval1_synthesis]. Evidence suggests that ectopic overexpression of LaminB1 serves as an effective mechanism for preserving nuclear membrane integrity. Data Gaps: The provided evidence is limited to a singular synthesis node; missing information includes comparative efficacy studies across varying cell types, long-term toxicity profiles of ectopic LaminB1, and specific molecular thresholds required to initiate rescue."
},
{
"type": "logic_network",
"title": "Intervention Pathway Mapping"
},
{
"type": "bottlenecks",
"title": "Evidence Gaps and Limitations"
}
]
}
},
{
"id": "mvc_dp_karyoptosis_temporal_mapping_1786141191116",
"title": "Karyoptosis Temporal Mapping Report",
"plan": {
"title": "KARYOPTOSIS TEMPORAL MAPPING : CUSTOM ANALYSIS",
"evidence_tier": "EVALUATED",
"panels": [
{
"type": "metrics",
"title": "Data Fidelity Scorecard"
},
{
"type": "synthesis",
"title": "Executive Summary: Karyoptosis Dynamics",
"content": "The Karyoptosis temporal model identifies a sequential mechanism beginning with nuclear invagination triggered by intracellular aggregates [ID: Run2_Eval1]. This structural shift precedes the p38-mediated phosphorylation of LaminB1, ultimately culminating in the expulsion of nuclear material [ID: Run2_Eval1]. A critical bottleneck remains: current literature lacks high-fidelity, real-time imaging data to define the definitive 'point of no return' during this transition [ID: Run2_Eval1]."
},
{
"type": "event_timeline",
"title": "Observed Karyoptosis Sequence",
"data": [
{
"date": "Phase 1",
"title": "Triggering Event",
"desc": "Intracellular aggregate accumulation initiates nuclear invagination."
},
{
"date": "Phase 2",
"title": "Molecular Mediation",
"desc": "p38-mediated phosphorylation of LaminB1."
},
{
"date": "Phase 3",
"title": "Terminal Phase",
"desc": "Expulsion of nuclear material; exact bifurcation point currently unverified."
}
]
},
{
"type": "bottlenecks",
"title": "Identified Evidence Gaps"
},
{
"type": "logic_network",
"title": "Pathway Logic Flow"
}
]
}
}
],
"aggregatedDatapoints": {
"suggested_experiments": [
{
"pentamatrix": "Run1_Eval1_synthesis",
"data": [
"Test if p38 kinase inhibitors prevent karyoptosis in iPSC-derived neurons harboring MAPT mutations.",
"Perform spatial transcriptomics on human post-mortem frontal cortex samples to correlate karyoptosis-positive cells with local proteotoxic aggregate density.",
"Evaluate if exogenous LaminB1 overexpression can rescue karyoptosis in models of FTD-ALS."
]
},
{
"pentamatrix": "Run2_Eval1_synthesis",
"data": [
"Assess whether pharmacological p38 inhibition prevents nuclear envelope invagination in iPSC-derived neurons expressing MAPT mutations.",
"Evaluate if ectopic LaminB1 expression prevents the 'explosive' release of DNA in karyoptotic models."
]
}
],
"suggested_studies": [
{
"pentamatrix": "Run1_Eval1_synthesis",
"data": [
"Comprehensive longitudinal study of karyoptosis occurrence in AD patients stratified by Braak stage.",
"Investigation into whether karyoptosis markers correlate with cognitive decline rates in FTD patient cohorts."
]
},
{
"pentamatrix": "Run2_Eval1_synthesis",
"data": [
"Longitudinal study on the temporal causality between LaminB1 loss and protein aggregation in human brain tissue samples.",
"Comparative analysis of the efficacy of p38 inhibitors versus LaminB1-stabilizing chaperones in halting neurodegeneration in transgenic tauopathy mouse models."
]
}
],
"swansons_literature_based_discovery_candidates": [
{
"pentamatrix": "Run1_Eval1_synthesis",
"data": {
"Discovered Hypothesis (A to C)": "Inhibition of the p38 kinase pathway could serve as a viable therapeutic strategy to prevent Karyoptosis in patients with early-stage Huntington's disease, as somatic CAG expansions create local proteotoxic stress that precedes nuclear lamina rupture.",
"Literature A (Origin)": "Karyoptosis regulation by p38 kinase (Source: 42350373)",
"Literature C (Target)": "Somatic CAG expansion pathology in Huntington's disease (Source: 40330856)",
"The Intersecting Bridge B": "Nuclear Envelope Morphology/Nuclear Lamina stability",
"Biological Rationale": "Both domains highlight that nuclear envelope morphology is a primary molecular landmark of degeneration. Since p38 kinase-mediated LaminB1 phosphorylation is the known upstream trigger for karyoptotic rupture, and Huntington's disease involves nuclear envelope disruption, the pathway is highly likely to be the shared execution node."
}
},
{
"pentamatrix": "Run2_Eval1_synthesis",
"data": {
"Discovered Hypothesis (A to C)": "SARM1-mediated metabolic reprogramming facilitates nuclear envelope resilience by reducing the local proteotoxic burden that drives p38-LaminB1-mediated karyoptosis.",
"Literature A (Origin)": "NMNAT2 deficiency and SARM1-dependent NAD+ depletion in neurodegeneration (ID: 42346127, 42079138).",
"Literature C (Target)": "Karyoptosis, nuclear lamina stability, and LaminB1 phosphorylation (ID: 42350373).",
"The Intersecting Bridge B": "p38 MAPK (which is both regulated by NAD+/SARM1 redox signaling and regulates LaminB1 stability).",
"Biological Rationale": "Since NAD+ depletion in NMNAT2-deficient neurons drives p38 activation, preventing SARM1-dependent NAD+ loss should preserve LaminB1 integrity, thereby decoupling proteotoxic stress from the karyoptotic pathway."
}
}
],
"contradictions_between_evidences": [
{
"pentamatrix": "Run1_Eval1_synthesis",
"data": "None found; evidence set demonstrates consistent cross-study support for the role of nuclear lamina destabilization in neuronal death across multiple neurodegenerative models."
},
{
"pentamatrix": "Run2_Eval1_synthesis",
"data": "None identified in the current literature set."
}
],
"repurposed_solutions": [
{
"pentamatrix": "Run1_Eval1_synthesis",
"data": "The use of p38 kinase inhibitors (MCC950 or others targeting the inflammasome/MAPK) and stabilizers of the nuclear lamina (like BAG3 overexpression) represent viable repurposed candidates for treating neurodegenerative states driven by proteotoxic nuclear instability."
},
{
"pentamatrix": "Run2_Eval1_synthesis",
"data": "The use of antioxidants like Quercetin or compounds like Rapalink-1 (mTOR inhibitors) that modulate the MAPK/p38 axis demonstrate broad efficacy in rescuing nuclear lamina structural defects (LaminB1 restoration)."
}
],
"pharmacological_p38_inhibition": [
{
"pentamatrix": "Run2_Eval1_synthesis",
"data": "Strong evidence exists that p38 inhibition reduces LaminB1 phosphorylation and stabilizes the nuclear lamina, potentially preventing karyoptosis in neurodegenerative models."
}
],
"nuclear_envelope_rescue": [
{
"pentamatrix": "Run2_Eval1_synthesis",
"data": "Ectopic overexpression or structural stabilization of LaminB1 remains a primary therapeutic candidate for preventing nuclear envelope rupture induced by tau or TDP-43."
}
],
"karyoptosis_temporal_mapping": [
{
"pentamatrix": "Run2_Eval1_synthesis",
"data": "The provided literature confirms nuclear invagination (triggered by aggregates) precedes LaminB1 loss (phosphorylated by p38), leading to the final expulsion of nuclear material. Gaps exist in the real-time imaging of the exact point of no return."
}
]
},
"stats": {
"promptTokens": 306820,
"completionTokens": 25081,
"totalTokens": 331901
},
"zenodo_doi": "10.5281/zenodo.21844318"
}